Regulation of glutamatergic AMPA receptor stability and trafficking by ubiquitination by Lin, Amy Wei Pey
Boston University
OpenBU http://open.bu.edu
Theses & Dissertations Boston University Theses & Dissertations
2013
Regulation of glutamatergic AMPA
receptor stability and trafficking by
ubiquitination
https://hdl.handle.net/2144/13152
Boston University
 
 
BOSTON UNIVERSITY 
GRADUATE SCHOOL OF ARTS AND SCIENCES 
 
 
Dissertation 
 
 
REGULATION OF GLUTAMATERGIC AMPA RECEPTOR STABILITY AND 
TRAFFICKING BY UBIQUITINATION 
 
by 
 
AMY WEI PEY LIN 
B.S., University of California at Los Angeles, 2003 
 
 
 
 
Submitted in partial fulfillment of the 
requirements for the degree of 
Doctor of Philosophy 
2013  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© Copyright by 
    AMY LIN 
    2013 
 
 
Approved by 
 
 
 
 
 
 
First Reader  ________________________________________________ 
    Hengye Man, M.D., Ph.D. 
    Associate Professor of Biology 
 
 
 
Second Reader ________________________________________________ 
         Angela Ho, Ph.D. 
         Assistant Professor of Biology 
 
iv 
 
Acknowledgements 
 
To everyone at Boston University, thank you so much.  To my thesis 
committee: Dr. Eldred, Dr. McCall, Dr. Lin, Dr. Man and Dr. Ho, thank you for 
your guidance throughout these years and your invaluable knowledge, 
suggestions and advice.  Dr. Man, thank you for your mentorship and patience, 
and for the opportunity to learn from you – it has been a privilege.  To members 
of the Man Lab, past and present, how do I even begin to thank you for 
everything?  I’ve been so honored to work with all of you.  Cheers! 
Many thanks to those who started me out on this journey – to Dr. Ellen 
Carpenter, thank you for setting a gold standard for a novice scientist and 
continuing to be both friend and mentor.  At last, it’s high tide – time to move out 
into the world.  To Dr. Lisa Ellerby, thank you for giving me the chance to work 
with you at the Buck Institute – everything I know about molecular biology, I 
learned because of you.  To my friends from the Buck, thank you for always 
making me smile.  I’m so thankful to have you in my life – Sylvia, Cameron, 
Michelle, Greg, Kally, John, Sandra.   
To the dear friends from all those little moments in my life, who have 
listened to me and fed me (Niko, LJay, Mary, Lisa), discussed games, WD and 
other craziness with me (“Yamato”, Greg, John) and continue to roll their eyes at 
me daily (Vince, ikuabwai), thank you.  You remind me there is life outside of 
v 
 
science, for those times when I’m not in the lab.  I wouldn’t know what to do 
without you. 
Last, but certainly not least, to my family, thank you for cheering me on 
each step of the way from at home in the U.S. or across borders and the Pacific.  
To Mom and Dad, an especial thank you for your constant love and unwavering 
belief that everything I attempt will succeed, if I try my best.  Every day, I’m 
reminded how lucky I am to have parents like you and I love you both so much.  
Thank you for always trusting in me and supporting me in all the things I do. 
vi 
 
REGULATION OF GLUTAMATERGIC AMPA RECEPTOR STABILITY AND 
TRAFFICKING BY UBIQUITINATION 
(Order No.  ) 
AMY WEI PEY LIN 
Boston University Graduate School of Arts and Sciences, 2013 
Major Professor: Hengye Man, Associate Professor of Biology 
ABSTRACT 
 
AMPA-type glutamate receptors (AMPARs) play a critical role in mediating 
the majority of fast excitatory synaptic transmission in the brain.  Alterations in 
AMPAR expression, distribution and trafficking have been shown to underlie 
synaptic plasticity and higher brain function.  However, the molecular 
mechanisms regulating AMPAR surface expression and turnover are still not fully 
understood.  We report that mammalian AMPARs are subject to post-
translational modification by ubiquitin, and identify Nedd4 as the E3 ligase 
responsible for mediating this process.  AMPAR ubiquitination enhanced receptor 
degradation and reduced AMPAR cell-surface expression.  Conversely, inhibition 
of proteasomal activity caused AMPAR accumulation.  Using site-directed 
mutagenesis, we mutated each of four lysine residues as putative ubiquitination 
sites on the AMPAR subunit GluA1 C-terminal with an arginine and identified 
critical residues for ubiquitination and receptor degradation.  Consistent with the 
role of protein ubiquitination, lysine mutation reduced the efficiency of AMPAR 
endocytosis.  We further investigated the molecular mechanisms involved in the 
vii 
 
internalization of ubiquitinated AMPARs.  We find that the endocytic adaptor 
protein Eps15 plays a critical role in this process.  siRNA-mediated suppression 
or overexpression of Eps15 results in changes in AMPAR surface expression.  
Eps15 interaction with AMPARs requires Nedd4-mediated GluA1 ubiquitination 
along with the ubiquitin interacting motif (UIM) of Eps15.  Consistent with 
ubiquitination-mediated receptor internalization, knockdown of Eps15 suppresses 
GluA1 internalization of wild-type GluA1, but not a mutant GluA1 lacking 
ubiquitination sites, indicating a crucial role for Eps15 in the trafficking of 
ubiquitinated AMPARs.  These findings reveal novel regulatory mechanisms in 
the control of glutamate receptor amount and distribution dynamics, which are 
key factors implicated in higher brain functions and neurological disorders.   
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CHAPTER ONE 
Introduction and Background Review 
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1.1       Introduction 
The brain is a highly complex organ that has evolved in form and function 
as the center of the vertebrate nervous system.    Within the brain, there are two 
major cell types: glia and neurons.  Glial cells function as neuronal partners, 
where they help to maintain homeostasis, form myelin and provide support and 
protection for neurons by supplying nutrients and oxygen, as well as protection 
from pathogens.  Neurons, on the other hand, are highly complex, electrically 
excitable cells that form a network of connectivity throughout the brain.   External 
cues from environmental stimuli – auditory, olfactory, tactile, gustatory or visual – 
are translated by specialized receptors into internal electrical and biochemical 
signals that propagate through this complex neuronal network to relay and store 
information in a process termed neurotransmission.     
 
1.2      General overview of excitatory synaptic transmission 
1.2.1 Neuronal and synaptic architecture 
  Neurons are polarized structures composed of three major parts: a soma, 
dendrites and an axon.  The main cell body of a neuron is the soma, from which 
elongated processes termed dendrites extend.  These dendrites function as 
signal receivers.  A specialized structure known as the axon, the longest 
extending process from the soma, functions as the signal propagator (Fig. 1.1 A).   
The junction at which a signal propagator transfers the signal to a signal receiver 
is termed a synapse.  Synapses are highly specialized structures and form a key 
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component underlying neurotransmission.  While synapses are often regarded as 
the basic computational units underlying brain function, their major importance 
resides in their ability to ultimately regulate higher brain processes such as 
learning and memory.  Therefore, understanding how synapses function is of 
much significance.    
  During excitatory neurotransmission, the dendrites and soma of a neuron 
receive electrical signals that cause the resting membrane potential of the neuron 
to rise until reaching a critical threshold.  When this threshold is reached, the cell 
fires a signal called an action potential that travels along the length of the axon 
until it reaches the presynaptic terminal.  Once the action potential reaches the 
presynaptic terminal, it opens up ion channels that allow an influx of Ca2+ ions to 
enter the cell.  This influx of Ca2+ ions then triggers the release of chemical 
neurotransmitters from presynaptic vesicles.  In the case of excitatory 
glutamatergic synapses, the neurotransmitter glutamate is released.  Upon its 
release from the presynaptic terminal, glutamate diffuses across the synaptic 
cleft where it binds to glutamate receptors on the postsynaptic membrane.  This 
causes the glutamate receptors to activate and open to allow an influx of 
positively charged ions into the cell.  The chemical signal is thus converted back 
into an electrical signal, which continues to propagate onto the next neuron (Fig 
1.1 B). 
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Figure 1.1. Synaptic transmission in the brain.  (A) A neuron consists of a cell 
body, called a soma, and processes that extend from the soma called dendrites.  
The longest process is termed an axon.  Electrical signals are received by the 
dendrites and propagated along the axon until reaching the presynaptic terminal.  
(B) Upon reaching the presynaptic terminal, the action potential causes the 
opening of ion channels, allowing an influx of Ca2+ to enter the cell.  This influx 
causes synaptic vesicles containing chemical neurotransmitters to fuse to the 
presynaptic membrane and release their contents into the synaptic cleft.  The 
neurotransmitters then diffuse across the synaptic cleft, where they bind to 
postsynaptic receptors.  This causes the postsynaptic receptors to open, allowing 
an influx of positive ions into the cell, thus converting the chemical signal back to 
an electrical signal that continues to propagate to the next neuron.  
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1.2.2 Glutamate receptors 
 Glutamate receptors are responsible for mediating the vast majority of 
excitatory synaptic transmission in the brain, where they are widely expressed 
(Fig. 1.2).  There are two main types of glutamate receptors: metabotropic and 
ionotropic.  Metabotropic glutamate receptors (mGluRs) operate by activating 
second messenger G-protein coupled signaling cascades.  Ionotropic glutamate 
receptors on the other hand, operate through the influx of ions upon glutamate 
binding.  The ionotropic glutamate receptors can be sub-divided into three groups 
– kainite receptors, N-methyl-D-aspartic acid-type receptors (NMDARs) and α-
amino-3-hydroxy-5-methyl-4-isoxazole propionic acid-type receptors (AMPARs).   
1.3      AMPARS 
AMPARs in particular are responsible for mediating the majority of fast 
excitatory neurotransmission in the brain, where they are highly regulated.  As 
alterations of excitatory synaptic strength is believed to form the cellular basis for 
learning and memory and AMPARs mediate most excitatory synaptic 
transmission, understanding the mechanisms underlying AMPAR trafficking is 
critical. 
1.3.1 AMPAR function and structure 
 AMPARs are glutamate-gated heterotetrameric ion channels composed of 
GluA1-4 subunits.  The stoichiometry of GluA1-4 subunit assembly appears to be 
governed mainly by the expression of the individual subunits, though GluA1 and 
GluA2 appear to bind preferentially as dimers of heteromers, while assembly of 
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Figure 1.2. Excitatory neurotransmission.  Glutamate receptors are 
responsible for mediating the vast majority of excitatory neurotransmission in the 
brain.  There are two main types: metabotropic and ionotropic.  Metabotropic 
glutamate receptors (mGluRs) operate through a G-protein coupled second 
messenger system.  On the other hand, ionotropic glutamate receptors operate 
by opening to allow an influx of ions upon glutamate binding.  The ionotropic 
glutamate receptors can be further divided into three groups: kainate receptors 
(KARs), N-methyl-D-aspartic acid-type receptors (NMDARs) and α-amino-3-
hydroxy-5-methyl-4-isoxazole propionic acid-type receptors (AMPARs).  
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 homomers is stochastic (Mansour et al., 2001).  Additionally, it is thought that 
GluA2 is the preferred binding partner as GluA2 knockout mice demonstrate 
abnormal GluA1/GluA3 heteromers and an increase of GluA1 and GluA3 
homomers along with less synaptic expression (Sans et al., 2003).  Interestingly, 
it appears that the subunit composition of AMPARs at synapses can change in 
response to synaptic activation, either due to targeted delivery of specific 
AMPAR complexes or a rearrangement of the subunits of existing AMPARs (S. 
H. Lee et al., 2004; Liu et al., 2002; Shi et al., 2001).   
 The molecular architecture of the subunits is very similar, with 
approximately 70% sequence homology between the genes encoding these 
subunits.  Each subunit contains an extracellular N terminus, along with four 
transmembrane domains (TM) and an intracellular C terminus (Fig. 1.3).  The 
extracellular N terminus consists of two domains.  The most distal is termed the 
N-terminal domain (NTD) while the remainder is termed the ligand-binding 
domain (LBD).  The LBD confers pharmacological specificity for glutamate 
binding (Stern-Bach et al., 1994; Stern-Bach et al., 1998).  The transmembrane 
domains consist of four hydrophobic domains, TM1-4, with TM1, 3 and 4 
spanning the transmembrane and TM2 forming a hairpin loop on the intracellular 
side of the membrane.  The intracellular C terminus of the AMPAR is a major 
interaction site for numerous proteins, as well as a major target for 
posttranslational modification (PTM) (Fig 1.3). 
10 
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Figure 1.3. AMPAR structure and C-terminal interactions.  AMPARs are 
heterotetrameric structures that consist of four subunits: GluA1-GluA4.  Each 
individual subunit consists of an extracellular N-terminal domain, four 
transmembrane domains with the second domain forming a hairpin loop, and an 
intracellular C-terminal domain.  The intracellular C-terminal domain is an 
important interaction site for numerous proteins as well as a major target for 
posttranslational modifications (PTMs).  On the GluA1 subunit, the proteins 
Band4.1N and SAP97 both bind to the C-terminus, while PTMs such as 
phosphorylation, palmitoylation, nitrosylation and calpain cleavage all occur. 
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 Thus far, GluA2 is the first and only complete subunit to have been 
crystallized (Sobolevsky et al., 2009), though the N-terminal domains of GluA1 
and GluA3 have recently been characterized (Sukumaran et al., 2011; Yao et al., 
2011).  Crystallization of the more flexible C terminus has not been fully 
characterized, though it remains of major interest and importance as a major site 
for synaptic protein binding and interaction as well as posttranslational 
modifications.  Regulation of AMPAR trafficking via its C terminus may have 
important implications for its role in synaptic function and plasticity. 
1.3.2 AMPARs in synaptic plasticity 
It is widely believed that alterations in synaptic transmission mediate the 
cellular and molecular basis underlying higher brain functions such as learning 
and memory.  The most characterized forms of synaptic plasticity in the 
mammalian brain are long-term potentiation (LTP) and long-term depression 
(LTD), where short periods of synaptic activity are able to trigger long lasting and 
persistent changes to synaptic strength and efficacy.  In contrast, homeostatic 
plasticity is believed to mediate synaptic changes within a set physiological range 
(Turrigiano, 2008).   
The majority of evidence linking AMPARs to LTP suggests that 
phosphorylation of the GluA1 subunit plays a major role.  One of the first kinases 
shown to be involved in LTP is CaMKII, which can directly phosphorylate GluA1 
at S831 (Banke et al., 2000; Barria et al., 1997; Derkach et al., 1999; H. K. Lee et 
al., 2000).  As phosphorylation of GluA1 at S831 can increase channel 
13 
 
conductance, this in part may mediate the potentiation of synaptic transmission 
during LTP (Derkach et al., 1999).  However, it is interesting to note that GluA1 
S831 phosphorylation has no effect on AMPAR insertion (Y. Hayashi et al., 2000; 
H. K. Lee et al., 2000).  CaMKII is also shown to phosphorylate the first 
intracellular loop of GluA1 at S567, though the possible effect on synaptic 
plasticity is yet unknown (W. Lu et al., 2010).  Protein kinase A (PKA) is another 
kinase shown to induce LTP by directly phosphorylating S845 on GluA1, leading 
to the insertion of AMPARs on the extrasynaptic membrane (Man et al., 2007; Oh 
et al., 2006) although PKA alone is not sufficient to induce GluA translocation 
(Esteban et al., 2003).  While both the S845 and S831 sites are phosphorylated, 
it is interesting to note that high-frequency stimulation of naïve or formerly 
depressed synapses preferentially increased phosphorylation of the CaMKII-
mediated Ser831 site over the PKA-mediated S845 site (H. K. Lee et al., 2000).  
Mice containing knockin mutations at S831 and S845, show a significant 
reduction in LTP in the hippocampal CA1 region.  While LTP is not completely 
abolished by these mutations, the mice demonstrate impairments in the retention 
of new learning (H. K. Lee et al., 2003).  In addition to CaMKII and PKA, protein 
kinase C (PKC) can phosphorylate GluA1 at Ser 816, S818 and T840, which 
promotes the insertion of AMPARs to the synapse (Boehm et al., 2006; Delgado 
et al., 2007; H. K. Lee et al., 2007; D. T. Lin et al., 2009).  Collectively, LTP can 
be regulated by a number of key kinases phosphorylating the GluA1 AMPAR 
subunit. 
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While enhanced AMPAR channel conductance and surface expression 
levels are linked with LTP, a decrease in AMPAR levels at the synapse on the 
other hand, has been shown to lead to LTD (Carroll, Lissin, et al., 1999; Lissin et 
al., 1999; Lissin et al., 1998; Man et al., 2000).  Though insertion of the GluA1 
subunit is well-studied in LTP, the GluA2 subunit is better characterized in LTD 
paradigms.  It is believed that LTD induction is a result of AMPAR endocytosis 
caused by destabilization of GluA2 interaction with PDZ proteins (Daw et al., 
2000; C. H. Kim et al., 2001).  In support of this, LTD is inhibited upon the 
perfusion of postsynaptic intracellular regions with a peptide disrupting 
interactions between GluA2 and its scaffolding proteins (Daw et al., 2000; C. H. 
Kim et al., 2001).  The interaction between GluA2 and glutamate receptor 
interacting protein (GRIP) is also disrupted by PKC-mediated phosphorylation of 
GluA2 at S880, which may cause receptor internalization (Chung et al., 2000; 
Matsuda et al., 2000; Matsuda et al., 1999; Xia et al., 2000) and stabilization by 
protein interacting with protein kinase C (PICK1) (C. H. Kim et al., 2001; Xia et 
al., 2000).  GluA2 also contains a unique phosphorylation residue at Y876 that is 
both necessary and sufficient for AMPAR-induced LTD (Ahmadian et al., 2004; 
T. Hayashi et al., 2004; Moult et al., 2006).  GluA2 phosphorylation and ligand-
binding cause the synaptic protein BRAG2 to bind directly to GluA2, which 
activates the coat-recruitment GTPase Arf6 to induce AMPAR endocytosis upon 
LTD induction (Scholz et al., 2010).  In general, LTD induction is associated with 
a net loss of AMPARs, likely through clathrin-mediated endocytosis (Man et al., 
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2000; Y. T. Wang et al., 2000), which is shown to be mediated by GluA2 (S. H. 
Lee et al., 2002). 
While LTP and LTD are both well characterized forms of synaptic 
plasticity, homeostatic synaptic plasticity is less well understood.  It is known to 
be a mechanism by which a neuron can reestablish its activity to a physiological 
set point in order to compensate for increased or decreased activity.  While the 
role of AMPARs in homeostatic synaptic plasticity is newly established, one well 
characterized modulator of AMPARs under this paradigm is Arc/Arg3.1, an 
immediate early gene product (Gao et al., 2010; Turrigiano, 2008) facilitating 
AMPAR internalization.  Another protein that may be involved in the regulation of 
homeostatic plasticity is Polo-like kinase 2 (Plk2), which binds the postsynaptic 
protein N-ethylmaleimide-sensitive factor (NSF) to trigger the removal of GluA2 
from the surface membrane (Evers et al., 2010).  Interestingly, GluA2-lacking 
AMPARs along with PI3-kinase signaling have been shown to mediate synapse-
specific homeostatic regulation during chronic inhibition of single synapses, with 
AMPAR accumulation selectively increasing while neighboring normal synapses 
remain unaffected (Q. Hou, Zhang, et al., 2008).  Conversely, when the activity of 
an individual presynaptic terminal is selectively elevated, AMPAR abundance at 
the excited synapses is subsequently selectively downregulated in an NMDAR-
dependent manner (Q. Hou et al., 2011). 
1.3.3 AMPAR trafficking 
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While LTP, LTD and homeostatic synaptic activity play a critical role in 
affecting the levels of AMPARs at the synapse, the cellular mechanisms 
underlying how AMPARs are synthesized and trafficked from intracellular 
compartments to the postsynaptic membrane are a major factor in determining 
synaptic strength (Fig 1.4).  AMPARs are synthesized in both the soma and in 
dendrites, in a manner similar to that of other transmembrane proteins.  
Translation of AMPARs occurs in the endoplasmic reticulum (ER).  Export of 
AMPARs from the ER is highly dependent upon transmembrane AMPAR 
regulatory proteins (TARPs) (Ziff, 2007).  Interestingly, AMPAR trafficking 
through the ER is also subunit-specific, with GluA1/GluA2 heterotetramers exiting 
rapidly from the ER and trafficking to the Golgi apparatus, where they are fully 
glycosylated (Greger et al., 2002).  On the other hand, GluA2/GluA3 
heterotetramers are retained longer in the ER, while a fraction of unassembled 
GluA2 subunits appear to remain within the ER (Greger et al., 2003; Greger et 
al., 2002).  Those AMPARs that traffic to the Golgi compartment are then 
packaged into vesicles that utilize molecular motor proteins kinesin and dynein to 
transport these vesicles in a microtubule-dependent manner until reaching the 
synapse (Perestenko et al., 2003).  Adaptor proteins, such as GRIP/ABP, which 
binds the PDZ motif of GluA2 and GluA3, are also utilized to shuttle AMPARs to 
their target destination for insertion (Setou et al., 2002).  AMPARs are also 
known to interact with the neuron-specific kinesin motor KIF1 using the adaptor 
molecule liprin-α (Shin et al., 2003; Wyszynski et al., 2002). 
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Figure 1.4.  AMPAR trafficking.  The abundance of AMPARs on the 
postsynaptic membrane is due to a balance between receptor synthesis and 
insertion along with receptor internalization and degradation.  AMPARs that are 
newly synthesized can be inserted into the postsynaptic membrane.  These 
AMPARs can then later be internalized.  Once internalized, they are either sorted 
to recycling pools and reinserted into the postsynaptic membrane, or degraded.
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Upon the delivery of AMPARs to the synapse, there are two basic 
processes through which AMPARs are delivered to their correct postsynaptic 
location on the membrane – direct insertion into the synaptic site (Beretta et al., 
2005) or lateral diffusion to the postsynaptic density (PSD) (Makino et al., 2009; 
Tardin et al., 2003; Yudowski et al., 2007).  During lateral diffusion, AMPARs 
from either perisynaptic sites (Yang et al., 2008) or extrasynaptic sites (D. T. Lin 
et al., 2009) utilize the actin-cytoskeleton as a means of transport to the PSD.  
Not only are newly synthesized AMPARs delivered in this fashion, but AMPARs 
that may have been stored in endosomal recycling pools can also be re-inserted.  
The small GTPases of the Rab family mediate most intracellular membrane 
sorting in eukaryotic cells (Zerial et al., 2001).  Rab8, for example, is necessary 
for GluA1 insertion and LTP (Gerges et al., 2004).  However, very little is known 
about the intracellular machinery that governs constitutive AMPAR cycling.  It 
appears that the Rab proteins normally associated with recycling endosomes, 
such as the exocytic Rab11 (Gerges et al., 2004), along with the endocytic Rab5 
(Brown et al., 2005), are not involved in constitutive AMPAR recycling.  However, 
Rab11 mediates activity-dependent delivery of GluA1 into synapses (M. Park et 
al., 2004) while Rab5 drives internalization of AMPARs during activity-dependent 
LTD (Brown et al., 2005).  This suggests that constitutive and regulated AMPAR 
internalization may recruit different endocytotic machineries.   
Activity-dependent internalization of synaptic AMPARs requires clathrin-
mediated endocytosis (Carroll, Beattie, et al., 1999; S. H. Lee et al., 2002; Man et 
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al., 2000) via the binding of clathrin, dynamin and endophilin, along with the 
adaptor protein AP2 to the intracellular C-terminals of AMPAR subunits (Carroll, 
Beattie, et al., 1999; Kastning et al., 2007; S. H. Lee et al., 2002; Man et al., 
2000).  AMPAR endocytosis is triggered by several signaling pathways.  While 
PICK1 is involved in general endocytosis, another major factor appears to involve 
PICK1-driven synaptic removal of phosphorylated GluA2 receptors (Chung et al., 
2003; C. H. Kim et al., 2001; Steinberg et al., 2006). 
 Upon internalization, a selection of AMPARs are either sorted to recycling 
pools or targeted for degradation through either the lysosomal or proteasomal 
pathway (Bingol et al., 2005; Carroll et al., 2001; Ehlers, 2000; Kessels et al., 
2009; Yi et al., 2007).  However, the mechanisms by which AMPARs are 
designated for sorting are not fully understood, and whether they are 
preferentially sorted to the lysosome or the proteasome and under which 
conditions remains controversial.   
1.3.4 AMPAR interacting proteins 
The trafficking of AMPARs is a complex and intricate process that can be 
mediated through a number of different means.  One important modulation of 
AMPAR trafficking are protein-protein interactions.  GluA subunits interact via 
their C-termini with a wide variety of cytoplasmic and transmembrane proteins, 
which can result in a number of different trafficking patterns (Barry et al., 2002; 
Malinow et al., 2002; Song et al., 2002).   
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While trafficking of AMPARs is a crucial process, protein-protein 
interactions can also function to stabilize AMPARs on PSD.  The PSD is a 
complex structure consisting of a network of scaffolding proteins, membrane 
proteins, cytoskeletal elements and cell adhesion molecules, along with 
trafficking, posttranslational modification and degradation machinery.  Within the 
PSD, regulation of receptor diffusion into and out of the synapse is regulated by 
synaptic adhesion molecules such as cadherins and cadherin-associated 
proteins (Ochiishi et al., 2008; Saglietti et al., 2007; Silverman et al., 2007; Tai et 
al., 2008), which physically interact with and stabilize glutamate receptors at the 
membrane.  Members of the MAGUK-PSD scaffolding family are also of 
particular importance in the stability of surface AMPARs.  One member of this 
family is PSD-95, which binds NMDARs directly but utilizes the protein stargazin 
as an adaptor to indirectly bind AMPARs.  Another member of this family, 
SAP97, directly binds AMPARs at the periphery of the synapse (DeGiorgis et al., 
2006; Ziff, 2007).  AMPARs can also be tethered to the membrane by the protein 
4.1N, which interacts with the actin cytoskeleton and the C-terminal of GluA1 and 
is shown to increase AMPAR insertion and surface expression levels (T. Hayashi 
et al., 2005; D. T. Lin et al., 2009; Shen et al., 2000).  GRIP/ABP, on the other 
hand, is a protein that functions as an adaptor directly binding GluA2/3 to 
molecular motor proteins that transport AMPARs from the soma to dendritic 
spines (Setou et al., 2002; Shin et al., 2003; Wyszynski et al., 2002).  
Phosphorylation of GluA2 is shown to interrupt the interaction between 
22 
 
GRIP/ABP and GluA2, resulting in LTD and AMPAR down regulation (Chung et 
al., 2000; Dong et al., 1997; T. Hayashi et al., 2004; C. H. Kim et al., 2001).  
GRIP/ABP is also important in endosomal recycling and AMPAR exocytosis 
(Gerges et al., 2006; Mao et al., 2010).  Also involved in AMPAR insertion and 
endosomal recycling is N-ethylmaleimide-sensitive factor (NSF).  By binding 
directly to the GluA2 C-tail, NSF disrupts GluA2 retention in recycling endosomes 
and stabilizes GluA2 surface expression (Huang et al., 2005).  However, this 
interaction can be disrupted by Plk2 to subsequently reduce surface AMPARs 
(Beretta et al., 2005; Evers et al., 2010).   
Although many AMPAR interacting proteins interact to stabilize AMPARs 
at the surface or to promote insertion of AMPARs, a number of other proteins 
function to destabilize AMPARs in order to promote receptor internalization, 
recycling or degradation. PICK1 is known to bind to GluA2/3 containing AMPARs 
through its PDZ domain, especially during LTD, which triggers Ca2+-mediated 
dissociation of NSF and GRIP1/ABP from GluA2 thus increasing PICK1 binding 
and AMPAR internalization (Hanley, 2007, 2008; Xia et al., 1999).  Another 
protein involved in AMPAR internalization is AP2.  AP2 binds directly to the 
GluA2 C-tail in a dynamin-dependent clathrin-mediated manner, resulting in 
AMPAR endocytosis (Kastning et al., 2007; S. H. Lee et al., 2002).  Recruitment 
of AP2 may also be triggered by activation of the GTPase Arf6 (Kastning et al., 
2007; Scholz et al., 2010). 
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AMPARs can also directly interact with proteins that regulate their 
trafficking indirectly, such as the Na,K-ATPase (NKA) pump.  The NKA maintains 
ion gradients by regulating sodium influx.  Inhibition of the NKA causes a rapid 
reduction in surface and total AMPAR expression levels, leading to a long-lasting 
depression in synaptic transmission (Zhang et al., 2009).  
However, although protein-protein interactions are a significant modulator 
of a diverse range of AMPAR expression and function, they are not the sole 
means of AMPAR regulation. 
1.3.5  AMPAR posttranslational modifications  
 Posttranslational modifications play a critical role in regulating a number of 
AMPAR functions, including trafficking and stability.  The most studied PTM on 
AMPARs is phosphorylation, although AMPARs can also undergo glycosylation, 
palmitoylation, nitrosylation and calpain cleavage.  
1.3.5.1 Phosphorylation 
 Phosphorylation, the attachment of a phosphate group (PO43-) to a protein, 
is arguably the most critical PTM on AMPARs.  Many major changes to AMPAR 
function and trafficking are phosphorylation-dependent (Banke et al., 2000; 
Derkach et al., 1999).  On the C-terminal tail of the GluA1 subunit, the two most 
characterized and understood phosphorylation sites are at S831, which 
enhances channel conductance (Benke et al., 1998), and S845, which delivers 
GluA1 subunits to the synapse (Man et al., 2007).  Double knockin mice lacking 
phosphorylation at both of these sites show impaired LTP and the retention of 
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newly acquired spatial memory (H. K. Lee et al., 2003).  Interestingly, knockin 
mice lacking phosphorylation at either one of these sites express normal LTP (H. 
K. Lee et al., 2010) suggesting that either site is sufficient for LTP.  However, for 
LTD the S845 site but not the S831 site is crucial, likely through regulation of 
AMPAR endocytosis (H. K. Lee et al., 2010).  The GluA1 S845 site is also shown 
to be crucial in the erasure of fear memory (Clem et al., 2010).  Phosphorylation 
also promotes the synaptic insertion of GluA1 into the extrasynaptic membrane 
through PKC-mediated phosphorylation at S818 which additionally modulates 
binding of the GluA1 subunit to protein 4.1N (Boehm et al., 2006; D. T. Lin et al., 
2009).  A more recently identified phosphorylation site at T840 that is 
phosphorylated by PKC in vitro does not appear to play a role in LTP but may 
rather function in LTD (Delgado et al., 2007; H. K. Lee et al., 2007).  
 In addition to the multiple sites on the GluA1 C-terminal tail, the Loop1 
domain of GluA1, which facilitates AMPAR synaptic targeting, is phosphorylated 
on S567 by CaMKII thereby negatively modulating Loop-1-mediated synaptic 
delivery of AMPARs (W. Lu et al., 2010).   
1.3.5.2 Glycosylation, palmitoylation, nitrosylation and calpain cleavage 
 Glycosylation is an enzymatic reaction during which glycans, poly or 
oligosaccharides, are attached to proteins.   N-linked glycans are attached to 
nitrogen, while O-linked glycans are attached to hydroxy oxygen.  Glycosylation 
can protect proteins from proteolytic degradation.  During assembly in the ER 
and Golgi, each AMPAR can be N-glycosylated at 4-6 different sites, though lack 
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of N-glycosylation does not appear to significantly affect either AMPAR synthesis 
or trafficking (Everts et al., 1997; Standley et al., 2000).  However, it has been 
recently shown that abnormal N-linked glysosylation of the GluA2 subunit occurs 
in schizophrenia (Tucholski et al., 2013).  Both GluA1 and GluA2 can be O-
glycosylated.  Inhibition of O-glycosylation has been shown to regulate AMPAR 
trafficking by facilitating basal synaptic transmission and the translocation of 
GluA1 and GluA2 to the plasma membrane (Kanno et al., 2010). 
 Palmitoylation is the covalent attachment of fatty acids, such as palmitic 
acid, which can regulate protein trafficking and cellular localization.  All AMPAR 
subunits can be palmitoylated at two cysteine residues located in TM2 and on the 
C terminus.  Palmitoylation on C585 on TM2 results in AMPAR accumulation in 
the Golgi and thus a reduction of surface AMPAR expression, while C-terminal 
palmitoylation at C811 reduces the interaction between AMPARs and the 
Band4.1N protein and mediates agonist-induced internalization (T. Hayashi et al., 
2005).  On the other hand, de-palmitoylation of GluA1 on C811 leads to PKC-
mediated phosphorylation of S816 and S818 and enhanced association with 
protein 4.1N, which leads to AMPAR insertion (D. T. Lin et al., 2009). 
 Nitrosylation involves the covalent incorporation of a nitric oxide group.  
Regulation of AMPARs by nitrosylation was previously shown to be indirect, with 
S-nitrosylation of NSF (Huang et al., 2005) and stargazin (Selvakumar et al., 
2009) mediating the surface expression of AMPARs.  Recently, a study 
demonstrates that direct S-nitrosylation of GluA1 at C875 coupled with NMDAR 
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activation results in enhanced S831 phosphorylation leading to endocytosis 
(Selvakumar et al., 2013). 
  Calpain-mediated proteolysis of the AMPAR GluA1 C-terminal is well-
characterized.   Calpains are a major superfamily of Ca2+-dependent cysteine 
proteases that have been implicated in numerous neurological conditions such 
as epilepsy, ischemic stroke and Alzheimer’s disease (Chan et al., 1999; Choi, 
1988; Saito et al., 1993).   Calpain activation by glutamate or NMDA treatment 
causes cleavage of the GluA1 C-terminal, leading to a loss of surface and total 
levels of GluA1 (Yuen, Gu, et al., 2007).  Two putative sites at residues N833 
and R837 on the GluA1 C-terminus have been classified as cut site I (Bi et al., 
1996), with another potential site at G885 classified as cut site II (Bi et al., 1997).  
Cut site cleavage determination may possibly be a consequence of calcium 
concentration (Bi et al., 1997).  The phosphorylation state of GluA1 has also 
been shown to determine susceptibility to calpain cleavage and suppression of 
AMPAR currents (Yuen, Liu, et al., 2007).   
 While there are a large number of AMPAR PTMs, one highly critical PTM 
that has not yet been examined in AMPARs is ubiquitination. 
1.4 Ubiquitin 
1.4.1 General overview of ubiquitin and ubiquitination 
Ubiquitin (Ub) is a highly conserved small protein expressed in all 
eukaryotic cells that functions as a highly versatile cellular signal with the ability 
to mediate an extensive range of biological functions including DNA repair, 
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transcription, endocytosis, autophagy and protein degradation.  The unique 
specificity of ubiquitin signaling is initially conferred through the conjugation of Ub 
to a lysine (K) residue of a target substrate through an enzymatic process termed 
ubiquitination.   
1.4.1.1 Ubiquitin structure, function and enzymatic cascade 
Structurally, ubiquitin is an 8.5 kDa, 76 amino acid polypeptide that forms 
a compact structure with an exposed carboxy terminal tail containing a diglycine 
motif that can be covalently ligated through an isopeptide bond to the primary ε-
amino group of K residues on a target substrate.  This occurs through 
ubiquitination, a reversible posttranslational modification that can affect the 
structure and activity of the targeted protein, along with its localization and 
binding interaction to other partners (Fig. 1.5).   
The first step of ubiquitination involves the biochemical priming of ubiquitin 
by the E1 ubiquitin-activating enzyme (E1) in an ATP-dependent manner.  E1 
initially binds both Mg2+ and ubiquitin to form an unstable intermediate ubiquitin-
adenylate species before ubiquitin is subsequently transferred to the catalytically 
active cysteine of E1 resulting in a thiol-ester bond between the cysteine of E1 
and the carboxy-terminal glycine (G76) of Ub (A. L. Haas et al., 1982; Hershko et 
al., 1983).  Once an ubiquitin molecule is activated by E1, it is then accepted by 
an E2 ubiquitin-conjugating enzyme (E2), which forms a thiol-ester bond with 
G76 of Ub (Pickart, 2001).  E2 then goes on to form a complex with an E3 
ubiquitin ligase enzyme (E3), which accepts the ubiquitin molecule from E2 in  
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Figure 1.5.  Enzymatic cascade leading to substrate ubiquitination.  Three 
sets of enzymes are required for ubiquitination of a targeted substrate: ubiquitin-
activating (E1), ubiquitin-conjugating (E2) and ubiquitin-ligase (E3) enzymes.  
There are two main classes of E3 enzymes – the RING and HECT classes, 
which differ in the manner by which they transfer Ub to a target substrate.  Once 
a Ub molecule is conjugated to its target protein, additional Ub molecules can be 
attached to form chains.  However, since ubiquitination is a reversible process, 
once Ub is attached, deubiquitinating enzymes (DUBs) can then hydrolyze the 
isopeptide bond between Ub and its target protein (shown by the small lightning 
bolt), and thus return the protein to its previous state and release Ub.  Substrates 
that contain polyUb chains are often targeted to the proteasome, where they are 
bound and subsequently degraded.  The proteasome is composed of a catalytic 
20S core particle structure and two 19S regulatory caps which together are 
collectively termed the 26S proteasome.  While some polyubiquitinated proteins 
can be bound directly through polyUb binding subunits on the proteasome, 
others must be shuttled to the proteasome via adaptor proteins (the binding site 
for Ub and adaptors is represented by a yellow circle).  Once the substrate is 
bound to the proteasome, many ATPase subunits that make up the proteasome 
utilize ATP to unfold the protein, simultaneously deubiquitinating the protein and 
releasing Ub while cleaving the protein into small peptide fragments. 
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order to catalyze its conjugation to a K residue on target substrates.  Of the 
enzymes involved during ubiquitination, it is the E3 ligase that confers substrate 
specificity.   
1.4.1.2 E3 Ligases: RING and HECT ligase families 
 In mammals, there are two isoforms of the E1 enzyme (E1a and E1b), 
while the E2 family of enzymes contains more than thirty genes.  As the E3 
ligase is responsible for catalyzing the attachment of ubiquitin to its specific 
target substrate, it is no surprise that the E3 ligase family contains over a 
hundred genes.  The E3 family of ligases is divided into two classes based on 
whether they contain the conserved homologous to E6-AP domains (HECT) or 
really interesting new gene (RING) domain.  The two classes differ mainly in how 
ubiquitin is transferred to the substrate.  HECT E3 enzymes contain a catalytic 
cysteine that accepts Ub from E2 enzymes before the Ub is transferred to the K 
residue of the target protein.  RING E3s on the other hand, act as scaffolds that 
facilitate E2 and substrate interaction in order to transfer the Ub from the E2 to 
the target substrate (Rotin et al., 2009).   
1.4.1.3 Forms of ubiquitination 
The consequences of ubiquitination come in many flavors (i.e., 
monoubiquitination, multi-monoubiquitination, polyubiquitination) depending on 
the number of ubiquitin moieties conjugated to the target and the specific type of 
Ub conjugation (Fig.1.6).  The attachment of a single ubiquitin protein to one site 
(monoubiquitination, monoUb) or the attachment of single Ub molecules to  
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multiple sites of a protein (multi-monoubiquitination) are generally involved in 
signaling, endocytosis and subcellular localization.  Additionally, ubiquitin itself 
can undergo ubiquitination to form distinct isopeptide-linked ubiquitin chains 
(polyubiquitination, polyUb) on any of its seven internal lysine residues (K6, K11, 
K27, K29, K33, K48 and K63), each of which can individually regulate a wide 
range of effects such as DNA repair, proteasomal or lysosomal degradation and 
protein trafficking (Husnjak et al., 2012).  To further complicate matters, atypical 
and forked Ub chains can occur, where two or more ubiquitin molecules are 
linked to adjacent lysines on the preceding Ub molecule to form branches (F. 
Ikeda et al., 2008).  Also, a novel class of enzymes, the polyubiquitin ligase 
enzymes (E4) are proposed to be involved in forming Ub chains (Hoppe, 2005). 
Though non-traditional, Ub can also modify non-lysine targets such as the amino 
acid methionine on the ubiquitin molecule at position 1 (Met1) (Kulathu et al., 
2012).  To increase the complexity of the Ub signal even further, the signal itself 
(monoUb or polyUb) on a target substrate can also be recognized by specific 
domains on Ub-binding proteins (also termed ubiquitin receptors) which can then 
interact with the target substrate and decode these signals to activate other 
biological cascades in the cell.   Collectively, the activity of this one small protein 
is responsible for the regulation of multiple aspects of cellular signaling and 
function.   
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1.4.1.4 Deubiquitination 
Ubiquitination is a reversible modification mediated by deubiquitinating 
enzymes (DUBs) that hydrolyze Ub-protein isopeptide bonds.  There are over 
100 DUBs that have been identified, which are categorized into five distinct 
subclasses.  The original two classes of DUBs include ubiquitin C-terminal 
hydrolases (UCHs), which are believed to interact with monoubiquitinated 
proteins, and ubiquitin-specific proteases (USPs) that appear to act primarily to 
disassemble polyubiquitin chains (K. D. Wilkinson, 2000).  The newer 
classifications include ovarian tumor proteases (OTUs), Josephin proteases and 
JAB1/MPN/Mov34 metalloenzymes (JAMMs) (Komander et al., 2009). 
1.4.1.5 Consequences of ubiquitination 
While the collective progression of ubiquitination and deubiquitination of a 
target protein results in a number of possible cellular processes, the ultimate 
result of synaptic protein ubiquitination is generally removal and eventual 
degradation of the targeted protein.  Ubiquitinated proteins are usually directed to 
the proteasome or lysosome for degradation.  For membrane proteins including 
neurotransmitter receptors, ubiquitination leads to protein internalization, after 
which the receptors will be sorted either to recycling endosomes for reinsertion, 
or to the proteasome or lysosome for degradation. 
1.4.2 Ubiquitination in the brain 
Through their intracellular domains, neurotransmitter receptors interact 
with multiple postsynaptic density (PSD) proteins.  Although the PSD is a 
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biochemically stable structure, its molecular architecture is highly responsive to 
changes in synaptic activity.  Neuronal activity can cause ubiquitin proteasome 
system (UPS)-dependent alterations in neurotransmitter receptors, as well as the 
composition and turnover of PSD proteins (Ehlers, 2003).  Malfunction of the 
ubiquitin system is also involved in the development of brain disorders such as 
autism, Alzheimer’s disease, Huntington’s disease, amyotrophic lateral sclerosis 
(ALS) and Parkinson’s disease (PD) (Mabb et al., 2010).  An increasing amount 
of research has shown that the UPS targets a wide range of neuronal proteins 
including both receptors and receptor-associated PSD proteins. 
1.4.3 Ubiquitination in the synapse: postsynaptic proteins 
1.4.3.1 PSD95 
 The postsynaptic density protein PSD-95 is an important scaffolding 
molecule regulating the localization of NMDARs and AMPARs (Schluter et al., 
2006) at the postsynaptic membrane (Fig. 1.7).  PSD-95 is known to be 
ubiquitinated by the E3 ligase Mdm2 (murine double minute) and degraded 
through the ubiquitin proteasome pathway in response to NMDA receptor 
activation (Colledge et al., 2003).  Mutations blocking PSD-95 ubiquitination, as 
well as proteasomal inhibition, both effectively prevented ubiquitination-mediated 
PSD-95 degradation and were sufficient to block the internalization of AMPARs 
induced by direct stimulation of NMDARs (Colledge et al., 2003).  Direct 
stimulation of AMPARs led to a decrease in PSD-95 expression, while 
overexpression of PSD-95 was correlated with a reduction in AMPAR  
35 
 
 
  
36 
 
Figure 1.7. Postsynaptic ubiquitination.  PSD-95 is ubiquitinated by Mdm2.  It 
is also monoubiquitinated at multiple sites, and may be polyubiquitinated under 
specific circumstances.  SPAR ubiquitination is reliant upon activity-dependent 
phosphorylation by Plk2 and regulated by the E3 complex SCFβ-TRCP.  Stimulation 
of neuronal activity can also cause TRIM3-mediated ubiquitination of GKAP.  
GKAP forms a scaffolding complex with Shank and GRIP, which are also 
ubiquitinated although their specific E3 ligases remain unidentified.  PICK1 
ubiquitination is mediated by parkin, which monoubiquitinates PICK1 to 
potentially regulate its downstream effects.   
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endocytosis (Bingol et al., 2004). PSD-95 appears to be monoubiquitinated on 
multiple lysines (Bianchetta et al., 2011) in response to a brief 10 minute 
treatment with NMDA (Colledge et al., 2003).  Interestingly, PSD-95 
ubiquitination results in an increased interaction with the β-adaptin subunit of the 
clathrin adaptor protein complex AP-2 that is Mdm2-dependent (Bianchetta et al., 
2011), suggesting the interesting possibility that PSD-95 ubiquitination may 
function as a signal for recruiting AP-2 to the postsynaptic membrane and 
subsequent AP-2-mediated AMPAR internalization (S. H. Lee et al., 2002). 
Likewise intriguing is that a reduction in Cdk5 (cyclin-dependent kinase 5) activity 
has been shown to increase Mdm2-mediated PSD-95 ubiquitination without a 
subsequent decrease in PSD-95 levels, indicating a potential non-proteolytic 
signaling function for PSD-95 ubiquitination (Bianchetta et al., 2011).  
1.4.3.2 GRIP1 
  The glutamate receptor interacting protein 1 (GRIP1), a scaffolding 
protein that binds directly to GluA2 (Dong et al., 1997) and tethers AMPARs to 
other signaling proteins, is another target of ubiquitination (Fig. 1.7).  Stimulation 
with glutamate down-regulated levels of GRIP1 along with surface expression of 
GluA2, which can be blocked by inhibition of proteasome activity by MG-132 and 
the NMDAR antagonist MK-801, but not the AMPAR antagonist CNQX or EGTA, 
suggesting that glutamate-induced GRIP1 proteasomal degradation is mediated 
through an NMDAR and Ca2+ pathway (Guo et al., 2007).  As of yet, an E3 ligase 
for GRIP1 has not been identified.  
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1.4.3.3 GKAP and Shank 
 The Shank family of scaffolding proteins has three known members 
(Shank1, 2, 3) and binds to the GKAP (guanylate kinase-associated protein) 
scaffolding protein through Shank’s PDZ domain.  By binding to PSD-95 and 
other scaffolding proteins such as GRIP1 and Homer, GKAP and Shank fulfill a 
role as “master scaffold” proteins holding NMDARs, mGluRs and AMPARs 
together as a super-complex (Sheng et al., 2000).  Protein levels of GKAP and 
Shank in the PSD are activity-regulated, leading to prominent ubiquitination of 
both proteins (Ehlers, 2003) (Fig 1.7).  Stimulation of neuronal activity causes the 
E3 ligase TRIM3 (tripartite motif-containing protein 3) to stimulate ubiquitination 
and proteasome-dependent degradation of GKAP, causing a subsequent 
reduction of GKAP and Shank from the PSD (Hung et al., 2010).  RNAi against 
TRIM3 on the other hand, prevents synaptic activity-induced loss of GKAP and 
results in an up-regulation of GKAP and Shank, along with an enlargement of 
dendritic spines (Hung et al., 2010).  Interestingly, in a mouse genetic model of 
autism, expression of a single copy of a Shank3 C-terminal deletion mutation 
results in increased polyubiquitination of both Shank3 and NMDAR GluN1 and a 
subsequent reduction of GluN1 (Bangash et al., 2011). 
1.4.3.4 PICK1 
 Protein interacting with C-kinase 1 (PICK1) is a synaptic scaffolding 
protein that interacts with the AMPAR GluA2 subunit (Xia et al., 1999) and other 
synaptic proteins such as transporters and ion channels (Madsen et al., 2005).  
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Parkin, a protein directly linked to Parkinson’s disease, functions as an E3 ligase 
to PICK1 (Fig 1.7).  Parkin binds to PICK1 through a PDZ-mediated interaction to 
enable PICK1 monoubiquitination (Joch et al., 2007).  Interestingly, while parkin 
does not cause PICK1 degradation, monoubiquitination of PICK1 by parkin may 
regulate the effects of PICK1 on the acid-sensing ion channel (ASIC), which may 
contribute to the symptoms observed in PD, such as affected signaling leading to 
excitotoxicity and dopaminergic neuron loss (Joch et al., 2007).  
1.4.3.5 SPAR 
  Spine-associated RapGAP (SPAR) is a multi-domain postsynaptic protein 
that forms a complex with PSD-95 and NMDARs by interacting with the 
guanylate kinase-like domain of PSD-95 to regulate actin dynamics and control 
dendritic shape (Pak et al., 2001).  SPAR undergoes activity-dependent 
phosphorylation-mediated degradation by a serum-inducible serine/threonine 
kinase (SNK) (Pak et al., 2003), also known as polo-like kinase 2 (Plk2).  In the 
presence of Plk2, SPAR physically associates with and is degraded by 
Skp1/Cul1/F-box β-TRCP (SCFβ-TRCP), a multi-subunit E3 ligase (Ang et al., 
2008).  Disruption of the SCFβ-TRCP complex can prevent Plk2-dependent 
degradation of SPAR (Ang et al., 2008).   
1.4.4 Ubiquitination of non-glutamate receptors 
1.4.4.1 GABA Receptors 
GABA receptors (GABARs) mediate the majority of fast inhibitory 
neurotransmission in the brain and are divided into two subclasses: ionotropic 
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GABAA receptors (GABAARs) and metabotropic GABAB receptors (GABABRs).  
GABAARs are heteropentameric chloride channels assembled from a large 
selection of subunits (α1- α6, β1-β3, ɣ1- ɣ3, δ, ε1-ε3, θ and π) which determine 
subsequent channel properties and localization (Jacob et al., 2008). 
GABAAR ubiquitination is strongly regulated by neuronal activity (Fig. 1.8).  
Chronic blockade of neuronal activity using tetrodotoxin (TTX) demonstrates a 
large increase in polyubiquitinated species of GABAARs and a resulting decrease 
in cell surface stability (Saliba et al., 2007).  Conversely, an increase in neuronal 
activity enhances GABAAR stability by decreasing GABAAR ubiquitination (Saliba 
et al., 2007).  Interestingly, ubiquitination appears to target mainly GABARs 
residing in the ER. Thus, increased polyubiquitination of GABAARs reduces 
receptor stability in the ER, leading to a reduction in receptor membrane insertion 
(Saliba et al., 2007). The mechanism underlying the proteasome-dependent loss 
of GABAARs following chronic activity blockade is still unclear but one possibility 
is through the L-type voltage-gated Ca2+ channels (VGCCs), which, when 
activated, alter the GABAAR turnover rate in a proteasome-dependent manner by 
regulating GABAAR insertion into the plasma membrane (Saliba et al., 2009).  
Studies find that the ubiquitin-like protein Plic-1, which does not function for 
ubiquitination, directly interacts with GABAARs to facilitate GABAAR cell surface 
expression (Bedford et al., 2001). Plic-1 can stabilize polyubiquitinated GABAARs 
in the ER, reduce endoplasmic reticulum-associated protein degradation (ERAD) 
and promote GABAAR surface expression (Saliba et al., 2008). Although it  
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Figure 1.8. Ubiquitination of non-glutamate receptors.  (A) GABAergic 
ubiquitination. The specific E3 ligase for GABARs has not been identified, 
although the ubiquitin-like protein Plic-1, which does not function for 
ubiquitination, directly interacts with GABAARs to affect insertion.  It stabilizes 
polyubiquitinated GABAARs in the ER to limit ERAD and promote GABAAR 
surface expression.  Unassembled GABAR subunits in the ER are usually 
ubiquitinated and targeted to the proteasome.  The lysosome also mediates 
GABAAR degradation by ubiquitinating a motif in the intracellular domain of the 
ɣ2 subunit.  (B) Cholinergic synapses.  In the cholinergic synapse, E3 ligases 
remain unidentified though it is known that ubiquitination of the α3, β2, and β4 
nAChR subunits are required for degradation.  (C) Glycinergic synapses.  In 
glycinergic synapses, extensive ubiquitination of the GlyR α1 subunit prior to 
internalization has been observed in Xenopus oocytes though this has not been 
repeated in a mammalian system.  However, it has recently been shown that the 
glycine transporter GLYT1 1b subunit undergoes ubiquitination at lysine 619, 
causing rapid endocytosis.  (D) Dopaminergic synapses.  In dopaminergic 
synapses, KLHL12 acts as an adaptor to the E3 ligase Cul3 to promote 
polyubiquitination of both immature ER-associated and mature membrane-
associated forms of the D4 receptor, though there is apparently neither 
proteasomal nor lysosomal degradation observed.  The D2 receptor subtype is 
known to be monoubiquitinated, although possible polyubiquitinated forms may 
also exist.  An E3 ligase has yet to be identified.  
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appears that the proteasome is heavily involved in GABAAR trafficking, the 
lysosome has also been shown to mediate GABAR degradation. GABAARs are 
targeted to the lysosomal degradation pathway via the ubiquitination of a motif 
within the intracellular domain of the ɣ2 subunit (Arancibia-Carcamo et al., 2009). 
For GABABRs, it has been shown that their degradation is enhanced by blockade 
of GABABR recycling (Grampp et al., 2007). 
1.4.4.2 Acetylcholine Receptors 
The nicotinic acetylcholine receptors (nAChRs) are heteropentamers, with 
the most common configuration as α4(2), β2(3) in the brain. Recent experiments 
in PC12 cells show that ubiquitination of the α3, β2, and β4 nAChR subunits are 
required for degradation (Rezvani et al., 2010) (Fig. 1.8).  Treatment with a 
proteasomal inhibitor demonstrates an increase in total subunit protein levels, as 
well as in fractions enriched for ER/Golgi, indicating a role for the ubiquitin 
pathway in nAChR trafficking. To date, the sites of ubiquitination and a potential 
E3 ligase remain unknown. 
1.4.4.3 Glycine Receptors 
Glycinergic receptors (GlyRs) are heteropentameric chloride channels 
consisting of multiple α (α1- α4) subunits and one β subunit (Betz et al., 2006).  
In Xenopus oocytes, antagonist stimulation causes extensive ubiquitin 
conjugation to the α1 subunit of the GlyR prior to internalization, after which 
internalized GlyRs are proteolytically nicked into small fragments (Buttner et al., 
2001) (Fig. 1.8).  However, the function of GlyR ubiquitination remains unclear 
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and it has not yet been shown in a mammalian system.  Also, the E3 ligase(s) 
that targets GlyRs remains to be determined. In addition, it has recently been 
shown that the glycine transporter GLYT1 1b subunit undergoes ubiquitination at 
lysine 619, causing rapid endocytosis.  This process can be stimulated by the 
PKC activator phorbol 12-myristate 13-acetate (Fernandez-Sanchez et al., 2009).   
1.4.4.4 Dopamine Receptors 
Dopamine receptors (DARs) are G-protein-coupled receptors (GPCRs) 
subdivided into two groups: D1-type (D1 and D5) and D2-type (D2, D3 and D4).  
The D4 receptor has been associated with attention deficit hyperactivity disorder 
and possesses an interesting polymorphism in its third intracellular loop.  
KLHL12, a BTB-Kelch protein, can specifically bind to this region and act as an 
adaptor to a Cullin3-based E3 ubiquitin ligase, thus promoting polyubiquitination 
of the D4 receptor (Rondou et al., 2008; Rondou et al., 2010) (Fig. 1.8).  
Ubiquitination assays of D1, D5 and D2L show that DAR subtypes other than D4 
can undergo basal ubiquitination, although KLHL12 appears to function solely as 
an adaptor for D4 ubiquitination (Rondou et al., 2008).  Further studies show that 
KLHL12 interacts with and promotes the ubiquitination of both immature ER-
associated and mature plasma membrane-associated D4 receptors (Rondou et 
al., 2010).  Surprisingly, experiments show that neither proteasomal ERAD 
degradation of new receptors nor lysosomal degradation of mature receptors 
occurs, an indication that GPCR ubiquitination may not always lead to 
degradation (Rondou et al., 2010).  Another study found that the D2 receptor 
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subtype can be mono-ubiquitinated at K241 in the absence of an agonist.  It is 
interesting to note that the ubiquitination pattern of a generated K241A mutant 
differs distinctly from that of the wild-type D2 receptor, suggesting that loss of the 
K241 site may promote ubiquitination of other lysine residues, thus rendering the 
protein more susceptible to proteasomal degradation.  This may be responsible 
for the observed reduction of mutant K241A membrane-associated DARs (O. J. 
Kim, 2008).   
1.4.5 Ubiquitination of glutamate receptors 
Glutamatergic synapses mediate the vast majority of fast excitatory 
neurotransmission in the brain.  Glutamate receptors are separated into two 
groups: the metabotropic mGluRs and the ionotropic glutamate receptors 
consisting of AMPARs, NMDARs and KARs. Given the importance of receptor 
accumulation at synapses, ubiquitination-dependent receptor trafficking and 
abundance is considered an important regulatory mechanism in synaptic 
plasticity (Fig. 1.9).  In addition to glutamate receptors, the main glutamate 
transporter GLT-1/EAAT2 is shown to be ubiquitinated by the ubiquitin ligase 
Nedd4-2, which mediates the PKC-dependent ubiquitination and down-regulation 
of GLT-1 (Garcia-Tardon et al., 2012; Gonzalez-Gonzalez et al., 2008; Martinez-
Villarreal et al., 2012; Sheldon et al., 2008). 
1.4.5.1 mGluRs 
 The mGluRs are GPCRs that belong to three groups consisting of 
mGluR1-8 and are divided by physiological activity.  The group one mGluRs  
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Figure 1.9. Ubiquitinated proteins at glutamatergic synapses in the 
mammalian system.  mGluR1 and mGluR5 can be ubiquitinated by the E3 
ligase Siah1A, which binds to a site in the C-terminus of both mGluRs.  In 
mGluR5, Siah1A has been shown to mediate ubiquitination at multiple lysine 
residues.  In the case of KARs, actinofilin acts as a scaffold to bind GluK2-
containing KARs to the E3 ligase Cul3.  During NMDAR assembly in the ER, 
glycosylated GluN1 is ubiquitinated by Fbx2, which also can recognize and 
ubiquitinate GluN2A.  Fbx2 can also couple with other co-chaperones such as 
CHIP to regulate GluN2A ubiquitination.  GluN2B on the other hand, is localized 
to the PSD and ubiquitinated by Mib2.  AMPAR ubiquitination in a mammalian 
system has not yet been reported. 
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(mGluR1 and mGluR5) localize primarily to the postsynaptic membrane while the 
remaining two groups localize to the presynaptic sites.  The RING family E3 
ubiquitin ligase, seven in absentia homolog (Siah1A), binds to a site in the C-
terminus of both mGluR1 and mGluR5 that can be competitively inhibited by 
Ca2+/calmodulin (CaM) in a Ca2+-dependent manner (Ishikawa et al., 1999).  
Siah1A-mediated degradation of the group one mGluRs is abolished by 
proteasomal inhibition, as well as by mutations in the RING-finger domain of 
Siah1A (Moriyoshi et al., 2004).  Subsequently, site-directed mutagenesis of 
mGluR5 lysine residues demonstrates that Siah1A-mediated ubiquitination can 
occur at multiple lysine residues (Moriyoshi et al., 2004).  A recent study 
describes a novel interaction between the mGluR-interacting protein Homer-3 
and the S8 ATPase regulatory subunit of the 26S proteasome. Thus, Homer-3 
may serve as an adaptor shuttling ubiquitinated mGluR1α to the proteasome for 
degradation (Rezvani et al., 2012). 
1.4.5.2 Kainate Receptors 
 KARs consist of GluK1-5 subunits. The GluK1-3 subunits can form both 
homomers and heteromers; however, GluK4 and GluK5 can only form functional 
channels in combination with GluK1-3.  GluK2 is targeted by the Cullin 3 (Cul3) 
E3 ubiquitin ligase complex for ubiquitination and degradation. The specificity is 
guided by the adaptor protein actinofilin, which interacts with the E3 ligase and 
the C-terminus of GluK2 (Marshall et al., 2011; Salinas et al., 2006).  It is 
interesting to note that GluK2 is also subject to modification by the small 
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ubiquitin-like modifier protein (SUMO) (Martin et al., 2007), leading to receptor 
internalization. During KAR-mediated LTD, KARs are heavily affected by PKC-
mediated phosphorylation GluK2 at S868, which promotes GluK2 SUMOylation 
at K886 and the subsequent internalization of GluK2-containing KARs 
(Chamberlain et al., 2012; Konopacki et al., 2011; K. A. Wilkinson et al., 2012).  
SUMOylation-induced GluK2 internalization promotes its binding with mixed 
lineage kinase-3 (MLK3), leading to the activation of the MLK3-JNK3 pathway 
that may be responsible for ischemic neuronal cell death (Zhu et al., 2012). 
1.4.5.3 NMDARs 
NMDARs are heterotetramers normally assembled from GluN1 and GluN2 
subunits that come from four gene products (GluN2A-D). During assembly of 
NMDARs, any GluN1 subunits bound to high-mannose glycans are ubiquitinated 
by the neuron-specific F-box protein Fbx2 and degraded through the ERAD 
pathway, with overexpression of Fbx2 leading to enhanced ubiquitination of 
glycosylated GluN1 (Kato et al., 2005).  GluN2 NMDAR subunits can also be 
ubiquitinated. While Fbx2 can recognize GluN1 and GluN2A in different contexts, 
it may couple with other co-chaperones such as CHIP (C-terminus of Hsp70-
interacting protein) to regulate ubiquitination of specific NMDAR subunits, in this 
case GluN2A (Nelson et al., 2006).  NMDAR GluN2B subunits on the other hand 
are ubiquitinated by the RING family E3 ligase Mindbomb2 (Mib2), which is 
localized to the PSD and directly interacts with and ubiquitinates GluN2B to 
down-regulate NMDAR activity (Jurd et al., 2008).  Phosphorylation by the Src-
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family protein-tyrosine kinase Fyn enhances the protein-protein interaction 
between Mib2 and GluN2B and subsequently, the ubiquitination of GluN2B by 
Mib2 (Jurd et al., 2008).  
1.5 AMPAR Ubiquitination 
1.5.1   Overview of AMPAR structure and ubiquitination probability 
 AMPA receptors (AMPARs) are heterotetrameric receptors containing 
subunits GluA1-4.  AMPARs play a critical role in mediating the majority of fast 
excitatory synaptic transmission in the brain, where alterations in receptor 
expression, distribution and trafficking have been shown to underlie synaptic 
plasticity and higher brain function.  Therefore it is critical to elucidate the 
mechanisms regulating AMPAR turnover in order to understand and differentiate 
between normal brain function and the pathology of neurological disorders.  
Evidence from several studies has emphasized the importance of the ubiquitin 
proteasome system (UPS) in mediating AMPAR receptor trafficking and synaptic 
strength both directly and indirectly.   
1.5.2   Non-mammalian AMPAR ubiquitination 
 The first system to show evidence of direct AMPAR ubiquitination was in 
C. elegans, where the corresponding GluR, GLR-1, is shown to be ubiquitinated 
in vivo (Burbea et al., 2002).  Mutations of GLR-1 lysine residues demonstrate an 
increase in GLR-1 synaptic quantity while overexpression of ubiquitin not only 
decreases GLR-1 expression at the synapse but also the density of synapses 
containing GLR-1 (Burbea et al., 2002).  In C. elegans, multiple ubiquitin ligases 
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have been implicated in UPS-dependent regulation of AMPAR synaptic 
abundance, including the anaphase-promoting complex (APC) (Juo et al., 2004), 
CUL3/KEL-8 (Schaefer et al., 2006) and RPM-1 (E. C. Park et al., 2009). AMPAR 
abundance can be affected by other pathways leading to degradation (Dreier et 
al., 2005; Rezvani et al., 2007; Zhang et al., 2009). 
1.5.3 Mammalian AMPAR ubiquitination 
 In a mammalian system, it was observed that pre-treatment with 
proteasomal inhibitors completely and efficiently prevented glutamate-induced 
receptor internalization, indicating the requirement of UPS-dependent protein 
degradation in AMPAR trafficking (Patrick et al., 2003).  However, although the 
UPS was shown to be recruited upon AMPAR activation in order to mediate 
AMPAR internalization, putative targets for degradation were believed to be 
proteins previously observed to interact with AMPARs, such as PSD-95 or other 
scaffolding proteins (Ehlers, 2003).  Whether direct ubiquitination of AMPARs 
occurs in a mammalian system has not yet been observed. 
1.6    Thesis Rationale  
 Understanding the role played by AMPARs in the mammalian brain has 
numerous implications in a number of neurological diseases and disorders, 
including, but not limited to, Alzheimer’s disease, fragile X syndrome and 
addiction.  Therefore, elucidating the underlying molecular mechanisms that 
regulate AMPAR trafficking and turnover is of much importance.  One highly 
studied means of protein regulation is posttranslational modification.  AMPARs 
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have been shown to be modulated by numerous posttranslational modifications; 
however, it was unknown whether ubiquitination, a modification that targets a 
number of neuronal receptors and proteins to regulate their fate and function, 
was also a modulator of AMPARs.  The earliest indication of AMPAR 
ubiquitination was observed in C. elegans, where multiple ubiquitin ligases have 
been implicated in regulating AMPAR synaptic expression levels and the GLR-1 
glutamate receptor is shown to be directly ubiquitinated (Burbea et al., 2002).  
Conversely, in a mammalian system, involvement of the UPS appeared to be 
indirect.  However, proteasomal inhibition effectively prevented glutamate-
induced AMPAR internalization, indicating that there could be a direct role for 
AMPAR ubiquitination.  It therefore became of special interest to investigate this 
possibility.  Towards this end, I performed the following series of experiments in 
order to determine whether mammalian AMPARs undergo ubiquitination, the 
molecular details that underlie how AMPAR ubiquitination occurs and the means 
by which ubiquitinated AMPARs are internalized. 
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CHAPTER TWO 
Materials and Methods 
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2.1 Mutagenesis 
2.1.1 Mutagenesis strategy.  The AMPAR subunit GluA1 contains four lysine 
(K) residues available for modification by ubiquitin at amino acids 813, 819, 822 
and 868.  In order to determine which site(s) are targets for GluA1 ubiquitination, 
various lysine residues on a previously described 8.2 kb GFP-tagged GluA1 
pRK5 construct (Man et al., 2007) were replaced with arginine (R) residues using 
Stratagene’s QuikChange Lightning Site-Directed Mutagenesis Kit optimized for 
plasmids from 4-14 kb.  Mutagenic primers were designed according to 
Stratagene’s primer design guidelines and assembled using oligonucleotide 
design software by Integrated DNA Technologies from which primers were also 
purchased. To create single mutants, the primer pairs for K813R, K819R, K822R 
and K868R were used to generate their respective mutants.  To create a mutant 
with the first three lysines K813/819/822 mutated to arginines (F3R), the GluA1 
K813R single mutant was used with the K819/822R primer pair to mutagenize 
both the K819 and K822 sites simultaneously, creating a triple mutant.  To create 
the 4KR mutant with all four lysine residues mutated to arginines, the F3R mutant 
with the first three lysines mutated to arginines was further mutagenized using 
the K868R primer pair.  Mutations were verified by DNA sequencing. 
2.1.2 Primer design. 
GluA1 K813R 
Forward:  
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5’ GCCTTAATCGAGTTCTGCTACAGATCCCGTAGCGAGTCGAAGCGG 3’ 
Reverse:  
5’ CCGCTTCGACTCGCTACGGGATCTGTAGCAGAACTCGATTAAGGC 3’ 
GluA1 K819R 
Forward: 5’ CGTAGCGAGTCGAGGCGGATGAAGGGTTTC 3’ 
Reverse: 5’ GAAACCCTTCATCCGCCTCGACTCGCTACG  3’ 
GluA1 K822R 
Forward: 5’ GATCAAACAGAAACCCCTCATCCGCTTCGACTC 3’ 
Reverse: 5’ GAGTCGAAGCGGATGAGGGGTTTCTGTTTGATC 3’ 
GluA1 K868R 
Forward: 5’ GTCAGCCAGGACTTCCCCAGGTCCATGCAATCCATTCCC 3’ 
Reverse: 5’ GGGAATGGATTGCATGGACCTGGGGAAGTCCTGGCTGAC 3’ 
GluA1 K819/822R 
Forward:  
5’ CCCGTAGCGAGTCGAGGCGGATGAGGGGTTTCTGTTTGATCCC 3’ 
Reverse:  
5’ GGGATCAAACAGAAACCCCTCATCCGCCTCGACTCGCTACGGG 3’ 
2.1.3 Polymerase chain reaction (PCR).  The mutagenesis PCR reaction 
cocktail was prepared with reagents provided in Stratagene’s QuikChange 
Lightning Site-Directed Mutagenesis Kit using the following recipe: 38.5 µl 
ddH2O, 5.0 µl 10X reaction buffer, 1.0 µl 125 ng Forward Primer, 1.0 µl 125 ng 
Reverse Primer, 1.0 µl dNTPs, 1.5 µl QuikSolution reagent, 1.0 µl QuikChange 
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Lightning Enzyme, and 1.0 µl 10-100 ng of the GFP-tagged GluA1 pRK5 
construct.  The reaction was then run in a PCR thermal cycler using the following 
cycles: denaturation for 2 minutes at 95ºC, followed by 18 cycles of annealing for 
20 seconds at 95ºC, 10 seconds of extension at 60ºC and about 5 minutes of 
extension (30 seconds per kb with GFP-tagged GluA1 at about 8.2 kb) at 68ºC.  
A final extension time of 5 minutes at the end of the cycles at 68ºC was included 
before holding at 4ºC until the PCR reaction was processed.  In order to clean up 
the PCR reaction mixture by digesting methylated parental DNA, 2 µl of DpnI 
restriction enzyme was added and the mixture incubated at 37ºC for 5 minutes.   
2.1.4 Transformation and colony selection.  In order to transform the PCR 
products, 50 µl of XL1-Gold Supercompetant cells were thawed on ice, added to 
pre-chilled snap-cap tubes, then pre-treated with 2 µl β-mercaptoethanol for 2 
minutes before 2 µl of DpnI treated DNA was added to the cells.  The cell mixture 
was then incubated on ice for up to 30 minutes before reactions were heat 
shocked for 30 seconds at 42ºC and cooled on ice for 2 minutes.  Afterwards, 
500 µl of NZY+ broth (10 g casein hydrolysate, 5 g yeast extract, 5 g NaCl, 
ddH2O to 1L, pH to 7.5 and autoclaved prior to the addition of 12.5 ml each of 
filter-sterilized 1 M MgCl2 and 1 M MgSO4 as well as 10 ml 2 M glucose) was 
added to the contents of the tube and incubated in a 37ºC shaker at 250 rpm for 
1 hour.  After 1 hour, the entire volume of the sample was plated onto ampicillin 
agarose plates and incubated overnight in a 37ºC incubator for about 16 hours.  
The following day, colonies were selected and innoculated in 2 mls of LB media 
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(Table 2.1) containing 1:1000 ampicillin (100 mg/ml stock) overnight in a 37ºC 
shaker at 250 rpm.  
2.1.5 Mini-prep.  DNA from the selected cultures was purified using QIAgen’s 
QIAprep Miniprep Kit.  Mini-prep cultures were transferred to microcentrifuge 
tubes and centrifuged on a table-top microcentrifuge for about 1 minute to pellet 
cells.  The supernatant was removed and the pellet was resuspended in 250 µl of 
Buffer P1.  After resuspension, 250 µl of Buffer P2 was added and the tube was 
gently mixed until homogenous.  Then 350 µl of Buffer N3 was added and the 
contents thoroughly mixed.  The tube was then centrifuged for 10 minutes at 
13,000 rpm (about 18,000 x g) in a table-top microcentrifuge.  The supernatants 
were then applied to a QIAprep spin column by pipetting and centrifuged for 60 
seconds.  The flow-through was discarded and the QIAspin column was washed 
with 750 µl of Buffer PE and centrifuged again for 60 seconds.  After discarding 
the flow-through, the spin column was centrifuged for an additional 1 minute to 
remove any residual wash buffer.  The QIAprep column was then placed in a 
clean microcentrifuge tube and 50 µl of Buffer EB was added.  After 1 minute of 
incubation, DNA was eluted with centrifugation for 1 minute. 
2.1.6 Restriction digest.  In order to confirm that the purified mini-prep DNA 
from selected colonies contained the correct DNA plasmid instead of damaged 
copies, a restriction digest was performed using the restriction enzymes EcoRI 
and HindIII.  The purified mini-prep DNA was digested for 1 hour on a 37ºC heat 
block either with or without restriction enzymes as a control.  For the digestion 
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with restriction enzymes, 3.0 µl of mini-prep DNA was added to 7.0 µl of a master 
mix containing 4.6 µl of ddH2O, 1.0 µl of 10X restriction enzyme buffer, 1.0 µl 
10X BSA and 0.2 µl each of EcoRI and HindIII per sample.  For the digestion 
control without restriction enzymes, 3.0 µl of mini-prep DNA was added to 7.0 µl 
of a master mix containing 5.0 µl of ddH2O, 1.0 µl of 10X restriction enzyme 
buffer and 1.0 µl 10X BSA per sample.  Control samples using the original GFP-
GluA1 DNA were also incubated with and without restriction enzymes, though 
due to the higher concentration of DNA, 0.5 µl of the control DNA was added to 
2.5 µl of ddH2O to make a DNA mixture of 3.0 µl for incubation.  During the one 
hour incubation, a 0.8% agarose gel was cast according to the following recipe: 
50 ml 1X TAE buffer (40 mM Tris, 20 mM glacial acetic acid, 1 mM EDTA), 0.4 g 
low-melt agarose and 0.5 µl of ethidium bromide.  When samples were finished 
incubating, 2 µl of 6X DNA loading buffer (Novagen) were added to each sample 
and mixed, before half of each sample was loaded into the DNA agarose gel and 
run at 100 mV in 1X TAE buffer using BioRad’s Mini-Sub cell GT system for 
horizontal nucleic acid gel electrophoresis.  DNA gels were visualized under UV 
light using BioRad’s Molecular Imager Gel Doc XR Imaging System.   Following 
confirmation of which cut and uncut samples matched those of the control 
template, selected samples were then sent to Genewiz for DNA sequencing in 
order to verify samples with successful mutagenesis of the template plasmid.  
Once plasmids containing the desired mutations sites were confirmed, more DNA 
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was generated using DH5α E. coli competent cells and the NucleoBond Xtra 
plasmid purification kit. 
 
2.2 Generation of bacterial E.coli competent cells.  E. coli cells were streaked 
from frozen stocks and cultured overnight on an LB plate in a 37ºC incubator.  
Several colonies were then selected and inoculated into 100 ml of SOB medium 
(Table 2.1) in a 1-liter conical flask.  The cells were cultured at room temperature 
with shaking at 250 rpm to an OD600 of 0.5-0.7 before being chilled on ice for 10 
minutes and collected by centrifugation at 2600 rpm for 5 minutes at 4ºC.  The 
pellets were resuspended in 30 ml of ice-cold TB buffer (Table 2.1) and 
incubated on ice for 10 minutes.  Cells were collected by centrifugation at 2600 
rpm for 5 minutes at 4ºC, then resuspended in 5 ml of ice-cold TB buffer.  DMSO 
was then added to a final concentration of 7% and the cell suspension was 
aliquoted into pre-cooled sterile eppendorf tubes at about 100 µl per tube.  The 
competent cells were then kept at -80ºC until needed. 
 
2.3 DNA plasmid purification. 
2.3.1 Transformation into bacterial E. coli competent cells.  DH5α E. coli 
cells were gently thawed on ice before 50 µl were aliquoted to pre-chilled snap 
cap tubes and 1 µl of DNA was added.  Tubes were swirled and incubated for 30 
minutes on ice before being heat shocked for 45 seconds in a 42ºC waterbath.  
After being chilled for 2 minutes on ice, 500 µl of LB media was added and cells 
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were incubated for 45 minutes in a 37ºC shaker.  Following incubation, 100 µl of 
cells were plated onto LB agar plates containing the appropriate antibiotic and 
allowed to sit for about 10 minutes at room temperature and incubated for about 
16 hours overnight in a 37ºC incubator. 
2.3.2 Colony selection and mini-prep.  Selected colonies were inoculated and 
grown in snap-cap tubes containing 2 ml LB media with antibiotics for 8 hours in 
a 37ºC shaker.  After 8 hours, a 1:1000 concentration of the cell suspension and 
1:1000 concentration of antibiotics was added to 100 ml of LB in a 500 ml 
autoclaved sterile flask and grown overnight in a 37ºC shaker. 
2.3.3 Midi-prep and DNA purification.  Midi-preps were performed using the 
NucleoBond Xtra plasmid purification kit.  Cells were harvested with 
centrifugation at 4000 rpm for 20 minutes and the pellets were resuspended in 8 
ml of RES solution containing RNAse A and transferred to a 50 ml conical tube.  
The contents were lysed by the addition of 8 ml of LYS solution and incubated for 
less than 5 minutes at room temperature.  In the meantime, NucleoBond Xtra 
columns with filters were equilibrated with 12 ml of EQU solution.  The lysed cell 
solution was then neutralized with 8 ml of NEU solution and inverted 10-15 times 
to mix before the contents were poured into the equilibrated columns and allowed 
to drain.  The filter columns were then washed with an additional 5 ml of EQU 
solution and the filters discarded before a final wash with 8 ml WASH solution.  
After the final wash, DNA was eluted from the columns by adding 5 ml of ELU 
solution and allowed to drain into centrifuge tubes.  The DNA eluate was 
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combined with 3.5 ml of isopropanol and allowed to sit at room temperature for 2 
minutes to precipitate the DNA.  The centrifuge tubes were then spun in a Sorvall 
centrifuge at 7,500 x g for 30 minutes at 4ºC.  The supernatant was discarded 
and 1 ml of 70% ethanol was added to the precipitated DNA and the contents 
were transferred to a microcentrifuge tube and spun at 14,000 rpm at 4ºC for 10 
minutes.  The supernatant was discarded and the tube was respun to eliminate 
residual traces of ethanol.  The pellet was dried for about 5-10 minutes at room 
temperature and then resuspended in sterile ddH2O.  The concentration of the 
DNA was read on a Nanodrop machine and adjusted with sterile ddH2O to a final 
concentration of 1 λ (1 mg/ml).  Stocks of DNA were kept at -20ºC while working 
stocks were kept at 4ºC to prevent DNA damage from continuous freeze/thaw 
cycles.   
 
2.4     Cell Culture 
2.4.1 Generation and maintenance of rat embryonic primary cell culture.  
Primary cultured cortical neurons were prepared from embryonic day 18 (E18) rat 
embryos.  Prior to dissection, dissection instruments were soaked in 70% 
ethanol, flame-sterilized and treated under a UV light for about 15 minutes.  The 
rat dam was anesthetized in a CO2 chamber for about one minute before cervical 
dislocation was performed to sacrifice the animal.  The uterine horns containing 
the embryos were then dissected out and placed in a sterile petri dish before E18 
embryos were removed from the uterine horns and decapitated.  Embryonic 
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brains were then removed from the heads via a lateral incision across the cranial 
midline and placed in a sterile petri dish containing HBSS (Thermo Scientific) on 
ice.  The dura was removed from both cortices before hippocampal regions and 
cortical regions were dissected and placed in separate dishes with HBSS on ice.  
Brain tissues (cortical and hippocampal) were then pipetted to separate tubes 
containing an appropriate volume of papain digestion solution (Table 2.1) and 
incubated in a 37°C water bath for 20 minutes with inversions every 5 minutes to 
digest the tissue thoroughly.  The tissue was then removed and placed into 
trituration solutions for cortex (18 ml HBSS, 2 ml 10/10, 20 µl 1% DNase) and 
hippocampus (6 ml HBSS, 670 µl 10/10, 6 µl 1% DNase).  Cells were triturated 
using a 5 ml pipet for about 20 strokes until the cells appeared dissociated.  
Untriturated cells were left at the bottom of the tube and the remainder was 
transferred to a new tube and centrifuged for about 3 minutes at 2.1 x g.  Cortical 
pellets were resuspended in about 50 ml of plating media (Table 2.1) and 
hippocampal pellets in about 3-5 ml of plating media.  Dissociated cortical 
neurons were then seeded onto poly-L-lysine-coated 60 mm dishes at 3x106 
cells per dish or poly-L-lysine-coated 6-well plates at 1x106 cells per well.  
Dissociated hippocampal neurons were plated at approximately 0.6x106 cells per 
60 mm dish containing five coverslips (coverslips were cleaned in nitric acid 
overnight, washed thoroughly in ddH2O and placed in 70% ethanol prior to being 
flame-sterilized and coated in poly-L-lysine).  Neurons were maintained in 
feeding medium (Table 2.1) made from Neurobasal medium (Gibco) for 2-3 
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weeks until use in a humidified 37°C incubator containing 5% CO2.  One week 
after plating, 5 µM of 5-Fluoro-2'-deoxyuridine (FDU) was added to the media to 
inhibit glial cell proliferation.   
2.4.2 Maintenance of human embryonic kidney (HEK) 293A cell cultures.  
Human embryonic kidney (HEK) 293A cells were cultured in Dulbecco’s Modified 
Eagle Medium (Gibco) supplemented with 10% heat-inactivated fetal bovine 
serum (FBS) and 1% penicillin/streptomycin and passaged at 100% confluency 
twice a week.  Cells were maintained in a humidified 37°C incubator with an 
atmosphere containing 5% CO2. 
 
2.5       Transfection. 
2.5.1    Primary cell culture transfection. 
2.5.1.1 Hippocampal culture coverslips.  Coverslips were transferred to 
individual wells of a 12-well dish containing 500 µl of feeding medium and 
transfections performed at about 10-11 days in vitro (DIV).  Lipofectamine 2000 
(Invitrogen) was used for transfection of cultured neurons according to 
manufacturer’s instructions.  In brief, for each well 1 µg of DNA total was added 
to 25 µl of serum-free media in a sterile microcentrifuge tube while 1 µl of 
Lipofectamine was added to 25 µl of serum-free media in another sterile 
microcentrifuge tube and both solutions were allowed to incubate for 5 minutes at 
room temperature.  The two solutions were then combined and incubated for 20 
minutes at room temperature before the contents were applied to a single well.  
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The transfection was allowed to proceed for about 4 hours in a 37°C incubator 
before the media was replaced with 1 ml of feeding media.  Cells were used for 
experiments approximately 2 days post-transfection. 
2.5.1.2 Cortical culture 60 mm dishes.  Transfections in cortical dishes were 
performed at about 10-11 DIV using Lipofectamine 2000.  For each dish 3 µg of 
DNA total was added to 50 µl of serum-free media in a sterile microcentrifuge 
tube while 3 µl of Lipofectamine was added to 50 µl of serum-free media in 
another sterile microcentrifuge tube and both solutions were allowed to incubate 
for 5 minutes at room temperature.  The two solutions were then combined and 
incubated for 20 minutes at room temperature before the contents were applied 
to a single dish.  The transfection was allowed to proceed for about 4 hours in a 
37°C incubator before the media was replaced with 3 ml of feeding media.  Cells 
were used for experiments approximately 2 days post-transfection. 
2.5.2 HEK 293A cell culture transfection. 
2.5.2.1 60 mm dishes.  Transfections were performed at approximately 50-70% 
confluency using Lipofectamine 2000.  For each dish 3 µg of DNA total was 
added to 50 µl of serum-free media in a sterile microcentrifuge tube while 3 µl of 
Lipofectamine was added to 50 µl of serum-free media in another sterile 
microcentrifuge tube and both solutions were allowed to incubate for 5 minutes at 
room temperature.  The two solutions were then combined and incubated for 20 
minutes at room temperature before the contents were applied to a single dish.  
The transfection was allowed to proceed overnight for about 12 hours in a 37°C 
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incubator before the media was replaced with 3 ml of fresh HEK feeding media 
(Table 2.1).  Cells were used for experiments approximately 2 days post-
transfection. 
2.5.2.2 6-well plates.  Transfections were performed at approximately 50-70% 
confluency using Lipofectamine 2000.  For each well, 2 µg of DNA total was 
added to 50 µl of serum-free media in a sterile microcentrifuge tube while 2 µl of 
Lipofectamine was added to 50 µl of serum-free media in another sterile 
microcentrifuge tube and both solutions were allowed to incubate for 5 minutes at 
room temperature.  The two solutions were then combined and incubated for 20 
minutes at room temperature before the contents were applied to a single well.  
The transfection was allowed to proceed overnight for about 12 hours in a 37°C 
incubator before the media was replaced with 2 ml of fresh HEK feeding media.  
Cells were used for experiments approximately 2 days post-transfection. 
 
2.6 siRNA.   
2.6.1 siRNA sequences.  Nedd4 siRNA (#sc-41080, Santa Cruz Biotechnology, 
Inc.) is a pool of three target-specific siRNAs (A, B and C) against the mouse 
Nedd4 sequence.  The sequences are as follows: (A) 
CCAUGAAUCUAGAAGAACA (B) GAUCACCUCUCAUACUUCA (C) 
CUGUUCACUUGUCCAGUUA.  The pool was initially chosen in order to 
knockdown Nedd4 in both rat and human cell lines.  The human Nedd4 
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sequence shares target sites A (100% homology) and B (94% homology), while 
the rat Nedd4 sequence shares all three sites (A 89%, B 100%, C 89%).      
 Eps15 siRNA (s162462, Ambion) is rat specific with the following sequence: 
GGCUUUUCACUUAAUCAAUtt. 
 Scrambled siRNA (Cat# 4390843, Ambion) was used as a control for both 
Nedd4 and Eps15 siRNA. 
2.6.2 siRNA transfection. Nedd4 siRNA and a scrambled siRNA control were 
transfected into HEK cells at 25 nM and into rat primary neurons at 1 nM using 
Lipofectamine 2000 according to manufacturer’s directions.  Eps15 siRNA and a 
scrambled siRNA control were transfected into rat hippocampal neurons at 20 
nM also using Lipofectamine 2000.  
 
2.7        Virus generation and production. 
2.7.1.   Subcloning into viral vectors.   
2.7.1.1 Strategy and primer design.  In order to observe the effect of Nedd4.1 
overexpression in primary cell culture via biochemistry, a virus was required to 
increase the rate of transfection.  Therefore, full length human Nedd4.1 in a 
pSwick (pMT3) vector (a kind gift from Dr. Peter M. Snyder, University of Iowa) 
was subcloned into the lentiviral vector pHAGE-CMV-MCS-1ZsGreenW (a kind 
gift from Dr. Angela Ho, Boston University) by PCR amplifying Nedd4.1 from its 
parent vector to include the restriction sites NotI and BamHI and subsequently 
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inserting it into the NotI and BamHI restriction sites in the MCS (multiple cloning 
site) region of the destination vector. 
The following oligonucleotides were designed and obtained from 
Integrated DNA Technologies and used for the amplification PCR to generate a 
Nedd4.1 insert flanked by NotI and BamHI: 
NotI-Nedd4.1: Forward  
5’ GCGCGGCCGCATGGCAACTTGCGCGGTGGAG 3’ 
BamHI-Nedd4.1: Reverse  
5’ GCGGATCCCTAATCAACTCCATCAAAGCCCTGGG 3’ 
2.7.1.2 PCR and DNA purification.   
Using the oligonucleotides described above, Nedd4.1 was PCR amplified.  
The PCR product was then run on a 0.8% DNA gel in 1X TAE buffer at 100 mV 
using BioRad’s Mini-Sub cell GT system for horizontal nucleic acid gel 
electrophoresis.  The gel was briefly visualized under UV light using BioRad’s 
Molecular Imager Gel Doc XR Imaging System to confirm the correct molecular 
weight of the amplified product).  The band was then visualized and excised with 
a clean razor blade using a UV-light box and placed in a sterile microcentrifuge 
tube.   
The resultant gel slice was subsequently purified using the QIAGEN 
QIAquick Gel Extraction Kit according to manufacturer’s instructions.  In brief, the 
gel slice was weighed and 3 volumes of Buffer QG were added to 1 volume of 
gel (100 mg ~ 100 µl) and incubated at 50ºC for up to 10 minutes for the gel slice 
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to completely solubilize.  Once the gel slice was dissolved completely, 1 gel 
volume of isopropanol was added to increase the yield of DNA fragments >4 kb.  
The contents of the tube were then applied to a QIAquick spin column in a 
provided 2 ml collection tube and centrifuged for 1 minute to bind the DNA to the 
column – the flow-through was discarded.  An additional 0.5 ml of Buffer QG was 
applied to the column and centrifuged for 1 minute to remove all traces of 
agarose, followed by a wash of 0.75 ml of Buffer PE and another 1 minute 
centrifugation with flow-through discarded in both instances.  Since Buffer PE 
contains ethanol, an additional centrifugation at 17,900 x g (13,000 rpm) for 1 
minute was performed to ensure that no residual traces of ethanol remained in 
the spin column.  The QIAquick column was then placed into a clean 1.5 ml 
microcentrifuge tube.  To elute the DNA from the column, 30 µl of Buffer EB was 
added to the center of the QIAquick membrane for 1 minute before being 
centrifuged for 1 minute. 
2.7.1.3 Restriction digests and ligation.  The destination vector pHAGE-CMV-
MCS-1ZsGreenW was digested with NotI and BamHI to expose the 
complementary sticky ends to the intended Nedd4.1 insert.  The Nedd4.1 insert 
was then ligated into the lentiviral vector to create pHAGE-Nedd4.1.  The NotI 
and BamHI sites were regenerated.  
In order to confirm correct subcloning of the Nedd4.1 insert into the 
lentiviral vector, the new pHAGE-Nedd4.1 vector was transformed into DH5α E. 
coli competent cells and mini-prepped.  Samples were then digested for 1 hour 
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on a 37ºC heat block either with or without NotI and BamHI.  For the digestion 
with restriction enzymes, 3.0 µl of DNA was added to 4.6 µl of ddH2O, 1.0 µl of 
10X restriction enzyme buffer, 1.0 µl 10X BSA and 0.2 µl each of NotI and 
BamHI.  For the digestion control without restriction enzymes, 3.0 µl of DNA was 
added to 5.0 µl of ddH2O, 1.0 µl of 10X restriction enzyme buffer and 1.0 µl 10X 
BSA.  After 1 hour, 2 µl of 6X DNA loading buffer (Novagen) was added to each 
sample and mixed, before half of each sample was loaded into a 0.8% DNA 
agarose gel and run at 100 mV on BioRad’s horizontal electrophoresis system.  
DNA gels were visualized under UV light using BioRad’s Molecular Imager Gel 
Doc XR Imaging System.  Upon confirmation of successful subcloning, mini-
prepped DNA was then transformed into DH5α E. coli competent cells and midi-
prepped to generate more DNA. 
2.7.2 Lentivirus purification and transduction.  To package lentiviral 
particles, 6-well plates containing HEK 293T cells at 80-90% confluency were 
transfected for 4 hours with 3 μg pHDM-Tat 1b (tat accessory protein), 3 μg 
pRC/CMV-Rev 1b (rev accessory protein), 3 μg pHDM-Hgpm2 (HIV gag-pol 
expression plasmid), 6 μg pHDM.G (env, VSVG pseudotype) and 12 μg of the 
target vector (either pHAGE control or pHAGE-Nedd4.1) using Lipofectamine 
2000 (Invitrogen) in OPTI-MEM (Gibco) medium.  After 4 hours, the transfection 
solution was replaced with fresh complete DMEM (10% FBS, 1% Pen/Strep).  
Approximately 48-72 hours posttransduction, cell debris was removed by 
centrifugation at 1750 x g for 5 minutes.  One volume of PEG-it Virus 
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Precipitation Solution (System Biosciences) was added to every 4 volumes of 
supernatant and the virus mixture was allowed to precipitate overnight at 4ºC.  
The following day, the supernatant was removed after 1500 x g centrifugation at 
4ºC for 30 minutes.  Residual supernatant was removed after an additional spin 
for 5 minutes.  The resultant pellet was resuspended in 200 μl OPTI-MEM and 
stored at -80ºC.  The pHAGE and pHAGE-Nedd4.1 viruses were used at 
approximately 1:50-1:100 to infect HEK 293A cells at 70% confluency and 
allowed to incubate without medium change until experiments 48-72 hours post-
infection.  For neuronal infection, 10-11 DIV cortical neurons were incubated with 
a similar concentration of control and Nedd4 viruses without medium change until 
use at DIV 14.   
2.7.3. Adenovirus purification and transduction.  The ubiquitin (Ub) 
adenovirus used was a kind gift from Dr. Fu Shang, Tufts University.  To prepare 
the adenovirus for use, approximately 2-5 μl of a 109 pfu/ml stock of Ub 
adenovirus was added to 2.5 ml DMEM/2% FBS, which was then added to a 10 
cm dish of 293A cells at 80-90% confluency and incubated for 1.5 hours.  Media 
was replaced with 20 ml DMEM containing 2%FCS/L-glutamine.  Cells were 
harvested after 30-48 hours and collected using centrifugation at 180 x g for 5 
minutes.  Cells were washed once with sterile PBS (Table 2.1), collected again at 
180 x g for 5 minutes and then resuspended in 0.2 ml of 10 mM Tris pH 8.1 and 
freeze/thawed 3-5x to release virus from the cells.  Lysates were then centrifuged 
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for 10 minutes at 4000 x g and frozen at -80°C.  The Ub adenovirus was used at 
concentrations of 1:500-1:1000 to treat primary neuronal cultures. 
 
2.8    Immunoprecipitation (IP). 
2.8.1 Standard IP and co-IP.  Cortical neurons were rinsed with 1 ml cold 1X 
artificial cerebral spinal fluid (ACSF, Table 2.1) while HEK cells were rinsed with 
1 ml of cold PBS.  Both types of cells were lifted from dishes using a cell scraper 
into their respective solutions and briefly centrifuged at about 1000 rpm (Thermo 
IEC Centra CL2) for 1 minute to collect cells.  The cells were then resuspended 
in 100-200 µl of modified RIPA lysis buffer (Table 2.1) containing mini complete 
protease inhibitor (Roche).  For IPs necessitating the preservation of ubiquitin 
chains, 5 μM of ubiquitin aldehyde (Sigma) was also added to the modified RIPA 
lysis buffer in order to inhibit deubiquitination.  For IPs requiring the inhibition of 
conventional protein-protein binding in order to confirm direct ubiquitination of 
targeted proteins, the modified RIPA lysis buffer contained 1% SDS, instead of 
0.1% SDS, along with 5 μM of ubiquitin aldehyde and mini complete protease 
inhibitor.   
 Lysates were further solubilized by sonication and 10 minutes of 
incubation on ice followed by centrifugation for 10 minutes at 13,000 x g to 
remove insolubilities.  Supernatants were then transferred to new tubes and a 
small volume of about 15 µl per sample reserved and combined with 15 µl 2X 
Laemmli buffer (Table 2.1) as input controls.   Volumes of remaining 
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supernatants were adjusted to 500 µl with NP40 IP buffer (Table 2.1) plus mini 
complete protease inhibitor.  Depending on experimental conditions, ubiquitin 
aldehyde and/or 1% SDS were also added to the NP40 IP buffer as required.  
Antibodies against the protein of interest were then added (Table 2.2) and 
incubated along with 30 µl of a 50% slurry of protein A-Sepharose beads (Santa 
Cruz Biotechnology) with rotation overnight for 8-12 hours at 4°C.  The following 
day, immunocomplexes were washed 3 times with ice-cold NP40 IP buffer, 
resuspended in 30 µl of 2X Laemmli buffer and proteins denatured on a 95°C 
heat block for 10 minutes.  Immunoprecipitates were separated by SDS-PAGE.   
2.8.2 Surface and intracellular double IP.  HEK 293A cells were transfected 
with GFP or GFP-GluA1 alone, or GFP-GluA1 together with HA-ubiquitin.   Two 
days post-transfection, live cells were incubated with anti-GFP antibodies (Table 
2.2) for 10 minutes in culture medium at room temperature.  After incubation, 
cells were washed three times with cold PBS on ice to remove free GFP 
antibodies and a cell lifter was used to transfer cells to microcentrifuge tubes.  
The tubes were briefly centrifuged at about 1000 rpm for 1 minute, the 
supernatant discarded and the cells lysed in 100 µl of modified RIPA lysis buffer 
with mini complete and ubiquitin aldehyde (5 µM).  Lysates were further 
solubilized by sonication and 10 minutes of incubation on ice.  A small volume of 
15 µl per sample was reserved and combined with 15 µl 2X Laemmli buffer as 
controls for total protein levels.  The volumes of remaining lysates were adjusted 
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to 500 µl with NP40 IP buffer containing mini complete and ubiquitin aldehyde (5 
µM).   
The lysates were then incubated with 30 µl protein A-Sepharose beads for 
2 hours on rotation at 4°C to isolate the live-labeled surface GFP-tagged 
proteins.  Following the incubation, the tubes were centrifuged to collect the 
beads while the supernatants were transferred to new microcentrifuge tubes.  
The beads from this first IP (surface) were resuspended in 30 µl of 2X Laemmli 
buffer and incubated on a 95°C heat block for 10 minutes to denature proteins.   
Meanwhile, the supernatants were incubated with 2 µl anti-GluA1Ct 
antibodies and 30 µl protein A-sepharose beads per sample to isolate 
intracellular GFP-GluA1 overnight on rotation at 4°C.  Afterwards, the tubes were 
centrifuged to collect the beads.  The beads from this second IP (intracellular) 
were resuspended in 30 µl of 2X Laemmli buffer and incubated on a 95°C heat 
block for 10 minutes to denature proteins.    
 The pellet eluates from both rounds of immunoprecipitation were 
subjected to SDS-PAGE gels and probed with anti-ubiquitin and anti-GluA1Ct 
antibody.  
 
2.9 Surface biotinylation.  Cells were washed twice with either ACSF (neurons) 
or PBS (HEK cells) and then incubated in a solution of 1 mg/ml EZ-Link Sulfo-
NHS-LC Biotin (Thermo Scientific) in aCSF or PBS for 15 minutes on ice.  Cells 
were then washed at least three times before lysis in 100 µl of RIPA buffer 
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containing protease inhibitor.  A sample of the total lysate was reserved for input 
while the remainder was incubated overnight at 4°C on a rotator with 60 µl of a 
50% slurry of NeutrAvidin Ultralink Resin (Thermo Scientific) and 400 µl of NP40 
IP buffer.  The following day, samples were washed at least three times and 
surface-linked complexes were eluted in 60 µl of Laemmli buffer at 95°C for 10 
minutes.  The eluates were then subjected to SDS-PAGE and probed with 
antibodies. 
 
2.10 Synaptosomal Preparations. 
2.10.1  Adult rat brain synaptosome isolation.  Cortical tissue dissected from 
rat brains was minced and homogenized in either ice cold RIPA lysis buffer (for 
control lysate) or in ice cold synaptosome solution (Table 2.1) for synaptosome 
purification.  Samples were then transferred to fresh 15 ml conical tubes and 
further solubilized by a half hour extraction at 4°C.  The sample was then 
centrifuged at 1,400 x g for 10 minutes.  The supernatant (S1) was transferred to 
a new tube, and centrifuged at 13,800 x g for 10 minutes.  The remaining pellet 
(P2) containing the synaptosomes was resuspended in RIPA lysis buffer.   
Protein amounts for both control and synaptosomal samples were obtained using 
the Pierce BCA Protein Assay kit and samples were diluted to the same protein 
concentration with RIPA lysis buffer.  2X Laemmli buffer was then added and 
samples were denatured on a 95°C heat block for 10 minutes.  Purity was further 
confirmed by western analysis. 
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2.10.2  Cortical culture isolation.  High-density cultured cortical neurons were 
scrapped into 500 µl of HEPES-buffered sucrose (Table 2.1) containing mini 
complete protease and phosphatase inhibitors (Roche).  Cells were then 
homogenized with 30 strokes of a glass pestle, transferred to a sterile 
microcentrifuge tube and solubilized by rotation at 4°C for 2 hours.  A small 
volume of the lysate was reserved at this point as “total lysate”.  To isolate cell 
nuclei from the lysate (P1), solubilized lysates were centrifuged at 800-1000 x g 
at 4°C for 1 minute.  The resulting supernatant (S1) was then centrifuged at 
about 10,000 x g (around 15,000 rpm) in an Optima TLX Ultracentrifuge using a 
Beckman TLA 110 rotor at 4°C for 15 minutes to yield the crude synaptosomal 
pellet (P2).  A small volume of the supernatant (S2) was reserved as a control for 
cytoplasmic and non-membrane bound proteins.  Reserved lysates were then 
lysed in modified RIPA lysis buffer containing protease and phosphatase 
inhibitors and a BCA protein assay was performed to normalize protein amounts 
across different fractions.  Samples were diluted to the same protein 
concentration with RIPA lysis buffer.  2X Laemmli buffer was then added and 
samples were denatured on a 95°C heat block for 10 minutes.  Purity was further 
confirmed by western analysis. 
 
2.11 Immunoblotting and biochemistry. 
2.11.1 Preparation of buffers and gels for SDS-PAGE.  Tris-Glycine SDS gels 
for electrophoresis were cast using 1.0 mm glass plates and Mini-PROTEAN 
76 
 
Tetra Cell casting modules from BioRad.  Gels contained about 5 mL of an 8% 
resolving gel (2.3 mL ddH2O, 1.3 mL 1.5M Tris-HCl pH 8.8, 0.05 mL 10% SDS, 
0.05 mL 10% Ammonium Persulfate, 1.3 mL 30% Acrylamide-BIS, 0.002 mL 
TEMED) overlaid with about 1 mL of a 5% stacking gel (0.68 mL ddH2O, 0.13 
mL 1.0M Tris-HCl pH 6.8, 0.01 mL 10% SDS, 0.01 mL 10% Ammonium 
Persulfate, 0.17 mL of a 30% Acrylamide-BIS, 0.001 mL TEMED).  1X Running 
Buffer was made from a 10X stock (Table 2.1) along with 1X Transfer Buffer 
(10% 10X stock, 20% methanol), also from a 10X stock (Table 2.1). 
2.11.2 SDS-PAGE running conditions and transfer to PVDF membranes.  
Once the gels were polymerized, they were assembled in BioRad’s Mini-
PROTEAN Tetra Cell system for vertical gel electrophoresis.  1X Running buffer 
was added to the anode and cathode chambers before samples were loaded 
onto the gels.  Electrophoresis was conducted at a constant voltage of 70 mV for 
about 30 minutes or until the dye front reached the resolving gel.  At that point, 
the voltage was increased to a constant 120 mV until the dye front reached the 
gel bottom.   
 After electrophoresis, a standard electroblotting transfer system was set 
up to transfer proteins from gels onto 0.2 µM polyvinylidene difluoride (PVDF) 
membranes, which are resistant to solvents and can easily be stripped and 
reprobed for new antibodies.  A sandwich was assembled in the following order 
from cathode to anode: sponge, Whatman filter paper, polyacrylamide gel, PVDF 
membrane, Whatman filter paper and sponge.  The Whatman filter paper was 
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first soaked in 1X transfer buffer and the PVDF membrane activated in 100% 
methanol.  Once the sandwich was assembled, it was placed into the transfer 
unit and enough 1X Transfer Buffer was added to cover the sandwich.  An 
electric current, here 350 mA constant for 1 hour on ice or 120 mA constant for 
14 hours in a 4˚C cold room, was then applied to drive proteins onto the PVDF 
membrane.   
2.11.3 Antibody labeling procedure and ECL detection.  After proteins were 
transferred to PVDF membranes, the membranes were blocked in 5% non-fat 
dried milk (NFDM) in TBST for 1 hour in order to reduce non-specific binding.  
The blots were then placed into a primary antibody solution overnight for about 8-
12 hours at 4˚C on rotation to allow primary antibodies to bind to their antigens.  
Primary antibody solutions were made from 5% NFDM, 10% sodium azide added 
as a preservative, and a concentration of primary antibody recommended from 
the vendor (Table 2.1).  The following day, the blot was washed 3x 10 minutes 
with TBST before being incubated with secondary antibodies conjugated to 
horseradish peroxidase (HRP) at a 1:5000 concentration in 5% NFDM/TBST for 
1 hour at room temperature.  After incubation in secondary, the blot was washed 
again 3x 10 minutes in TBST. 
 Labeled proteins were detected using enhanced chemiluminescence 
(ECL), with the HRP conjugated to secondary antibodies acting as a reporter.  
The western blot was incubated for at least 1 minute with a substrate (Amersham 
ECL Western Blotting kit) containing luminol.  HRP then catalyzed the oxidation 
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of luminol, producing an enhanced chemiluminescent signal that was detected 
with photographic film (Fuji medical x-ray film).  Protein levels were then 
analyzed using densitometry. 
2.11.4 Membrane stripping protocol.  In order to investigate the presence of 
other proteins, western blots were often stripped and reprobed with new 
antibodies.  To strip a blot, up to four membranes were placed in 50 ml of 
stripping solution (62.5 mM Tris pH 6.8, 2% SDS) containing 357 ul β-
mercaptoethanol for about 10-30 minutes in a 55˚C water bath with periodic 
agitation.  The blots were then washed at least three times in TBST before being 
blocked in 5% NFDM/TBST for an hour prior to incubation in a new primary 
antibody solution. 
 
2.12 Immunocytochemistry (ICC). 
2.12.1 Basic immunocytochemistry.  Transfected or treated hippocampal 
neurons on coverslips were fixed for 10 minutes in an ice-cold solution of 4% 
paraformaldehyde (PFA), washed twice briefly with 1X ACSF (150 mM NaCl, 10 
mM HEPES pH 7.4, 3 mM KCl, 2 mM CaCl2, 10 mM glucose) then permeabilized 
with 0.3% Triton X-100/ACSF for 10 minutes before being blocked for 1 hour in 
10% normal goat serum (NGS) in ACSF to reduce background and non-specific 
staining.  Coverslips were then incubated with primary antibodies in 10% 
NGS/ACSF for either 2 hours at room temperature or overnight at 4ºC.  After 
incubation in primary, the coverslips were washed 3 times for 5 minutes with 1X 
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ACSF and then incubated in the dark for 1 hour at room temperature with Alexa 
Fluor-conjugated secondary antibodies (1:500-1:700).  Coverslips were washed 
an additional 3 times for 5 minutes in the dark to remove unbound secondary 
antibodies before being mounted with ProlongGold Antifade (Invitrogen) onto 
slides.  Slides were cured overnight in the dark before viewing. 
2.12.2 Surface-only labeling and surface/total double labeling.  To examine 
surface proteins only, transfected or treated hippocampal neurons were first fixed 
with 4% PFA for 10 minutes, washed 2X with ACSF and left non-permeabilized 
to prevent staining of intracellular compartments.  Cells were blocked for 1 hour 
in 10% NGS/ACSF then incubated with primary antibody.  This was followed by 3 
5-minute washes in ACSF before cells were incubated for 1 hour at room 
temperature in the dark with an Alexa Fluor-conjugated secondary antibody 
(1:500) followed by three 5-min washes before mounting the coverslips onto 
glass slides.  Slides were cured overnight in the dark before viewing. 
To examine the distribution of specific proteins both at the surface alone 
and in total, cells were first fixed with 4% PFA for 10 minutes, washed 2X with 
ACSF and temporarily left non-permeabilized in order to prevent staining of 
intracellular compartments.  Cells were blocked for at least 30 minutes in 10% 
NGS/ACSF then incubated with the first primary antibody (species one).  This 
was followed by 3 5-minute washes in ACSF before cells were permeabilized 
with 0.3% Triton X-100/ACSF for 10 minutes at room temperature then blocked 
again for at least 30 minutes in 10% NGS/ACSF.   Cells were then incubated with 
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the second primary antibody (species two).  After 3 5-minute washes, the cells 
were then incubated for 1 hour at room temperature in the dark with two Alexa 
Fluor-conjugated secondary antibodies, one color against each separate species, 
followed by three 5-min washes before mounting the coverslips onto glass slides.  
Slides were cured overnight in the dark before viewing. 
2.12.3 Internalization assays and ICC.  To perform internalization assays on 
transfected AMPARs, live hippocampal neurons were incubated in media 
containing 1:500 anti-GFP antibodies for 10 minutes on ice to label surface 
GluA1.  Cells were washed once in ACSF then incubated in media containing 25 
μM glutamate for 10 minutes in the 37ºC incubator to promote receptor 
endocytosis.  After 10 minutes, the media was replaced with fresh and returned 
to the incubator for 20 minutes to allow further receptor internalization.  Following 
the time-chase, cells were fixed with ice-cold 4% PFA for 10 minutes then 
washed 2X with ACSF and blocked for at least 30 minutes in 10% NGS/ACSF.  
The remaining surface-associated antibodies were blocked with non-conjugated 
secondary antibodies under non-permeant conditions (1:300) for 2 hours at room 
temperature, followed by 3 5-minute washes in ACSF before cells were 
permeabilized with 0.3% Triton X-100/ACSF for 10 minutes at room temperature 
then blocked again for at least 30 minutes in 10% NGS/ACSF.  The remaining 
internalized antibody-bound AMPARs were then incubated with Alexa Fluor-
conjugated secondary antibodies (1:700) for 1 hour at room temperature in the 
81 
 
dark followed by three 5-min washes before mounting the coverslips onto glass 
slides.  Slides were cured overnight in the dark before viewing. 
 
2.13 Fluorescent microscopy.  Images were collected with an inverted 
fluorescence microscope at a 63x oil objective (Zeiss Axiovert 200M).  The 
exposure time for fluorescence signal was first set automatically by the software 
then adjusted manually so that the signals were within the full dynamic range.  
Either the glow scale look-up table or the histogram was used to monitor the 
saturation level.  When analyzed using Image J software, images were 
thresholded to select GluA1 puncta for quantitative measurement.  Original 
images were directly analyzed to assess total protein levels. Image J is free 
software available for download from the NIH website 
(http://rsbweb.nih.gov/ij/download.html). 
 
2.14 Statistics.  All values were reported as means ± SEM.  Statistical analysis 
was performed using the two-population student’s t test or two-way ANOVA as 
indicated.  n indicates the number of independent experiments in westerns, or 
the number of cells in immunostaining assays (where the number of independent 
assays was also specified).   
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Table 2.1 Solution preparation 
Media or 
solutions Preparation Reference 
0.1 M Borate 
buffer 
3.1 g boric acid; 4.75 g borax; 1000 
ml diH2O pH 8.5 
(Hou et al., 2008) 
1% DNase 1% DNase stock in EBSS, store -
20⁰C 
(Hou et al., 2008) 
10/10 solution 10 mg/ml bovine serum albumin 
(BSA); 10 mg/ml type II-O, chicken 
white egg partially purified 
ovomucoid in Earle’s balanced salt 
solution (EBSS), sterile filter, store -
20⁰C 
(Hou et al., 2008) 
2X Laemmli 
Buffer 
100 mM Tris-HCL (pH 6.8), 4% 
SDS, 200 mM DTT, 0.1% 
bromophenol blue, 20% glycerol 
(Schagger and 
von Jagow, 1987) 
Artificial 
Cerebral Spinal 
Fluid (ACSF) 
150 mM NaCl; 10 mM HEPES; 30 
mM KCl; 2.6 mM CaCl2; 1mM 
MgCl2; 10mM D-glucose, pH7.4 
(Hou et al., 2008) 
Cysteine 4 mg/ml in HBSS (Hou et al., 2008) 
HEK feeding 
medium 
500 ml Dulbecco’s Minimal 
Essential Medium (DMEM); 10% 
fetal bovine serum (FBS) and 1% 
P/S/G, Invitrogen 
(Harrison et al., 
1977; Graham et 
al., 1977) 
HEK freezing 
medium 
40% FBS, 10% dimethylsulfoxide 
(DMSO), 1% P/S/G 
(Harrison et al., 
1977; Graham et 
al., 1977) 
HEPES-
buffered 
sucrose 
0.32 M sucrose, 4 mM HEPES pH 
7.4 
(Ehlers, 2003) 
LB (agar plates) Tryptone, 10 g; yeast extract, 5 g; 
NaCl, 10 g, 15 g agar powder, pH 
7.5 
(Sambrook et al., 
1989) 
LB (Luria broth) Tryptone, 10 g; yeast extract, 5 g; 
NaCl, 10 g, pH 7.5 
(Sambrook et al., 
1989) 
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Table 2.1 continued 
Media or 
solutions Preparation Reference 
Neuron culture 
plating medium 
500 ml Minimal Essential Medium 
(MEM); 10% fetal calf serum (FCS); 
5% horse serum (HS); 31 mg 
cystine; 1% penicillin/streptomycin 
and L-glutamine mixture (1% 
P/S/G) 
(Hou et al., 2008) 
NP40 IP buffer 50 mM HEPES pH 7.5, 150 mM 
NaCl, 5 mM EDTA, 1% NP40 
(Lin et al., 2011) 
Papain 15 mg/ml in Hank’s buffered salt 
solution (HBSS) 
(Hou et al., 2008) 
Papain 
digestion buffer 
14 ml HBSS; 1.0 mg/ml papain; 5 
mM EDTA 
(Hou et al., 2008) 
PBS 
(phosphate 
buffered saline) 
137 mM NaCl, 2.7 mM KCl, 4.3 mM 
Na2HPO4, 1.47 mM, KH2PO4, pH 
7.4 
(Harrison et al., 
1977; Graham et 
al., 1977) 
Poly-L-Lysine 
(PLL) 
0.1 mg/ml poly-l-lysine in borate 
buffer, pH 8.5, sterile filtered, store -
20⁰C 
(Hou et al., 2008) 
RIPA buffer 
(modified) 
50 mM Tris-HCl pH 7.4, 150 mM 
NaCl, 1% NP40, 1% SDOC, 0.1% 
SDS 
(Lin et al., 2011) 
SDS-PAGE 
running buffer 
(10X) 
0.25 M Tris, 1.92 M glycine, 1% 
SDS 
(Schagger and 
von Jagow, 1987) 
SDS-PAGE 
transfer buffer 
(10X) 
0.125 M Tris, 1 M glycine pH 8.3 (Schagger and 
von Jagow, 1987) 
SOB Tryptone, 20 g; yeast extract, 5 g; 
NaCl, 0.5 g; 10 ml of 250 mM KCl; 
pH 7.0, sterilize by autoclaving and 
add 5 ml of sterile 2 M MgCl2 
(Sambrook et al., 
1989) 
Synaptosome 
solution A 
0.32 M sucrose, 4 mM HEPES, pH 
7.4 
(Nakamura et al., 
1993; Grilli et al., 
2004) 
TB 10 mM PIPES, 55 mM MnCl2, 15 
mM CaCl2, 250 mM KCl 
(Inoue et al., 
1990) 
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Table 2.1 continued 
Media or 
solutions Preparation Reference 
TBST 20 mM Tris base; 137 mM NaCl; 
0.1% Tween-20, pH 7.4 
(Schagger and 
von Jagow, 1987) 
TE buffer 10 mM Tris-HCl pH 8.0, 1 mM 
EDTA 
(Sambrook et al., 
1989) 
Trituration 
buffer 
18 ml EBSS; 2 ml 10/10 solution; 20 
l 1% DNase 
(Hou et al., 2008) 
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Table 2.2 Antibodies 
Specificity Species Concentration Source 
Eps15 Rb ICC: 1:100; IP: 
2ul/rxn 
Santa Cruz 
Eps15 Rb IB: 1:100 BD Biosciences 
GFP Rb IB: 1:1000; IP: 
1ul/rxn; surface 
1:100 
Applied Biological 
Materials, Inc. 
GluA1 C-terminal Rb IB: 1:1000; ICC: 
1:200; IP: 1ug/rxn 
Man lab, Boston 
University 
GluA1 N-terminal Ms IB:1:1000; ICC: 
1:400; IP: 1ug/rxn 
Millipore 
GluA2 N-terminal Ms IB: 1:1000; ICC: 
1:400; IP: 1ug/rxn 
Millipore 
Hemagglutinin (HA) Ms IB: 1:500; ICC: 
1:100; IP: 1ul/rxn 
Applied Biological 
Materials, Inc. 
IgG Rb IB: N/A; ICC: N/A; 
IP: 1ug/rxn 
Sigma 
IgG Ms IB: N/A; ICC: N/A; 
IP: 1ug/rxn 
Sigma 
Nedd4 Rb IB: 1:4000; ICC: 
1:500; IP: 1ul/rxn 
Abcam 
NR1 C-terminal Rb IB: N/A; ICC: 1:300; 
IP: N/A 
Millipore 
PSD-95 Rb IB: 1:500; ICC: 
1:300; IP: N/A 
Abcam 
PSD-95 Ms IB: 1:500; ICC: 
1:500; IP: N/A 
Neuromab 
Tubulin Ms IB: 1:4000 Sigma 
Ubiquitin Rb IB: 1:2000; ICC: 
1:500; IP: 1ug/rxn 
Fu lab, Tufts 
University 
Ubiquitin Ms IB: 1:2000; ICC: 
1:500; IP: 1ug/rxn 
Sigma 
Ubiquitin (FK1) Rb IB: 1:2000; ICC: 
1:500; IP: 1ug/rxn 
Enzo Life Sciences 
Ubiquitin (P4D1) Rb IB: 1:2000; ICC: 
1:500; IP: 1ug/rxn 
Enzo Life Sciences 
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CHAPTER THREE 
Nedd-4 mediated AMPA receptor ubiquitination regulates receptor turnover 
and trafficking 
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3.1     Abstract 
AMPARs are the primary mediators of excitatory synaptic transmission in the 
brain.  Alterations in AMPAR localization and turnover have been considered 
critical mechanisms underpinning synaptic plasticity and higher brain functions, 
but the molecular processes that control AMPAR trafficking and stability are still 
not fully understood.  Here, I report that mammalian AMPARs are subject to 
ubiquitination in neurons and in transfected heterologous cells.  Ubiquitination 
facilitates AMPAR endocytosis, leading to a reduction in AMPAR cell-surface 
localization and total receptor abundance.  Mutation of lysine residues to arginine 
residues at the glutamate receptor subunit 1 (GluA1) C-terminus dramatically 
reduces GluA1 ubiquitination and abolishes ubiquitin-dependent GluA1 
internalization and degradation, indicating that the lysine residues, particularly 
K868, are sites of ubiquitination.  I also find that the E3 ligase neural precursor 
cell expressed, developmentally down-regulated 4 (Nedd4) is enriched in 
synaptosomes and co-localizes and associates with AMPARs in neurons.  Nedd4 
expression leads to AMPAR surface expression and suppressed excitatory 
synaptic transmission.  Conversely, knockdown of Nedd4 by specific siRNAs 
abolishes AMPAR ubiquitination.  These data indicate that Nedd4 is the E3 
ubiquitin ligase responsible for AMPAR ubiquitination, a modification that 
regulates multiple aspects of AMPAR molecular biology including trafficking, 
localization and stability. 
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3.2       Introduction 
The majority of excitatory neurotransmission in the brain is mediated by 
the glutamate-gated AMPAR ion channels.  Alteration in AMPAR synaptic 
expression has been considered the most important molecular mechanism in the 
formation of both Hebbian-type and homeostatic synaptic plasticity (Collingridge 
et al., 2004; Malinow et al., 2002; Turrigiano, 2008).  As AMPARs traffic rapidly 
between the plasma membrane and cytosolic compartments via vesicle-
mediated membrane insertion, internalization and recycling (Malinow et al., 2002; 
Newpher et al., 2008; Song et al., 2002), levels of surface AMPAR accumulation 
can be efficiently regulated by altering receptor dynamics.  Ultimately, the total 
abundance of AMPARs is determined through a balance between receptor 
synthesis and degradation.  However, exactly how neurons regulate AMPAR 
trafficking and turnover, a question critical to our understanding of synaptic 
plasticity and higher brain functions, remains less well understood. 
 Ubiquitin is a small 76 amino acid protein ubiquitously expressed in all 
eukaryotes.  Ubiquitin can be covalently conjugated to other proteins 
(ubiquitination) through a series of reactions catalyzed by three enzymes: E1-E3.  
The ubiquitin-activating enzyme E1 activates ubiquitin in an ATP-dependent 
manner, while E3 is the ligase that links ubiquitin to its substrate at lysine 
residues and determines substrate specificity.  Once a single ubiquitin is 
conjugated to the target protein (monoubiquitination), an internal lysine in 
ubiquitin itself can be linked to a second ubiquitin and so on to form a ubiquitin 
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chain (polyubiquitination).  Ubiquitination of membrane proteins functions as a 
tag that can be readily recognized by endocytotic machinery, leading to receptor 
internalization.  Polyubiquitinated proteins are often sorted to the proteasome or 
lysosome for degradation (Nandi et al., 2006; Schmitt, 2006).  Of particular 
interest is the ubiquitin-proteasome system (UPS), which is present in synapses 
(Bingol et al., 2006; Bingol et al., 2010) and plays an important role in synaptic 
function, including synapse development and maturation (DiAntonio et al., 2001; 
Ding et al., 2008), synaptic plasticity (Hegde, 2004), presynaptic vesicle release 
(Willeumier et al., 2006) and postsynaptic reorganization through proteolysis of 
post-synaptic proteins including PSD-95 and GRIP (Bingol et al., 2004; Colledge 
et al., 2003; Ehlers, 2003; Guo et al., 2007).  Futhermore, ubiquitination has been 
implicated in glutamate receptor trafficking and turnover, including NMDARs 
(Kato et al., 2005) and AMPARs (Bingol et al., 2004; Patrick et al., 2003).  In C. 
elegans, ubiquitination of AMPARs regulates glutamate receptor synaptic 
accumulation (Burbea et al., 2002).  Consistently, in Drosophila, inhibition of the 
proteasome by subunit mutation increases GluRIIB expression and enhances 
synaptic transmission at the neuromuscular junction (K. F. Haas et al., 2007).  
However, in the mammalian system, direct evidence for AMPAR ubiquitination 
and the identity of the participating E3 ligase(s) remain to be established. 
 Here, I have examined the existence and functions of AMPAR 
ubiquitination in a mammalian system.  I found that AMPARs in rat neurons are 
subject to direct ubiquitination.  Conjugation of multiple ubiquitin molecules to 
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lysine residues at the intracellular C-terminals of GluA1 subunits facilitated 
AMPAR internalization and reduced receptor cell-surface expression.  
Importantly, I identified Nedd4 as the E3 ligase involved in AMPAR ubiquitination.  
Nedd4 was enriched in synapses, co-distributed and physically associated with 
AMPAR subunits.  Nedd4 expression induced GluA1 ubiquitination, resulting in a 
reduction in AMPAR surface expression.  Consistently, Nedd4 knockdown 
suppressed ubiquitin-induced GluA1 ubiquitination.  These results strongly 
indicated an important role for Nedd4-mediated ubiquitination in AMPAR 
trafficking. 
3.3 Results 
3.3.1 AMPAR subunits are subject to ubiquitination 
To examine whether AMPARs are capable of being modified by 
ubiquitination, I co-expressed HA-tagged ubiquitin (Ub) together with GFP-
tagged GluA1 subunits (GluA1) in HEK293A cells.  2 days after transfection, 
GluA1 subunits were immunoprecipitated with anti-GFP antibodies and anti-HA 
antibodies were used to confirm the presence of ubiquitination.  In support of 
AMPAR ubiquitination, a strong ubiquitin smear, which is a typical biochemical 
signature for protein ubiquitination resulting from conjugation with a varied 
number of ubiquitin moieties, was reliably observed in isolated GluA1 (Fig 3.1 A, 
left and B).  In contrast, despite similar levels of intense total ubiquitination 
species in lysates (Fig. 3.1 A, right), control cells expressing free GFP and HA-
ubiquitin showed no ubiquitin signals in GFP immunoprecipitates (Fig. 3.1 A, left).   
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Figure 3.1. AMPAR GluA1 subunits are subject to ubiquitination.  (A) HEK 
cells were co-transfected with GFP-GluA1 or GFP as a control, together with HA-
ubiquitin (Ub).  The same amount of pcDNA vector was also transfected as a 
control.  Cell lysates were prepared in a denaturing lysis buffer and GluA1 or 
GFP proteins were immunoprecipitated with anti-GFP antibodies and probed with 
anti-HA for ubiquitin.  A heavy ubiquitin smear indicating GluA1 ubiquitination (left 
panel) was detected for GFP-GluA1, but not for the GFP control sample.  A 
protein band around 50 kD indicates the antibody used for immunoprecipitation 
(Ab).  The same western blot was reprobed to confirm pull-down of GluA1 
(middle) and general ubiquitination levels in ubiquitin transfected cell lysates 
(right).  Note a non-specific band in the pcDNA lane.  (B) Measurement of 
ubiquitination intensity (n=8 independent experiments).  (C) HEK 293A cells 
transfected with GluA1 and ubiquitin were incubated with anti-GFP antibodies to 
isolate surface GluA1 following immunoprecipitation.  The remaining 
supernatants were then incubated with anti-GluA1Ct antibodies to isolate 
intracellular GluA1.  Strong ubiquitination signals were detected in isolated cell-
surface GluA1 (Surf, left panel), but not in cytosolic GluA1 of intracellular 
compartments (Cyto, right panel).  GluA1 was reprobed in immunoprecipitates.  
Lysate tubulin was probed as a loading control (bottom panel).  (D) Pooled data 
of average levels of GluA1 ubiquitination (n=3 independent experiments).  Bar 
graph data represent means ± SEM, * p<0.05, t test.  
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All the cell lysates used for ubiquitination assays in this study were prepared 
under denaturing conditions to avoid conventional protein-protein association.  
Therefore, the ubiquitination signals represent a bona fide conjugation of 
ubiquitin to GluA1 subunits.  The high molecular weight of the ubiquitin smear 
indicates the conjugation of multiple ubiquitin molecules with GluA1 subunits.  
The high molecular weight of the ubiquitin smear indicates the conjugation of 
multiple ubiquitin molecules with GluA1 subunits.  To examine whether AMPAR 
ubiquitination occurs at the plasma membrane, I incubated GluA1-expressing 
HEK cells with anti-GFP antibodies to immunoprecipitate surface GluA1.  
Following a first round of immunoprecipitation to isolate surface GluA1, the 
remaining supernatants were incubated with anti-GluA1 antibodies to isolate 
intracellular GluA1.  Western analysis revealed intense ubiquitination of surface 
GluA1 (Fig. 3.1 C, left and D).  However, although more GluA1 was isolated from 
the cytosolic compartment, no significant ubiquitination signals were detected 
(Fig. 3.1 C, right and D).  These results indicate that ubiquitination occurs mainly 
on surface GluA1 subunits.  The minimal ubiquitination of intracellular receptors 
may indicate that the ubiquitinated intracellular receptors are degraded with high 
efficiency. 
3.3.2 Ubiquitination facilitates GluA1 degradation 
 A physiological consequence of protein ubiquitination, especially 
polyubiquitination, is to direct the protein to degradation pathways.  To examine 
the effect of ubiquitination on AMPAR turnover, I co-expressed GFP-GluA1 in 
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HEK293A cells with varied amounts of ubiquitin.  I found that the abundance of 
GluA1 showed linear down-regulation along with higher levels of ubiquitin 
expression (Fig. 3.2 A).  To directly investigate GluA1 degradation, I treated cells 
with 5 mM anisomycin to inhibit protein synthesis and time chased the remaining 
GluA1 abundance up to 4 h.  GluA1 levels showed a time-dependent decrease, 
with about 40% decrease (63% ± 12%, n = 3) after 4 h of anisomycin incubation, 
indicating constitutive receptor degradation.  In contrast, in cells transfected with 
HA-ubiquitin, GluA1 abundance showed a facilitated rate of reduction.  At 4 h of 
anisomycin treatment, GluA1 was reduced by approximately 80 % (23% ± 3%, n 
= 3) (Fig. 3.2 B), strongly indicating that ubiquitination enhances AMPAR 
turnover. 
3.3.3 Lysine residues at the GluA1 C-terminal are targets of ubiquitination 
and responsible for degradation 
During ubiquitination, a ubiquitin molecule is covalently conjugated to a 
lysine residue of the target protein.  When the intracellular domain of the GluA1 
subunit was examined, I found four lysine residues all localized on the C-
terminus.  To identify the site(s) of ubiquitination, I replaced each lysine with 
arginine at each individual site (K813R, K819R, K822R and K868R) or all four 
lysines together (4KR) (Fig. 3.3 A) in an N-terminal GFP-tagged GluA1 construct.  
Mutation sites were confirmed by sequencing.  In HEK293A cells co-transfected 
with the KR mutants and HA-ubiquitin, GFP-tagged GluA1 mutants were 
immunoprecipitated with anti-GFP antibodies and ubiquitinated species in the  
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Figure 3.2.  Ubiquitination causes a reduction in GluA1 protein abundance.  
(A) GluA1 was transfected in HEK 293A cells with varied amounts of HA-
ubiquitin.  GluA1 abundance (top) showed an inverse relationship to the level of 
ubiquitination (middle).  Tubulin was probed as a control for equal loading (n=1).  
(B) GluA1 degradation time course in the presence of anisomycin (Aniso, 5 μM).  
Co-transfection of ubiquitin facilitated GluA1 degradation rate (n=3 independent 
experiments).  Data represent means ± SEM, * p<0.05, two-way ANOVA test. 
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immunoprecipitates were proved with anti-HA antibodies.  We found that typical 
ubiquitination smears were still detected in K813R, K819R and K822R.  In 
contrast, the intensity of the ubiquitin conjugates in K868R was markedly 
reduced.  Consistently, GluA1 ubiquitination intensity was also significantly 
reduced when all four lysines were mutated (4KR) (Fig. 3.3 B).  Ubiquitination 
signals were normalized to GluA1 protein abundance.  A clear reduction in 
ubiquitination intensity on K868R and 4KR was revealed following normalization 
(Fig. 3.3 B).  Results from these experiments indicate lysine 868 as the principal 
residue for GluA1 ubiquitination. 
 I found that elevated protein ubiquitination was accompanied with 
enhanced GluA1 degradation (Fig. 3.2).  However, this degradation could be a 
consequence of ubiquitination of other proteins, which in turn modulates GluA1 
proteolysis.  I reasoned that if this ubiquitin-dependent receptor degradation is 
due to direct ubiquitination on GluA1 subunits, the KR mutants should become 
resistant to the degradation process.  To test this, I expressed GluA1WT and 
GluA1 KR mutants in HEK cells to compare their degradation rates.  Following 
incubation with 5 mM anisomycin to inhibit protein synthesis for 0, 3 and 6 h, 
transfected cells were lysed and probed for total GluA1 abundance.  I found that 
protein levels of K813R, K819R and K822R decreased at a rate comparable to 
that of the wild type GluA1.  In contrast, the amount of K868R and 4KR showed 
little change over a course of 6 h (Fig. 3.3 C and D).  The reduced degradation  
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Figure 3.3. Lysine residues at GluA1 C-terminus are sites of ubiquitination.  
(A) Illustration of the lysine residues at the C-terminus of GluA1 and various 
forms of KR mutants.  (B) Ubiquitination assays on HEK 293A cells 
overexpressing GFP-GluA1 wildtype or KR mutants, together with HA-ubiquitin.  
Bar graphs show normalized ubiquitination intensity to total GluA1 protein levels.  
Ubiquitination intensity in K813R, K819R and K822R mutants was comparable to 
that of wildtype GluA1, whereas K868R and 4KR showed significant reductions in 
ubiquitination intensity (n=4 independent experiments; image courtesy Stephen 
Amato). (C) HEK 293A cells transfected with GluA1 or KR mutants were 
incubated with anisomycin for 3 or 6 hrs to block protein synthesis, and the 
remaining GluA1 amount was examined to indicate protein degradation.  Tubulin 
was reprobed as a loading control.  (D) In the presence of anisomycin, GluA1 
wildtype (wt) and K813R, K819R and K822R mutants showed a similar time-
dependent reduction. In contrast, GluA1 degradation was completely abolished in 
K868R and 4KR mutants (n=2-3 independent experiments). Data represent 
means ± SEM, * p<0.05, t-test.  
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rate in K868R and 4KR mutants is consistent with the important role of K868 in 
ubiquitination. 
3.3.4 Ubiquitination and proteasomal degradation of AMPARs in neurons 
  I then explored the occurrence of AMPAR ubiquitination in neurons.  
Because AMPARs are enriched at the postsynaptic domain on dendritic spines, 
we first examined whether ubiquitin is localized at the vicinity of synapses.  In 
cultured cortical neurons, ubiquitin and a synaptic marker protein PSD-95 were 
immunostained.  Ubiquitin signals were detected throughout the neuron.  In 
dendrites, ubiquitin formed intense clusters, most of which co-distributed with the 
post-synaptic scaffolding molecule PSD-95 (Fig. 3.4 A), indicating a concentrated 
localization of ubiquitin in spines.  Consistently, western blotting demonstrated 
strong ubiquitin immunosignals in brain synaptosomal preparations compared to 
the lysate (Fig. 3.4 B), indicating the occurrence of ubiquitination modification on 
synaptic proteins. 
 Polyubiquitinated proteins are normally directed to the proteasome for 
degradation.  Many membrane receptors can be degraded by the proteasome, 
including the IL-2 receptor, growth hormone receptor, opioid receptor and the 
inhibitory GABAA receptors (Hegde, 2004).  Degradation of synaptic scaffolding 
proteins such as PSD-95 is also proteasome dependent (Colledge et al., 2003).  
In cultured cortical neurons at basal conditions, I failed to observe obvious 
AMPAR ubiquitination.  This might be because of either a minimal level of 
ubiquitination or rapid degradation and removal of ubiquitinated receptors by the  
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Figure 3.4.  Ubiquitination and proteasome-mediated degradation of 
AMPARs in neurons.  (A) Double staining of ubiquitin (green) and the 
postsynaptic marker protein PSD-95 (red) in 2 wk old cultured cortical neurons.  
The boxed area was zoomed in for clarity (bottom).  Arrows indicate co-localized 
puncta.  Two independent immunostainings showed a similar distribution pattern. 
(B) Western blotting showed high levels of ubiquitin (Ub) immunosignals in a 
synaptosome fraction prepared from rat brain cortical tissue.  Protein assays 
were performed in lysates prior to westerns to ensure that equal amount of total 
protein was loaded.  (C) Cultured cortical neurons were incubated with MG132 (5 
µM) for 24 hrs, followed by receptor ubiquitination assays. A strong ubiquitin 
smear was detected in MG treated neurons, indicating endogenous AMPAR 
ubiquitination.  (D and E) Cultured cortical neurons were treated for 3 hours with 
different proteasomal inhibitors including MG-132 (5 µM) (n=4 independent 
experiments), lactacystin (Lac, 10 µM), PR11 (0.5 µM) and epoxomicin (Epo, 10 
µM).  Proteasome inhibition induced a significant increase in GluA1 amount.  Bar 
graph data represent means ± SEM, * p<0.05, t test. Scale bar, 10 µm. 
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proteasome.  To accumulate ubiquitinated receptors for better detection, I pre-
incubated neurons with the proteasome inhibitor MG-132 (5 µM) for 24 h.  Under 
this condition, a strong ubiquitination smear was detected in immunoprecipitated 
GluA1 subunits (Fig. 3.4 C), indicating the presence of receptor ubiquitination in 
neurons.  In agreement with proteasome-mediated degradation, we found a rapid 
elevation of AMPAR amount when proteasomal activity was inhibited.  Treatment 
of cultured cortical neurons with MG-132 (5 µM) for 3 h significantly increased 
GluA1 levels (Fig. 3.4 D).  To confirm that the effect was indeed proteasome 
dependent, I found a similar increase in GluA1 by other proteasome specific 
inhibitors including lactacystin (10 µM) and epoxomicin (10 µM), as well as PR11 
(0.5 µM) (Fig. 3.4 E), indicating proteasome-mediated AMPAR degradation at 
basal conditions. 
3.3.5 Ubiquitination regulates AMPAR internalization and cell-surface 
expression 
A major function of ubiquitination is to sort membrane proteins to the 
endocytic pathway (d'Azzo et al., 2005).  To directly assess effects of 
ubiquitination on AMPAR trafficking, I performed internalization assays (Q. Hou, 
Huang, et al., 2008; Man et al., 2007).  Cortical neurons were transfected with 
GFP alone or together with HA-ubiquitin.  2 days after transfection, neurons were 
incubated with anti-GluA1 N-terminal antibodies at 4ºC to label receptors on the 
cell surface.  Cells were then treated with glutamate (50 µM) at 37ºC for 15 min 
to induce receptor internalization.  Following blockade of the remaining surface 
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receptors with non-conjugated secondary antibodies, the internalized receptors 
were then specifically labeled under permeant conditions by fluorescent 
secondary antibodies.  I found that GluA1 internalization was markedly enhanced 
in cells over-expressing ubiquitin compared to those transfected with GFP alone 
(internalized GluA1 intensity: 3301 ± 140, n = 15 cells in GFP alone control; 3997 
± 140, n = 17 cells in GFP + ubiquitin) (Fig. 3.5 A and B).  
A direct consequence of receptor endocytosis is to down-regulate surface 
receptor expression.  In addition, the internalized AMPARs can be recycled back 
to the plasma membrane, while a fraction of those can be sorted for degradation 
(Ehlers, 2000), resulting in a loss of total receptor amount.  To examine the effect 
of ubiquitination on AMPAR surface localization and stability, cortical neurons 
were transfected with HA-ubiquitin plus GFP, or GFP alone as a control.  Surface 
and total endogenous GluA1 subunits in transfected neurons were 
immunolabeled under non-permeant and permeant conditions with antibodies 
against GluA1Nt and GluA1Ct, respectively.  In neurons over-expressing 
ubiquitin, GluA1 surface expression was reduced by 45% (control, 1272 ± 11, n = 
19 cells; ubiquitin, 691 ± 13, n = 16 cells) (Fig. 3.5 C and D).  Meanwhile, 
ubiquitin expression also reduced the total amount of GluA1 by 25% (control, 399 
± 8, n = 19 cells; ubiquitin, 302 ± 10, n = 16 cells) (Fig. 3.5 C and D), consistent 
with ubiquitination-dependent AMPAR internalization and degradation in 
neurons.  To ensure that the GFP signals could reliably indicate ubiquitin over-
expression, I immunostained HA (in red) in neurons co-transfected with HA- 
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Figure 3.5.  Ubiquitin regulates AMPAR internalization and surface 
expression.  (A and B) Cultured neurons were transfected with GFP or GFP plus 
HA-ubiquitin.  Endogenous surface AMPARs were labeled with anti-GluA1Nt 
antibodies then treated with glutamate (50 μM) to induce receptor internalization.  
Internalized receptors were specifically labeled under permeant conditions by 
fluorescent secondary antibodies (red, Intern GluA1).  Ubiquitin expression 
increased GluA1 internalization. (n=15-17 cells from two independent assays). 
(C) Neurons were transfected with HA-ubiquitin together with GFP or GFP alone 
as a control.  Surface GluA1 was labeled with anti-GluA1Nt antibodies under 
nonpermeant conditions (Surf GluA1, red), and total GluA1 was labeled with anti-
GluA1C under permeant conditions (Total GluA1, blue) (top panels).  To confirm 
co-expression of HA-ubiquitin and GFP, cells were double-stained with 
antibodies against HA (red) and GluA1C (blue) (bottom panel).  (D) 
Measurement of surface and total GluA1 immunointensity.  (E and F) Neurons 
were transfected with wildtype and 4KR mutant GFP-GluA1, together with or 
without HA-ubiquitin.  Surface receptors were labeled with anti-GFP antibodies 
and receptor internalization was induced with glutamate.  Following blockade of 
remaining surface receptors with non-conjugated secondary antibodies, 
internalized receptors were specifically labeled under permeant conditions by 
fluorescent secondary antibodies (n=20-23 cells from two independent assays).   
Bar graph data represent means ± SEM, * p<0.05, t-test.  Scale bar, 20 µm.  
Figure courtesy of Qingming Hou.  
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ubiquitin and GFP.  I found that all of the green cells contained red (50 green 
cells were all red), and most of the red cells contained green (in 50 red cells, 45 
showed green) (Fig. 3.5 C, bottom), indicating reliable co-expression of double 
transfected constructs. 
To further confirm that ubiquitination on GluA1 is necessary for receptor 
internalization, the effects of the KR mutations on AMPAR trafficking were 
evaluated.  Cortical neurons were transfected with GFP-GluA1 or GFP-4KR, with 
or without HA-ubiquitin.  24 h later, cells were incubated with anti-GFP antibodies 
at 4ºC to label surface GluA1 and then treated with glutamate (50 µM) at 37ºC for 
15 min to induce receptor endocytosis.  Immunofluorescence intensity acquired 
following a blockade of the remaining surface receptors was used to indicate 
receptor internalization.  Internalized GluA1 immunofluorescence of 4KR was 
significantly reduced compared with wildtype GFP-GluA1 (Fig. 3.5 E and F), 
indicating a role for GluA1 ubiquitination in basal receptor trafficking.  More 
importantly, I found that whereas over-expression of HA-ubiquitin markedly 
enhanced internalization of wildtype GFP-GluA1, co-transfection with ubiquitin 
failed to facilitate 4KR internalization (1669 ± 125, n = 23 cells in GluA1 alone; 
2032 ± 119, n = 23 cells in GluA1 + ubiquitin; 1385 ± 138, n = 20 cells in 4KR; 
1411 ± 119, n = 20 cells in 4KR + ubiquitin) (Fig 3.5 E and F).  These results 
strongly indicate that ubiquitin-induced receptor internalization results from direct 
ubiquitination of lysine residues at the GluA1 C-terminus. 
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3.3.6 The E3 ligase Nedd4 induces AMPAR ubiquitination in heterologous 
cells 
During ubiquitination, an E3 ligase interacts with a particular substrate 
protein and conjugates ubiquitin molecules to a lysine residue, thus achieving 
specificity in protein ubiquitination.  In searching for the E3 ligase responsible for 
AMPAR modification, our recent study demonstrated that intracellular 
accumulation of sodium triggers proteasome-mediated AMPAR degradation, 
suggesting the presence of sodium-related machinery in AMPAR ubiquitination.  I 
therefore chose to examine the role of Nedd4 in AMPAR ubiquitination.  Indeed, 
in our earlier work we have identified Nedd4 as an AMPAR E3 ligase (Zhang et 
al., 2009).  Nedd4 is a homologous to E6-associated protein carboxy terminus 
(HECT) domain-containing single molecule E3 ligase (Ingham et al., 2004), 
which is highly expressed in neurons and has been shown to be regulated by 
sodium (Dinudom et al., 2001; Harvey et al., 1999; Kabra et al., 2008).  Nedd4 
ligases have been implicated in regulating the trafficking and turnover of many 
membrane proteins including sodium channels (Kabra et al., 2008; Snyder, 2005; 
Staub et al., 2000).  To examine the interaction of Nedd4 with its substrate 
AMPARs, I transfected HEK cells with GFP-GluA1, and performed co-
immunoprecipitation assays with antibodies against endogenous Nedd4.  GluA1 
was positively detected in immunoprecipitated Nedd4 complexes, but not in the 
IgG immunoprecipitation control (Fig. 3.6 A).  In order to evaluate the role of 
Nedd4 in AMPAR ubiquitination, I transfected HEK cells with GFP-GluA1 alone,  
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Figure 3.6. Nedd4 mediates GluA1 ubiquitination.  (A) Lysate of HEK cells 
expressing GFP-GluA1 was incubated with anti-Nedd4 antibodies to isolate 
endogenous Nedd4.  The immunoprecipitates were probed for GluA1 (left panel) 
or Nedd4 (Nd4, right panel).  GluA1 was positively detected in Nedd4 complexes, 
indicating an association.  IgG was used as a control.  (B) HEK cells were 
transfected with GluA1, Nedd4, ubiquitin, and pcDNA or GFP as a control.  
GluA1 was immunoprecipitated and probed for ubiquitin.  Co-expression of 
GluA1 with Nedd4 markedly increased receptor ubiquitination, which was further 
enhanced by expressing ubiquitin (left panel).  The membrane was reprobed to 
confirm the pull-down of GluA1 (right panel).  (C) HEK cells were transfected with 
siRNA specific for Nedd4 and cell lysates were examined for endogenous Nedd4 
levels.  siRNA dramatically reduced Nedd4 abundance, indicating the efficiency 
of siRNA-mediated knockdown.  (D) HEK cells were transfected with GFP-GluA1, 
HA-ubiquitin, together with Nedd4 siRNA, or scrambled siRNA as a control.  
GFP-GluA1 was immunoprecipitated for ubiquitination assays.  Overexpression 
of ubiquitin markedly enhanced GluA1 ubiquitination, which was abolished by the 
siRNA against Nedd4, but not affected by the scrambled siRNA control, 
indicating Nedd4 as an E3 ubiquitin ligase mediating GluA1 ubiquitination.  The 
immnoprecipitation blot was reprobed for GluA1, and cell lysate was probed for 
Nedd4 (Nd4) and GluA1. 
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or together with Nedd4, or Nedd4 plus HA-ubiquitin.  GluA1 was 
immunoprecipitated with anti-GFP and probed with anti-ubiquitin antibodies.  As 
shown previously (Fig. 3.1 C), little ubiquitination of GluA1 from HEK lysate was 
detected under basal conditions (Fig. 3.6 B), indicated inefficient ubiquitination in 
heterologous cells.  However, co-transfection of GFP-GluA1 with Nedd4 
produced a significant amount of ubiquitination species in GFP-GluA1 
immunoprecipitates, which was further enhanced by co-expressing ubiquitin (Fig. 
3.6 B), indicating GluA1 as a substrate of the Nedd4 ligase. 
To further confirm the involvement of endogenous Nedd4, I introduced an 
siRNA specifically targeting Nedd4.  The effect of the siRNA was confirmed by a 
dramatic reduction in Nedd4 levels in HEK cells transfected with Nedd4 siRNA 
(Fig. 3.6 C).  I then expressed GFP-GluA1 and HA-ubiquitin, together with Nedd4 
siRNA or a scrambled siRNA control.  As shown earlier in this study (Fig. 3.1 A), 
expression of ubiquitin induces strong ubiquitination of GluA1 (Fig. 3.6 D).  
However, in the presence of Nedd4 siRNA, which reduced total Nedd4 in the 
lysate, ubiquitin over-expression failed to induce GluA1 ubiquitination as 
compared to cells expressing scrambled siRNA control (Fig. 3.6 D).  These 
results strongly indicate that endogenous Nedd4 mediates the ubiquitination 
effect and functions as the ubiquitin ligase for AMPAR ubiquitination. 
3.3.7 Nedd4 co-localizes and associates with AMPARs in neurons 
If Nedd4 functions as a ligase for AMPAR ubiquitination, it should be localized in 
close proximity to its target so as to promote efficient ubiquitin ligation.  Towards  
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Figure 3.7.  Nedd4 localizes at the synapse and associates with AMPARs in 
neurons.  Doubble staining in cortical neurons indicates co-localization of Nedd4 
with AMPAR GluA2 (A) or the synaptic protein Shank (B).  The boxed area was 
enlarged (bottom panel) for clarity.  Arrows indicate puncta of co-distruibution.  
(C) Wesetern blots of synaptosome fractions prepared from cortical rat brain 
tissue.  Protein assays were performed in lysates prior to westerns to ensure 
equal loading.  AMPAR subunits and Nedd4 were enriched in synaptosomes.  
(D) Using lysates from rat primary culture, Nedd4 was detected in 
immunoprecipitates of anti-GluA1 antibodies, but not IgG control (left panel), 
indicating associateion of Nedd4 and AMPARs.  Reprobing of the membrane 
confirmed specific pull-down of GluA1 (right panel).  Scale bar, 10 µm. 
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this end, I double stained Nedd4 with AMPAR GluA2 subunits, and the synaptic 
protein shank in cultured cortical neurons.  The Nedd4 immunofluorescence 
signal showed a punctate pattern in dendrites, and co-distributed with both 
AMPARs (Fig. 3.7 A) and Shank (Fig. 3.7 B), indicating an enrichment of Nedd4 
at synaptic sites.  Furthermore, rat brain lysates and synaptosome preparations 
of equal total protein amounts were analyzed by western blotting.  The 
synaptosome sample showed markedly higher amounts of AMPAR subunits and 
Nedd4 compared to brain lysate, confirming synaptic distribution of the Nedd4 
ligase (Fig. 7C).  Similar to the results observed from transfected HEK cells (Fig. 
3.6 A), I found that GluA1 co-immunoprecipitated with Nedd4 using lysates from 
cultured cortical neurons (Fig. 3.7 D), suggesting a possible role for Nedd4 as an 
AMPAR ubiquitin ligase in neurons. 
3.3.8 Nedd4 ubiquitinates AMPARs and regulates AMPAR surface stability 
in neurons 
In order to confirm the involvement of Nedd4 in AMPAR ubiquitination in 
neurons, I cloned Nedd4 into a lentiviral vector so that biochemical analysis could 
be performed.  To test the Nedd4 lentiviral constructs, HEK cells were 
transfected with HA-ubiquitin and GFP-GluA1 followed by viral Nedd4 infection.  
A marked increase in Nedd4 amount was observed in viral Nedd4-infected cells 
(Fig. 3.8 A, right).  Correspondingly, Nedd4 infection increased GluA1 
ubiquitination levels, which was further enhanced by co-expression of HA-
ubiquitin (Fig. 3.8 A, left).  Consistently, incubation of viral Nedd4 with cultured  
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Figure 3.8.  Nedd4 ubiquitinates AMPARs and suppresses receptor surface 
expression in neurons.  (A) HEK cells were first transfected with GluA1 and 
HA-ubiquitin cDNA plasmids and then incubated with lentiviral Nedd4 and a viral 
vector control.  GluA1 immunoprecipitates were probed with anti-ubiquitin 
antibodies (left panel).  Nedd4, GluA1 and tubulin were probed in cell lysates 
(right panel).  (B) Neurons were infected with viral Nedd4 and ubiquitination of 
endogenous GluA1 was examined.  Probing of cell lysates for Nedd4, GluA1 and 
tubulin showed overexression of Nedd4 and equal loading (left panel).  Pooled 
data are shown in the bar graph (right panel, n=3).  (C) Neurons were transfected 
with Nedd4 siRNA or scrambled control siRNA, with a subsequent incubation 
with the viral ubiquitin construct.  Nedd4 siRNA suppressed Nedd4 expression 
and reduced GluA1 ubiquitination (n=3).  (D and E) Neurons were transfected 
with GFP and Nedd4, or GFP alone as a control.  Surface (Surf) and total GluA1 
were detected sequentially with anti-GluA1Nt antibodies under nonpermeant, and 
anti-GluA1Ct antibodies under permeant conditions (n=19 cells in control and 
n=17 cells in Nedd4, from two independent assays).  Bar graph data represent 
means ± SEM, * p<0.05, t test. Scale bar, 20 µm.  
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neurons also increased Nedd4 expression and levels of GluA1 ubiquitination 
(Nedd4, 140% ± 22%, n = 3) (Fig. 3.8 B).  To investigate the role of endogenous 
Nedd4 in AMPAR ubiquitination, cultured cortical neurons were transfected with 
Nedd4-specific siRNA followed by infection with an ubiquitin adenovirus to 
elevate basal ubiquitination levels.  I found that siRNA knockdown reduced 
Nedd4 abundance in neurons, and significantly reduced GluA1 ubiquitination as 
compared to the scrambled siRNA control (siRNA, 73% ± 8%, n = 3) (Fig. 3.8 C), 
strongly indicating that Nedd4 functions as an endogenous AMPAR E3 ubiquitin 
ligase in neurons.  If so, Nedd4 activity should have a similar effect on AMPAR 
surface localization as that from ubiquitin over-expression.  Surface and total 
GluA1 levels were thus examined under non-permeant and permeant conditions, 
respectively, in cortical neurons.  Two days after Nedd4 transfection, a marked 
reduction in surface-localized GluA1 was observed compared to the GFP 
transfection control (control, 1246 ± 15, n = 19 cells; Nedd4, 736 ± 7, n = 17 
cells) (Fig. 3.8 D & E).  Interestingly, unlike the effect of ubiquitin over-
expression, Nedd4 showed no significant effect on total AMPAR protein amount 
(control, 412 ± 9, n = 19 cells; Nedd4, 417 ± 12, n = 17 cells) (Fig. 3.8 D & E).  
These data strongly indicate that endogenous Nedd4 in neurons catalyzes 
AMPAR ubiquitination and regulates receptor cell-surface localization. 
3.4 Discussion 
I show that mammalian AMPARs are subject to direct modulation by 
ubiquitination.  Covalent conjugation with ubiquitin molecules shifts the molecular 
118 
 
weight of GluA1 from 100 kDa to as high as approximately 300 kDa, indicating 
the addition of a large number (more than 20) of ubiquitin moieties.  Given the 
spectrum of the ubiquitin smear in isolated GluA1, AMPARs are likely modified 
mainly by polyubiquitination, but could be multi- or monoubiquitinated as well.  
This is consistent with recent studies showing high molecular weight 
ubiquitinated receptors including glutamate receptors (Rezvani et al., 2007) and 
GABAA receptors (Saliba et al., 2007).  In C. elegans, only five ubiquitin moieties 
or less are conjugated with GluA1 (Burbea et al., 2002), suggesting a more 
intense ubiquitination process in mammalian AMPARs.  At basal conditions, only 
a limited amount of ubiquitin conjugation can be detected on AMPARs, similar to 
previous work on C. elegans AMPARs (Burbea et al., 2002) and mammalian 
GABAA receptors (Saliba et al., 2007).  This might result from an inactive 
ubiquitination process at basal neuronal activity levels, or short-lived 
ubiquitinated receptors.  In neurons, AMPARs are normally assembled into 
heterotetrameric complexes with the most typical combinations being either 
GluA1 and GluA2 or GluA2 and GluA3 subunits (W. Lu et al., 2009).  In 
heterologous cells, transfected GluA1 subunits are known to form 
homotetrameric channels which, like endogenous receptors, can be targeted 
onto the plasma membrane and respond to agonist activation.  Nevertheless, 
transfected GluA1 might be processed differently; for instance, proteins may be 
misfolded, leading to an endoplasmic reticulum-associated degradation (ERAD) 
response, where defective proteins are selectively ubiquitinated prior to 
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proteasome-mediated degradation (Plemper et al., 1999).  If this is the case, 
ubiquitination should occur on GluA1 localized within intracellular compartments, 
but not at the plasma membrane.  Contrary to this possibility, my results from 
surface pulldown assays reveal that ubiquitin conjugation occurs mainly on cell-
surface, rather than intracellular AMPARs, which argues against the involvement 
of ERAD.  The preference of ubiquitination on surface AMPARs may be because 
of plasma membrane-limited localization of participating ubiquitin ligases such as 
Nedd4 (Dunn et al., 2004; Ingham et al., 2004).  There are four lysine residues 
residing at the intracellular C-terminus of GluA1.  Mutation of K868 or all four 
lysines to arginines dramatically suppressed the intensity of GluA1 ubiquitination, 
indicating that the last lysine residue at GluA1 C-terminus K868 is the key site for 
ubiquitin conjugation, consistent with previous work showing the involvement of 
C-terminal lysines in C. elegans AMPAR ubiquitination.  Reasons for the 
incomplete knockdown of ubiquitination in the lysine mutant remain unclear, but it 
might be attributable to ubiquitination at non-lysine residues (M. Ikeda et al., 
2002).   
 My results demonstrate that over-expression of ubiquitin increases 
receptor internalization and reduces GluA1 surface expression, indicating a role 
for the UPS in AMPAR internalization.  Similar results have been observed in a 
recent study published during the revision of this paper (Schwarz et al., 2010).  
Interestingly, Schwarz et al. show that AMPAR ubiquitination is facilitated by 
AMPA treatment, indicating the existence of activity-dependent receptor 
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autoregulation.  The observed effects might potentially be a result of 
ubiquitination of other synaptic proteins, such as PSD-95, which subsequently 
destabilizes surface AMPARs (Bingol et al., 2004; Colledge et al., 2003).  
However, my data show that mutation of the lysine residues at the GluA1 
intracellular terminus suppresses both constitutive and glutamate-induced 
receptor internalization, supporting a role for the direct involvement of GluA1 
ubiquitination in AMPAR internalization.  The molecular basis underlying 
ubiquitination-mediated endocytosis remains unclear.  It has been established 
that AMPARs internalize via the clathrin-coated pit pathway following the binding 
of the clathrin adaptor protein AP2 to the GluR C-terminus (S. H. Lee et al., 2002; 
Man et al., 2000).  Given that AP2 binding is not directly regulated by 
ubiquitination, it is intriguing to postulate that a distinct ubiquitination-sensitive 
clathrin adaptor, such as EPS15 (Piper et al., 2007), might be implicated in 
ubiquitination-dependent AMPAR trafficking. 
 In line with the role of ubiquitination in directing proteins to the degradation 
pathway, I observed that over-expressing ubiquitin reduces total receptor 
abundance in neurons.  Similarly, in C. elegans GluR ubiquitination also leads to 
a reduction in GluR synaptic accumulation (Burbea et al., 2002).  In Drosophila, 
inhibition of the proteasome by subunit mutation increases GluRIIB expression 
and enhances synaptic transmission at the neuromuscular junction (K. F. Haas et 
al., 2007).  These findings strongly indicate the involvement of the UPS in 
AMPAR turnover.  Because AMPARs can also be degraded by the lysosome 
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(Ehlers, 2000), it would be interesting to know whether the distinct machineries 
involved in AMPAR degradation are exclusively utilized under different 
conditions, or are employed in a sequentially coordinated manner so as to 
accomplish complete proteolysis (Geetha et al., 2008). 
 The E3 ligase is a key component in the molecular machinery of AMPAR 
ubiquitination.  Although activity of several E3 ligases such as the anaphase-
promoting complex (Juo et al., 2004) as well as the Skp1/Cullin/F Box 
component including LIN-23 (Dreier et al., 2005) and KEL-8 (Schaefer et al., 
2006) have been implicated in AMPAR turnover, they do not seem to directly 
target AMPARs for ubiquitination.  I found that Nedd4 is preferentially localized in 
synapses and associates with AMPARs in neurons.  Over-expression of Nedd4 
causes GluA1 ubiquitination, which is accompanied by suppression of AMPAR 
cell-surface expression.  Consistently, knockdown of endogenous Nedd4 
reduces AMPAR ubiquitination.  All of these results strongly indicate a role for 
Nedd4 as an AMPAR E3 ligase.  For protein association, Nedd4 typically binds to 
a proline proline X tyrosine, where X is any amino acid (PPXY) domain in its 
substrates such as epithelial sodium channels via its tryptophan tryptophan 
(WW) domain (Snyder, 2005; Staub et al., 1996).  However, no such domain 
exists at the GluA1 C-terminus, suggesting the involvement of an unconventional 
interacting motif or an unidentified intermediate protein.  Indeed, many substrates 
of Nedd4-like E3 ligases such as EPS15, Notch and transforming growth factor 
beta (TGF-β) receptor 1 do not contain the PPXY domain (C. Chen et al., 2007).  
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In addition, the WW domain has been shown to be able to interact with a motif 
containing a phosphorylated serine or threonine (P. J. Lu et al., 1999).  
Interestingly, unlike the effect of ubiquitin, Nedd4 over-expression in neurons 
only decreases surface AMPAR expression without changing the total receptor 
amount.  This could be because of a mild effect of Nedd4 on AMPAR 
ubiquitination compared to a stronger ubiquitin-induced effect.  Alternatively, 
Nedd4 might participate in other cellular functions such as the facilitation of 
AMPAR gene transcription or translation, which in turn would counterbalance 
ubiquitination-dependent AMPAR degradation.  Indeed, Nedd4 has been shown 
to be able to translocate into the nucleus and regulate nuclear targets (Hamilton 
et al., 2001).  An important feature of Nedd4 is that it contains a C2 domain, 
through which Nedd4 associates with plasma membrane phospholipids in a 
calcium-dependent manner (Ingham et al., 2004; J. Wang et al., 2010).  It is 
intriguing to postulate that calcium-induced membrane translocation of Nedd4 
may be important in linking neuronal activity to surface receptor ubiquitination, 
endocytosis and degradation.  In addition, whether Nedd4 is the sole E3 ligase 
for AMPAR ubiquitination in vivo remains to be addressed with more thorough 
investigation. 
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CHAPTER FOUR 
Endocytic adaptor Eps15 is involved in the trafficking of ubiquitinated 
AMPA receptors   
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4.1 Abstract 
AMPA type glutamate receptors (AMPARs) play a critical role in mediating fast 
excitatory synaptic transmission in the brain.  Alterations in receptor expression, 
distribution and trafficking have been shown to underlie synaptic plasticity and 
higher brain functions including learning and memory, as well as brain 
dysfunctions such as drug addiction and psychological disorders.  Therefore, it is 
essential to elucidate the molecular mechanisms that regulate AMPAR dynamics.  
I have previously shown that mammalian AMPARs are subject to 
posttranslational modification by ubiquitin, with AMPAR ubiquitination enhancing 
receptor internalization and reducing AMPAR cell-surface expression.  Here, I 
report a crucial role for epidermal growth factor receptor substrate 15 (Eps15), an 
endocytic adaptor, in ubiquitination-dependent AMPAR internalization.  I find that 
suppression or overexpression of Eps15 results in changes in AMPAR surface 
expression.  Eps15 interacts with AMPARs, which requires Nedd4-mediated 
GluA1 ubiquitination and the ubiquitin interacting motif (UIM) of Eps15. 
Importantly, I find that Eps15 plays an important role in AMPAR internalization. 
Knockdown of Eps15 suppresses the internalization of GluA1, but not the mutant 
GluA1 that lacks ubiquitination sites, indicating a role of Eps15 for the 
internalization of ubiquitinated AMPARs.  These results reveal a novel molecular 
mechanism employed specifically for the trafficking of the ubiquitin modified 
AMPARs.   
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4.2  Introduction 
 AMPA receptors (AMPARs) are glutamate-gated heterotetrameric ion 
channels responsible for mediating the majority of fast excitatory 
neurotransmission in the brain.  Modifications in AMPAR synaptic expression 
have long been considered the critical molecular mechanism underlying both 
Hebbian-type (Collingridge et al., 2004; Malinow et al., 2002) and homeostatic 
(Pozo et al., 2010; Turrigiano, 2008; G. Wang et al., 2012) synaptic plasticity.  
AMPARs traffic rapidly between the plasma membrane and intracellular 
compartments, and while total AMPAR abundance is maintained through a 
balance between receptor synthesis and degradation, AMPAR surface 
accumulation is regulated by means of receptor insertion, internalization and 
recycling.  However, how specific surface AMPARs are selected and recognized 
by trafficking machinery remains unclear.  One mechanism is post-translational 
modification of surface proteins via ubiquitination. 
 Ubiquitin is a highly conserved, 8.5 kDa 76 amino acid protein, which can 
be covalently conjugated to a lysine residue in a target substrate. The specificity 
is determined by the E3 ligase. Ubiquitinated membrane proteins are recognized 
by endocytotic machinery for internalization, with polyubiquitinated proteins often 
being sorted to the proteasome or lysosome for degradation (Nandi et al., 2006). 
Ubiquitination has been implicated in the trafficking of glutamate receptors 
including NMDA receptors (Kato et al., 2005) and AMPARs (Bingol et al., 2004; 
Q. Hou et al., 2011; Patrick et al., 2003).  Recent studies have shown that 
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mammalian AMPARs are subject to direct ubiquitination (A. Lin et al., 2011; 
Lussier et al., 2011; Schwarz et al., 2010). 
 AMPARs can be internalized through the clathrin-coated-pits pathway via 
binding of the adaptor protein AP2 with the intracellular C-terminals of AMPAR 
subunits (Carroll, Beattie, et al., 1999; Kastning et al., 2007; S. H. Lee et al., 
2002; Man et al., 2000).  However, since AP2 lacks ubiquitin-dependent 
regulation, a distinct adaptor may be required to recognize ubiquitin-modified 
receptors. To serve this function, EGFR protein tyrosine kinase substrate 15 
(Eps15) emerged as an excellent candidate. Structurally, Eps15 is divided into 
four domains.  Domain III contains several DPF motifs that interact with adaptor 
proteins AP1 (Chi et al., 2008) and AP2 (Benmerah et al., 1996).  Of particular 
interest is regulatory domain IV, which contains two ubiquitin interacting motifs 
(UIM).  These UIM domains play a critical role in the association with and sorting 
of ubiquitinated receptors (Piper et al., 2011; Traub, 2009; van Bergen En 
Henegouwen, 2009).   
 Here, I report an important role for Eps15 in mediating ubiquitinated-
AMPAR trafficking.  I find that Eps15 is synaptically localized and that alterations 
in Eps15 expression significantly affect surface levels of GluA1.  Furthermore, I 
demonstrate that the interaction between Eps15 and GluA1 is dependent upon 
GluA1 ubiquitination and the Eps15 UIM regions.  I also show that the E3 ligase 
Nedd4 is involved in this interaction and that the internalization pathway of 
ubiquitinated AMPARs is mediated by the clathrin-coated-pits pathway.  These 
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results collectively reveal a novel ubiquitination-specific aspect of the molecular 
assembly utilized in AMPAR trafficking. 
 
4.3 Results 
4.3.1 Synaptic localization of Eps15 
To examine the subcellular distribution pattern of endogenous Eps15, 
cultured rat hippocampal neurons were immunostained for Eps15 along with 
either the postsynaptic marker protein PSD-95 or AMPAR GluA1 subunits. Eps15 
immunosignals were detected throughout the neuron but formed intense clusters 
along the dendrites, partially co-localizing with the post-synaptic density 
scaffolding molecule PSD-95 (Fig. 4.1 A).  Similarly, most of the Eps15 clusters 
appeared to co-distribute with GluA1 along the dendrites (Fig. 4.1 B), indicating 
synaptic localization of Eps15.  To further examine the relative protein distribution 
of Eps15 at synapses, we prepared synaptosomes from both adult rat brain 
lysate and cultured rat cortical cell lysates.  Western blotting demonstrated a 
strong enrichment of Eps15 in synaptosomal preparations compared to cell 
lysates (Fig. 4.1 C and D). Synaptosomal purification was confirmed by an 
enrichment of known synaptic proteins PSD-95 and GluA1. 
4.3.2 Regulation of AMPAR surface expression by Eps15 
 As an endocytic adaptor, Eps15 is involved in the regulation of membrane 
protein dynamic distribution. Given the enrichment of Eps15 in the synapse, we 
wanted to examine whether Eps15 is implicated in AMPAR surface expression. If  
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Figure 4.1.  Synaptic localization of Eps15.  (A,B) Double staining in cultured 
rat hippocampal neurons indicates partial co-localization of either (A) Eps15 (red) 
and PSD-95 (green) or (B) Eps15 (red) and GluA1N (green).  Boxed area was 
enlarged (bottom) for clarity; scale bars represent 20 µm on images and 5 µm on 
dendrite enlargement. Arrows indicate puncta of co-distribution. (C,D) 
Synaptosomal fractions of rat cortical lysate (C) and cultured rat cortical neurons 
(D) show synaptic enrichment of Eps15, GluA1 and the synaptic marker PSD-95.
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Eps15 is involved in promoting AMPAR internalization, a depletion of Eps15 
should cause an accumulation of surface AMPARs.  To examine this possibility, 
a siRNA against Eps15 was utilized and at least a 60% reduction of endogenous 
Eps15 was observed in siRNA-expressing neurons compared to cells expressing 
scrambled siRNA.  To determine the effect of Eps15 knockdown on AMPAR 
surface expression, transfected neurons were immunostained with anti-GluA1 N-
terminal antibodies under non-permeant conditions.  In cells transfected with the 
Eps15 siRNA I found a significant increase in surface GluA1 
immunofluorescence intensity compared to cells transfected with scrambled 
siRNA siRNA (Soma, 145.0% ± 3.5%; Puncta 182.7% ± 5.8% of the control) (Fig. 
4.2 A and B). 
 Next, I wanted to examine whether overexpression of Eps15 would have 
the opposite effect.  If Eps15 knockdown increases surface AMPARs by 
impeding AMPAR internalization, Eps15 overexpression should lead to 
decreased surface AMPARs by enhancing internalization. Towards this end, an 
Eps15 construct was used to overexpress Eps15 in hippocampal neurons.  
Immunostaining revealed an approximately 50% increase in Eps15 expression in 
Eps15-transfected cells compared to the pcDNA control cells. As expected, non-
permeant staining of GluA1N showed a significant decrease in surface GluA1 in 
both soma (73.6% ± 2.3%) and puncta (45.5% ± 3.0%) (Fig. 4.2 C and D).  It is 
interesting to note that Eps15 overexpression produced a lesser overall effect on  
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Figure 4.2.  Eps15 regulates GluA1 surface expression in neurons. (A) 
Eps15 siRNA (siEps15) or scrambled control siRNA (Scram) were co-transfected 
with GFP and cell surface GluA1 was stained with anti-GluA1N antibodies (red) 
under non-permeant conditions.  (B) Pooled data from A (Soma, n=57-63 cells; 
Puncta, n=250-300 puncta). Bar graphs represent means ± SEM; **p<0.01, t-
test. (C) Either pcDNA or Eps15 were co-transfected with GFP and cell surface 
GluA1 was stained with anti-GluA1N antibodies (red) under non-permeant 
conditions. (D) Pooled data from C (Soma, n=151-154 cells; Puncta, n=350-300 
puncta). Bar graphs represent means ± SEM; **p<0.01, t-test.  
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GluA1 surface localization than Eps15 knockdown, suggesting a high level of 
endogenous Eps15 amount or activity in the regulation of AMPAR trafficking.   
4.3.3 Eps15 regulates AMPAR internalization 
 I found that Eps15 overexpression or knockdown alters surface AMPAR 
expression, suggesting a role for Eps15 in AMPAR internalization. To examine 
AMPAR endocytosis, I knock down Eps15 in cultured hippocampal neurons then 
performed internalization assays.  In brief, surface AMPARs were live-labeled 
using anti-GluA1N antibodies.  After washing, cells were incubated at 37ºC for 20 
minutes to allow receptor internalization.  Any remaining surface-bound 
antibodies were then blocked with a secondary antibody while internalized 
receptors were specifically labeled with fluorescent antibodies for visualization.  I 
found that under basal conditions, Eps15 knockdown caused a modest, but 
significant decrease in receptor internalization both in soma (75.2% ± 2.2%) and 
puncta (61.4% ± 2.0%) (Fig. 4.3 A and B). Under glutamate-induced 
internalization, a similar but more pronounced reduction was observed (Soma, 
65.9% ± 3.4%; Puncta, 51.0% ± 1.5%) (Fig. 4.3 E and F).  Next, I performed 
internalization assays in neurons that overexpressed Eps15. I found that 
overexpression of Eps15 resulted in an increase in the intensity of internalized 
AMPARs under basal conditions (soma 116.4% ± 3.3%); puncta 143.8% ± 5.7%) 
(Fig. 4.3 C and D). A more dramatic effect was observed in glutamate-induced 
internalization (Fig. 4.3 G and H) in both soma (127.0% ± 5.8%) and puncta 
(158.4% ± 8.36%).  
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Figure 4.3.  Eps15 regulates AMPAR endocytic trafficking. In hippocampal 
neurons, GFP was co-transfected with siEps15 (or scrambled siRNA as control) 
or Eps15 (or pcDNA as control). Surface GluA1 subunits were labeled with anti-
GluA1N antibodies and internalization assays of constitutive (A-D) and 
glutamate-induced (50 µM, 10 min treatment and time chased for 20 min) (E-H) 
AMPAR internalization were performed.  Knockdown of Eps15 inhibited basal 
and induced AMPAR internalization (A and B: Soma, n=145-150 cells; Puncta, 
n=250-300 puncta; E and F: Soma, n=40-50 cells; Puncta, n=500-550 puncta). 
Overexpression of Eps15 promoted AMPAR internalization (C and D: Soma, 
n=120-140 cells; Puncta, n=200-250 puncta; G and H: Soma, n=50-55 cells; 
Puncta, n=550-600 puncta). Bar graph data represent means ± SEM, **p<0.01, t-
test.   
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4.3.4 Eps15 and GluA1 interaction is ubiquitin-dependent 
Although it is clear that Eps15 overexpression and knockdown have an 
effect on both surface AMPAR localization and AMPAR trafficking, the 
mechanisms underlying its interaction with AMPARs remain unclear.  A 
commonly recognized cellular signaling mechanism for the internalization of 
membrane proteins by endocytotic machinery is ubiquitination.  We and other 
labs have found that AMPARs are subject to ubiquitination (A. Lin et al., 2011; 
Lussier et al., 2011; Schwarz et al., 2010).  I show that surface GluA1 subunits 
are preferentially ubiquitinated by the E3 ligase Nedd4, leading to an increase in 
receptor internalization and degradation, and a decrease in receptor surface 
expression (A. Lin et al., 2011). However, how ubiquitinated AMPARs are 
selectively recognized for internalization remains unknown.  Because Eps15 can 
specifically interact with ubiquitin moieties, it may function as an adaptor to 
associate with ubiquitinated AMPARs. Therefore, I examine whether 
ubiquitination is implicated in Eps15 and GluA1 interaction.  In HEK 293T cells, 
GFP-tagged GluA1 (GFP-GluA1) was co-transfected with either pcDNA as a 
control or HA-tagged ubiquitin.  Eps15 was immunoprecipitated with anti-Eps15 
antibodies, and the immunocomplex was probed with anti-GluA1N antibodies to 
confirm protein interaction. In lysates co-transfected with pcDNA, only a minimal 
level of GluA1 was detected, indicating a weak interaction under basal 
conditions.  However, in lysates co-transfected with ubiquitin, a higher level of 
GluA1 was co-immunoprecipitated with Eps15 (374% ± 49.2% of the control, n = 
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6) (Fig. 4.4 A), strongly indicating that ubiquitination plays a positive role in 
Eps15 interaction with GluA1.  To confirm this effect in neurons, cultured cortical 
neurons were treated for 24 hours with the proteasomal inhibitor MG-132 in order 
to increase the amount of ubiquitinated species.  Immunoprecipitation assays 
showed that proteasome inhibition also significantly increased the association of 
GluA1 with Eps15 (315.3% ± 35.7%, n=5) (Fig. 4.4 B).  Because AMPAR 
ubiquitination is regulated by glutamatergic activities (Jarzylo et al., 2012; 
Schwarz et al., 2010), I wanted to examine whether glutamate affects Eps15 
interaction. Towards this end, we treated cultured cortical neurons with 50 µM 
glutamate for 10 minutes.  Compared to the control, glutamate treatment 
increased GluA1 and Eps15 interaction (171.2% ± 20.2%, n=5) (Fig. 4.4 C), 
consistent with the requirement of AMPAR ubiquitination in receptor-Eps15 
interaction. 
4.3.5 UIM domain mediates Eps15 interaction with AMPARs 
Structurally, Eps15 has two domains of particular interest – two ubiquitin 
interacting motif (UIM) regions at its C-terminus and an AP2 binding region (Fig. 
4.4 D).  Due to the increased interaction between Eps15 and GluA1 in the 
presence of ubiquitin, I proposed that the UIM regions were the critical site of 
Eps15-GluA1 interaction.  Also, the adaptor protein AP2 is known to interact with 
AMPAR to initiate receptor internalization.  Given the AP2 binding domain in 
Eps15, it is possible that the EPS-GluA1 association is indirect, mediated by 
AP2. To address these possibilities, I used a set of GFP-tagged Eps15 domain  
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Figure 4.4.  Eps15 and GluA1 interaction is ubiquitin-dependent.  (A) GFP-
GluA1 was co-transfected in HEK cells with or without HA-tagged Ub.  The 
presence of ubiquitin increased the amount of GluA1 co-immunoprecipitated with 
Eps15 (top left panel) although a similar amount of Eps15 was pulled down 
(bottom left panel). Similar amounts of proteins were shown in the lysates (input).  
(B) Cultured rat cortical neurons were treated with 5 µM of the proteasome 
inhibitor MG-132 (MG).  MG significantly increased the amount of GluA1 and 
Eps15 interaction in 5 individual experiments.  (C) Cortical neurons were treated 
with glutamate (50 µM, 10 min), and Eps15-GluA1 interaction was examined by 
co-IP.  Glu treatment significantly increased GluA1 and Eps15 interaction in 5 
individual experiments.  (D) Illustration of wild-type Eps15 and Eps15 deletion 
mutants.  (E) GFP-tagged Eps15 deletion mutants were co-transfected with non-
tagged GluA1 in HEK 293 cells. Deletion of a region containing 2 ubiquitin 
interacting motifs (E∆C) abolished Eps15 and GluA1 interaction, while deletion of 
the AP2 binding region of Eps15 (E∆AP) had no effect.  Similar results were 
observed in 3 individual experiments.  
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deletion mutants (a kind gift from Dr. Alexandre Benmerah, Institut Cochin, 
Université Paris Descartes) that lack either the C-terminus UIM regions (E∆C) or 
the AP2 binding region (E∆AP) (Fig. 4.4 D).  I transfected HEK293T cells with 
either GFP-tagged wild-type or mutant Eps15 together with non-tagged GluA1. 
Eps15 immunoprecipitates obtained with anti-GFP antibodies were probed for 
GluA1.  In support of a role for ubiquitination and the requirement of the UIM 
motif in Eps15-GluA1 interaction, I found that deletion of the UIM regions of 
Eps15 completely abolished Eps15-GluA1 interaction (Fig. 4.4 E). However, 
deletion of the AP2 binding region of Eps15 had no effect on Eps15-GluA1 
interaction (Fig. 4.4 E), suggesting a direct, UIM-mediated association. 
4.3.6 Ubiquitination of the GluA1 K868 site is critical for Eps15 and GluA1 
interaction  
Despite the observations that ubiquitin increases the interaction between 
Eps15 and GluA1, it remained uncertain whether this was a consequence of 
direct ubiquitination of GluA1, or an indirect result of ubiquitination on some 
intermediates.  I therefore turned to closer examination of the role of GluA1 
ubiquitination.  During ubiquitination, a ubiquitin molecule is covalently 
conjugated to a lysine residue on its target substrate.  Within the GluA1 
intracellular domains, there are four lysine residues at the C-terminal available for 
ubiquitin modification.  In an earlier study, I have found that while all lysine 
residues can be targeted, the last lysine on the GluA1 C-terminus (K868) was a 
primary site for GluA1 ubiquitination (A. Lin et al., 2011).  I therefore reasoned 
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that this site might also be the critical site in the interaction of GluA1 with Eps15.  
To examine this possibility, I replaced the first 3 lysine residues (K813R, K819R, 
K822) at the GluA1 C-terminal with arginine to create a triple mutant (F3R), 
leaving K868 as the sole site for ubiquitination (Fig. 4.5 A). The previously 
described K868R single mutant and 4KR mutant with all four lysine residues 
mutated to arginines (A. Lin et al., 2011) were also used (Fig. 4.5 A).  Wild-type 
GluA1 and mutant constructs (F3R, K868R and 4KR) were co-transfected with 
ubiquitin in HEK 293T cells, and GluA1-Eps15 interaction was analyzed by co-
immunoprecipitation.  As described above (Fig.4. 4 A), ubiquitin overexpression 
enhanced Eps15 interaction with GluA1.  Interestingly, a similar increase in 
protein interaction by ubiquitin was still observed in F3R, indicating that a single 
intact K868 site is sufficient for ubiquitination-dependent GluA1 interaction with 
Eps15. In line with this, despite the 3 remaining lysine residues in the K868R 
mutant, ubiquitin expression showed only a minimal amount of interaction 
between Eps15 and GluA1, comparable to the 4KR mutant in which interaction of 
Eps15 with GluA1 is abolished even in the presence of ubiquitin.   
To directly examine the requirement of receptor ubiquitination in Eps15-
dependent internalization, we transfected cultured hippocampal neurons with the 
varying lysine mutants and either an Eps15 siRNA or a control scrambled siRNA, 
and performed GluA1 internalization assays using glutamate to promote 
internalization.  In brief, surface GFP-GluA1 was labeled with anti-GFP 
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Figure 4.5.  GluA1 ubiquitination is required for Eps15 association.  (A) 
Illustration of lysine residues at the C-terminus of GFP-tagged GluA1 and various 
forms of KR mutants.  (B,C) GluA1 lysine mutants were co-transfected with or 
without HA-ubiquitin in HEK 293 cells, and co-IPs were performed to examine 
GluA1-Eps15 interaction. Ub expression increased Eps15 association with GluA1 
and F3K, but not K868R nor 4KR (n=4-7). Values were normalized to paired 
controls.  (D,E,F) siEps15 or scrambled control siRNAs were co-transfected with 
GFP-tagged WT or KR mutants of GluA1 in cultured rat hippocampal neurons. 
Internalization assays were performed by labeling surface GluA1 with anti-GFP 
antibodies, followed by 10 min glutamate treatment (50 µM). Compared to paired 
controls, Eps15 knockdown significantly decreased internalization of GluA1 and 
F3K, but had less of an effect on K868R and no significant effect on 4KR. Scale 
bars represent 40 µm.  Bar graph data represent means ± SEM, Soma (D), 
n=63-110 cells; Puncta (E), n=450-500 puncta, **p<0.01, *p<0.05 t-test, n.s. 
denotes “not significant”. 
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antibodies, and internalization was triggered by glutamate treatment (50 µM, 10 
min) at 37oC.  Cells were time-chased for an additional 20 minutes at 37oC to  
allow for further internalization. Among cells expressing scrambled siRNA, F3R 
was internalized to a level comparable to that of wild-type GluA, whereas the 
internalization of both K868R and 4KR was markedly reduced (Fig. 4.5 D,E,F).  
Knockdown of Eps15 caused at least a 40% reduction in wild-type GluA1 and 
F3R.  In contrast, Eps15 siRNA resulted in smaller changes in the internalization 
rate of K868R and 4KR compared to their own respective controls (Fig. 4.5 
D,E,F).  These findings strongly indicate that GluA1 ubiquitination, primarily at 
the residue of K868, is required for Eps15-mediated internalization. 
4.3.7 Nedd4 enhances Eps15 interaction with GluA1 
During ubiquitination, the final conjugation of a ubiquitin molecule to a 
lysine residue on the target substrate is mediated by an E3 ligase that confers 
target specificity.  Recent studies have identified Nedd4 as the E3 ligase 
responsible for AMPAR GluA1 ubiquitination (A. Lin et al., 2011; Schwarz et al., 
2010). I thus wanted to know whether Nedd4, via ubiquitinating GluA1, may 
facilitate Eps15 interaction with AMPARs.  In HEK cells, GFP-tagged GluA1 was 
co-transfected with either pcDNA as a control or Nedd4, and anti-Eps15 
antibodies were used to examine co-immunoprecipitation of GluA1.  In lysates 
transfected with Nedd4, the amount of GluA1 in Eps15 immunoprecipitates was 
markedly increased compared to the control (210.1% ± 35.5%, n=5) (Fig. 4.6 A).  
To further confirm the effect of Nedd4 in neurons, viral Nedd4 and pHAGE  
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Figure 4.6.  Nedd4 enhances Eps15 association with GluA1.  (A) GFP-tagged 
GluA1 was co-transfected in HEK cells with either pcDNA (pc) or Nedd4 (N4).  
Co-IP of GluA1 by Eps15 was significantly enhanced by N4 consistently 
observed in five individual experiments.  (B) Cultured rat cortical neurons were 
transduced with either a control or N4 virus. The N4 virus significantly increased 
GluA1 and Eps15 interaction.  Similar results were observed in four individual 
experiments.  (C,D) GFP-GluA1 was co-transfected in HEK cells with either 
ubiquitin (Ub) or pcDNA as control.  Each set was additionally co-transfected with 
either scrambled siRNA (scram) or siRNA against Nedd4 (siN4).  Knockdown of 
Nedd4 markedly reduced basal and ubiquitin-enhanced Eps15-GluA1 
association. Bar graphs represent means ± SEM, n=4, *p<0.05, t-test. 
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control constructs were introduced to cortical neuronal cultures as described 
previously (A. Lin et al., 2011).  Similar to the results from HEK cells, 
immunoprecipitation assays showed that Nedd4 overexpression resulted in a 
higher level of interaction between Eps15 and GluA1 (425.8% ± 60.2%, n=4) 
(Fig. 4.6 B).  I next decided to examine the effect of Nedd4 knockdown on 
Eps15-GluA1 interaction.  HEK cells were transfected with GFP-GluA1 and 
ubiquitin, together with siRNAs targeting Nedd4 or scrambled siRNAs as a 
control.  Eps15 was immunoprecipitated for GluA1 detection.  While the presence 
of ubiquitin was able to enhance GluA1 and Eps15 interaction in scrambled 
siRNA controls (170.0% ± 22.1%, n=4), ubiquitin failed to affect GluA1-Eps15 
interaction in neurons expressing Nedd4 siRNA (105.3% ± 15.6%, n=4) (Fig. 4.6 
C and D).  These experiments support the scenario in which Nedd4 targets 
GluA1 for ubiquitination, which then recruits Eps15 for interaction. 
4.3.8 Eps15-mediated internalization of GluA1 is clathrin-mediated 
Having established that Eps15 interacts with ubiquitinated AMPARs to 
cause receptor internalization, I was interested to examine the internalization 
machinery involved. The clathrin-coated-pits pathway is the canonical 
mechanism for the internalization of most of the membrane receptors, including 
AMPARs.  AMPAR internalization begins with an association with the adaptor 
protein AP2, or Eps15 for the ubiquitinated receptors, followed by the recruitment 
of clathrin to form clathrin-coated pits. Clathrin interacts with amphiphysin, which 
then brings in dynamin to subsequently pinch off the coated pits to form 
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endocytic vesicles. As Eps15 is known to mediate receptor internalization 
through a clathrin-independent pathway (H. Chen et al., 2005; Sigismund et al., 
2005), I therefore wanted to confirmed whether the Eps15-dependent 
internalization of ubiquitinated AMPARs utilized the clathrin-mediated pathway.  I 
took advantage of a newly developed clathrin inhibitor, Pitstop (von Kleist et al., 
2011) which binds to clathrin and competitively blocks the recruitment of 
amphiphysin, leading to a potent suppression of clathrin-dependent 
internalization.  I tested the efficiency of Pitstop by treating cultured hippocampal 
neurons with Pitstop for 0, 10 or 30 min and examining receptor surface 
expression.  We found that at a concentration of 15 µM, Pitstop caused a marked 
increase in GluA1 surface accumulation (T0, 100% ± 4.5%; T30, 137.5% ± 5.6%; 
T60, 162.1% ± 8.0%), indicating its effectiveness in blocking receptor 
internalization (Fig. 4.7 A and B).  To determine the dependency of the clathrin 
pathway for the internalization of ubiquitinated AMPARs, we examined 
constitutive and glutamate-induced receptor internalization in neurons 
transfected with GFP-GluA1 and ubiquitin.  Under constitutive conditions, 
ubiquitin increased the amount of GFP-GluA1 internalization (125.5% ± 6.6%).  
Application of Pitstop suppressed AMPAR internalization (56.8% ± 2.8%), and 
abolished the ubiquitin-caused increase in AMPAR internalization (46.4% ± 
2.1%) (Fig.4.7 C and D).  Glutamate-treated neurons showed an increased 
amount of GluA1 internalization compared to the control (Glu: 123.0% ± 4.9%) 
(Fig. 4.7 E and F).  Interestingly, glutamate had less effect in neurons over-  
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Figure 4.7.  Eps15-mediated AMPAR internalization is clathrin-dependent.  
(A,B) Treatment of cultured hippocampal neurons with the clathrin-inhibitor 
Pitstop (15 µM) efficiently blocked AMPAR internalization (n=18-19 cells).  Scale 
bars represent 40 µm.  (C,D) Neurons were transfected with GFP-GluA1, 
together with  either ubiquitin or pcDNA as control. 2 d after transfection, surface 
GluA1 was labeled with anti-GFP antibodies and internalization was allowed in 
the presence of Pitstop (Pit) for 10 min. Pitstop effectively blocked basal and 
ubiquitin-enhanced GluA1 internalization (n=45-95 cells).  (E,F) The experiment 
in (C) was repeated to examine glutamate-induced internalization. Cells were 
treated with glutamate (Glu, 50 µM, 10 min) to induce internalization. Pitstop was 
applied prior to and during glutamate treatment. Pitstop effectively blocked both 
glutamate and ubiquitin-stimulated GluA1 internalization (n=43-174 cells). Bar 
graph represents means ± SEM, **p<0.01, *p<0.05, t-test, n.s. denotes “not 
significant”.  
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expressing ubiquitin (Glu+Ub: 130.7% ± 5.3%) (Fig. 4.7 E and F), likely due to a 
ubiquitin-caused saturation in internalization prior to glutamate treatment.  In 
neurons treated with Pitstop, glutamate-induced GluA1 internalization was 
decreased even in the presence of Ub (Pit+Glu: 73.4% ± 5.2%; Pit+Glu+Ubi: 
68.7% ± 3.7%) (Fig. 4.7 E and F). These data support the utilization of the 
clathrin-dependent pathway for Eps15-mediated internalization of ubiquitinated 
AMPARs. 
 
4.4   Discussion 
 Upon conjugation with ubiquitin, AMPARs are recognized for 
internalization (A. Lin et al., 2011; Schwarz et al., 2010), but the molecular steps 
involved in ubiquitination-triggered internalization are unknown.  I show that the 
Eps15 adaptor protein plays an important role in ubiquitin-mediated 
internalization by interacting specifically with ubiquitinated GluA1 subunits to 
initiate AMPAR internalization via the clathrin-coated-pits pathway. In support of 
this process, I found that Eps15 interacts with GluA1 subunits in a ubiquitination-
dependent manner. This interaction is enhanced when GluA1 ubiquitination is 
induced by overexpressing ubiquitin, the E3 ligase Nedd4 (A. Lin et al., 2011), or 
glutamate treatment (Schwarz et al., 2010). In contrast, the interaction is 
abolished by mutation of GluA1 ubiquitination sites, or deletion of the ubiquitin 
binding motifs in Eps15.  Furthermore, Eps15 overexpression enhances AMPAR 
internalization and reduces receptor surface expression, which is abolished in 
152 
 
cells expressing GluA1 without ubiquitination sites, or by inhibition of the clathrin-
dependent pathway.  
 Ubiquitin is conjugated to lysine residues during ubiquitination.  Among 
the intracellular domains in GluA1, there are four lysines in total, all within the C-
terminus.  Although all the lysine residues are targeted, the last lysine (K868) 
appears to be the primary site for Nedd4-mediated ubiquitination (A. Lin et al., 
2011).  Consistently, I found that the expression of ubiquitin, in order to enhance 
GluA1 ubiquitination, strengthens GluA1-Eps15 association.  This effect remains 
in GluA1-F3KR, but is completely abolished in K868R and 4KR, indicating K868 
as the dominant site for ubiquitination.  
 In the AMPAR endocytic process, AP2 has been well-studied as a 
clathrin adaptor interacting with GluA1, GluA2 and GluA3 (Carroll, Beattie, et al., 
1999; Kastning et al., 2007; S. H. Lee et al., 2002; Man et al., 2000).  On GluA2, 
AP2 binds to a domain containing the core sequence KRMKV located at the C-
terminus proximal to the plasma membrane (S. H. Lee et al., 2002).  A 
corresponding sequence, KRMKG, exists in GluA1 and is highly homologous to 
that in GluA2.  Interestingly, this AP2 binding domain contains two lysine 
residues available for ubiquitin modification. It is possible that ubiquitination of 
these sites affects AP2 binding affinity. In line with this idea, mutation of the first 
lysine within this binding sequence abolishes AP2-GluA2 interaction (S. H. Lee et 
al., 2002). Thus, ubiquitination may block AP2 binding and switch the endocytic 
adaptor to Eps15.  
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 Since Eps15 is known to be constitutively associated with AP2 
(Benmerah et al., 1996; Benmerah et al., 1995), it is therefore possible that 
Eps15 associates with AMPARs indirectly through AP2.  Utilizing an Eps15 
mutant lacking the AP2 binding region, I found that the mutant Eps15 was able to 
interact with GluA1.  I also find that the UIM domains in Eps15 as well as GluA1 
ubiquitin modification are required for their interaction.  These findings strongly 
indicate a more direct interaction between the Eps15 UIM motifs and ubiquitin 
modification at the GluA1 C-terminal. Endogenous AMPARs are heterotetramers 
mostly composed of GluA1/A2 or GluA2/A3. Although both GluA1 and GluA2 are 
known to be regulated by ubiquitination, GluA2 does not appear to bind Eps15 
(Kastning et al., 2007). Therefore, GluA1 C-terminal ubiquitination and Eps15-
mediated internalization may specifically regulate GluA1-containing AMPAR 
trafficking. Eps15 appears to be self-sufficient in mediating AMPAR 
internalization.  In a mutant GluA1-K868R that should presumably have only 
minimal levels of ubiquitin modification but retains an intact AP2 binding domain, 
I showed that glutamate-induced internalization is significantly suppressed.  
 Several types of adaptor proteins are involved in membrane receptor 
internalization (Traub, 2009).  Of these, Epsins are members of the same family 
as Eps15.  Because Epsins and Eps15 show overall structural similarity and 
functional redundancy, it is reasonable to postulate that Epsins may also be 
involved in ubiquitination-dependent AMPAR trafficking. This may explain, 
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together with insufficient Eps15 knockdown, the incomplete abolishment of 
GluA1 internalization following Eps15 siRNA application. 
 The relative contribution of AP2 and Eps15 may depend on cellular and 
synaptic activity status. Under basal conditions, there is only a low level of 
AMPAR ubiquitination (Burbea et al., 2002; A. Lin et al., 2011; Schwarz et al., 
2010), where Eps15 interaction is minimal and receptor internalization is mainly 
mediated by AP2.  During neuronal activation, which is accompanied by elevated 
receptor ubiquitination, Eps15 plays an important role in AMPAR internalization.  
Indeed, at basal conditions, siRNA knockdown of Eps15 decreased GluA1 
internalization by 20% (Fig. 4.3).  In contrast, under glutamate incubation, which 
causes AMPAR activation and ubiquitination (Schwarz et al., 2010), Eps15 
knockdown reduced GluA1 internalization by 40% (Fig. 4.3 and 4.5). It is 
intriguing to postulate that AP2 is responsible for constitutive internalization, 
whereas Eps15 is used for activity-dependent facilitated trafficking (Fig. 4.8).  
Indeed, in GluA2 mutants that lack AP2 association, although NMDA-induced 
internalization is inhibited, AMPA treatment remains able to stimulate 
internalization (S. H. Lee et al., 2002).  Given that GluA1 ubiquitination is induced 
by application of AMPA but not NMDA (Schwarz et al., 2010), it may indicate that 
AMPAR activation utilizes ubiquitination/Eps15-dependent internalization, 
whereas NMDAR-dependent internalization is ubiquitination-independent and is 
mediated mainly by AP2.  
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Figure 4.8. An illustration of Eps15-mediated ubiquitination-dependent 
AMPAR endocytosis.  (Left) During basal activity, AMPAR endocytosis is AP2-
mediated and internalized receptors are mostly shuttled to recycling pathways.  
(Right) In contrast, ubiquitination of GluA1, particularly at K868, recruits the 
adaptor protein Eps15 via its UIM domain, with or without AP2 participation. 
Following Eps15-mediated internalization, the ubiquitinated AMPARs are 
destined for degradation. 
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How ubiquitination-dependent AMPAR internalization is regulated remains 
unclear.  Clearly, ubiquitination of AMPARs and their interaction with Eps15 can 
be regulated by the amount and activity of the E3 ligase Nedd4 and 
deubiquitinating enzymes (Kowalski et al., 2011). In addition to the extent of 
general ubiquitination, types of ubiquitination can also serve as a regulatory 
element.  AMPARs are subject to mono- and polyubiquitination (Burbea et al., 
2002; A. Lin et al., 2011; Schwarz et al., 2010), but polyubiquitination seems to 
be the dominant form in mammalian neurons (A. Lin et al., 2011).  Because 
monoubiquitin appears to have low binding affinity to UIMs compared to 
polyubiquitin chains (Hawryluk et al., 2006; Madshus, 2006), preferential 
polyubiquitination will strengthen AMPAR association with Eps15.  Furthermore, 
different types of ubiquitin chains can be formed by the further conjugation of 
ubiquitin units to one of seven lysines on a ubiquitin molecule.  It remains 
unknown which type(s) of polyubiquitination is formed at AMPARs; however, if 
GluA1 conjugates with multiple forms of ubiquitin chains, it may offer distinct 
affinity for Eps15 binding.  It has been shown that Eps15 prefers to interact with 
K63-linked polyubiquitin, due to the conformational selectivity of the two UIM 
domains (Sato et al., 2009; Sims et al., 2009). Interestingly, Nedd4, the identified 
GluA1 E3 ligase, preferentially catalyzes K63 ubiquitination (H. C. Kim et al., 
2009).  Furthermore, phosphorylation can regulate, and in some cases is a 
prerequisite for, ubiquitination (Sehat et al., 2007).  Given that GluA1 is under 
constant modification by phosphorylation, which plays an important role in 
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receptor trafficking (Song et al., 2002) it is interesting to postulate that GluA1 
ubiquitination and thus Eps15-mediated internalization is regulated upstream by 
protein kinases and receptor phosphorylation.  
 Ubiquitinated receptors are internalized via clathrin pathways.  However, 
clathrin-independent processes have also been observed (Aguilar et al., 2005; H. 
Chen et al., 2005; Sigismund et al., 2005).  For instance, following agonist 
binding and ubiquitin modification, the transforming growth factor (TGF)-β 
receptors rapidly internalize via both clathrin-dependent and independent, lipid 
raft-mediated pathways, which direct internalized receptors for recycling and 
degradation, respectively (Di Guglielmo et al., 2003).  In the case of epidermal 
growth factor (EGF) receptor (EGFR), a low level of EGF stimulation that does 
not cause ubiquitination leads to internalization via the clathrin pathway, whereas 
a high concentration of EGF leads to EGFR ubiquitination and recruitment to lipid 
rafts for internalization (Sigismund et al., 2005).  Using a clathrin-specific 
inhibitor, I found that blocking the clathrin-dependent pathway increases surface 
AMPAR expression.  Importantly, both basal and glutamate or ubiquitin-
enhanced internalization are equally suppressed by clathrin inhibition, indicating 
that  the clathrin-dependent pathway is utilized in Eps15-mediated internalization 
of ubiquitinated AMPARS, consistent with other studies showing the involvement 
of the clathrin route in ubiquitination/Eps15-mediated receptor internalization 
(Benmerah et al., 1999; Benmerah et al., 2000).  
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5.1 Summary of findings 
AMPAR trafficking is believed to underlie higher brain functions such as 
learning and memory.  Additionally, AMPAR trafficking has been implicated in a 
number of neurological diseases and disorders, including Alzheimer’s disease, 
fragile X syndrome and addiction.  It is therefore of significant importance to 
elucidate the underlying molecular mechanisms that regulate AMPAR trafficking 
and turnover.  A major cellular means of protein regulation is posttranslational 
modification (PTM).  While AMPARs are known to be modified by numerous 
PTMs, it was unknown whether AMPAR trafficking is modulated by ubiquitination.  
Ubiquitination is a PTM involved in virtually every cellular process and known to 
regulate the fate and function of a large number of neuronal receptors and 
synaptic proteins.  My studies have focused on the question of whether AMPAR 
ubiquitination occurs in mammalian cells, how AMPAR ubiquitination occurs and 
its role in AMPAR trafficking.  I found that AMPAR subunit GluA1 C-terminal is 
subject to ubiquitination primarily at the K868 residue and identified Nedd4 as the 
specific E3 ligase responsible for GluA1 ubiquitination.  I also found that 
expression of Nedd4 induced GluA1 ubiquitination, which led to AMPAR 
internalization and a subsequent reduction in AMPAR surface expression that 
was inhibited by siRNA knockdown of Nedd4.  Additionally, I showed that the 
adaptor protein Eps15 plays an important role in the internalization of 
ubiquitinated AMPARs.  I found that the interaction between Eps15 and GluA1 is 
dependent upon GluA1 ubiquitination and the Eps15 UIM regions.  I further 
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showed that the E3 ligase Nedd4 is involved in the interaction between GluA1 
and Eps15 and that the internalization pathway of ubiquitinated AMPARs is 
mediated by the clathrin-coated-pits pathway.  These results collectively revealed 
a novel ubiquitination-specific aspect of the molecular assembly utilized in 
AMPAR trafficking. 
 
5.2 The role of AMPAR ubiquitination in the brain   
Although many studies have examined the role of the ubiquitin 
proteasome system (UPS) in the brain, it is unclear the role ubiquitination plays 
in regulating AMPAR trafficking at the synapse.  While many studies establish a 
role for the UPS in synaptic plasticity, AMPAR involvement is only implicated 
indirectly.  Early findings show that in Aplysia, direct inhibition of the proteasome 
in isolated postsynaptic motor neurons produces an increase in glutamate-
evoked postsynaptic potentials and induces long-term facilitation and an increase 
in synaptic strength, suggesting that the UPS functions in mature neurons as an 
inhibitory constraint on synaptic strengthening (Zhao et al., 2003).  In the 
mammalian system, one of the first links between the UPS and synaptic plasticity 
demonstrate that mice lacking neuronal expression of the ubiquitin ligase E6AP, 
which is mutated in Angelman Syndrome, are prone to seizures and have 
widespread deficits in synaptic plasticity and contextual learning, along with an 
impairment of hippocampal LTP (Jiang et al., 1998; van Woerden et al., 2007; 
Yashiro et al., 2009).  Ubiquitination is also shown to control behavior and higher 
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brain functions, such as learning (Lopez-Salon et al., 2001), likely as a 
consequence of regulating synaptic plasticity.  Fear conditioning experiments in 
rats demonstrate an increase in GluA1-containing AMPARs (Rumpel et al., 2005) 
that can be augmented by pharmacological inhibition of the proteasome (Yeh et 
al., 2006).  The UPS also plays an important role in LTD, where inhibition of 
proteasomal activity is shown to reduce NMDAR- and mGluR-dependent LTD 
(Colledge et al., 2003; L. Hou et al., 2006).  Proteasomal activity is also involved 
in homeostatic synaptic regulation, with synaptic activity leading to site-specific 
increases in the ubiquitin ligase Nedd4, polyubiquitination and a reduction in cell-
surface AMPARs (Q. Hou et al., 2011).   
More direct studies examining the effects of the UPS on AMPAR 
trafficking show that pre-treatment with proteasomal inhibitors completely and 
efficiently prevent glutamate-induced receptor internalization, indicating the 
requirement of UPS-dependent protein degradation in AMPAR trafficking (Patrick 
et al., 2003).  Findings show that AMPAR activation recruits the UPS in order to 
mediate AMPAR internalization.  However, putative targets for degradation were 
believed to be proteins previously observed to interact with AMPARs, such as 
PSD-95 or other scaffolding proteins (Ehlers, 2003).  Subsequent studies confirm 
that ubiquitin-dependent changes in PSD proteins occur during in vivo learning 
paradigms.   
More recently however, my studies and others show that the mammalian 
AMPAR subunits GluA1 and GluA2 are direct targets of ubiquitination (A. Lin et 
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al., 2011; Lussier et al., 2011; Schwarz et al., 2010).  GluA1 ubiquitination is 
enhanced by glutamate but not NMDA application, indicating possible self-
regulation of AMPAR amounts following AMPAR activation (Schwarz et al., 
2010). On the other hand, an increase of synaptic activity by application of the 
GABAA antagonist bicuculline rapidly induced GluA2 ubiquitination, which is 
reversible by restoring basal neuronal activity (Lussier et al., 2011).   
5.2.1 Subcellular localization affects AMPAR subunit ubiquitination  
Interestingly, in contrast to GluA1 where ubiquitination occurs mainly on 
the cell surface (A. Lin et al., 2011),  GluA2 ubiquitination appears to occur after 
receptor endocytosis (Lussier et al., 2011).  Since GluA1 and GluA2 normally 
form heterotetramers, in future studies it will be interesting to examine what role 
this preferential ubiquitination of surface-localized GluA1 subunits versus 
endocytosed GluA2 subunits may play in determining AMPAR sorting and 
receptor fate.  It is possible that GluA1 ubiquitination may be responsible for 
activity-dependent AMPAR endocytosis and possible proteasomal degradation 
while GluA2 ubiquitination may be involved in constitutive AMPAR sorting and 
lysosomal degradation.  To address this, it would be necessary to first confirm by 
surface labeling double IPs that GluA1 and GluA2 indeed demonstrate location-
specific ubiquitination under basal and activity-dependent conditions.  A 
degradation assay combining the protein synthesis inhibitor anisomycin with 
either a lysosomal or proteasomal inhibitor could be used to determine if surface-
labeled GluA1 or GluA2 are preferentially sorted to either the lysosome or 
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proteasome.  It would also be helpful to generate a GluA2 mutant with no 
available lysine residues for ubiquitination and to compare its trafficking with that 
of the GluA1 4KR along with the respective wild-types.  Endosomal sorting of 
AMPARs remains a controversial topic, as AMPARs were previously believed to 
be targeted to lysosomes, though in recent studies other groups and I observe 
proteasome-mediated AMPAR degradation.  Clarifying the role of individually 
ubiquitinated subunits may aid in the understanding of how AMPARs are 
selected for endosomal sorting. 
5.2.2 AMPAR subunit specificity for E3 ligases 
 Substrate specificity for ubiquitination is conferred by E3 ligases.  In 
mammalian GluA1 ubiquitination, I and others identified Nedd4 as the E3 ligase 
involved (A. Lin et al., 2011; Schwarz et al., 2010).  Another group identify 
anaphase-promoting complex (APC) as another E3 ligase for AMPARs that 
targets GluA1 for proteasomal degradation (Fu et al., 2011).  However, neither 
Nedd4 nor APC are shown to be E3 ligases for GluA2 (Fu et al., 2011; Schwarz 
et al., 2010).  A distinct E3 ligase for GluA2 likely exists in order to selectively 
ubiquitinate GluA2 subunits.  Recently, the ubiquitin ligase RNF167, a member of 
the RING family of E3 ligases, has been identified as an E3 ligase for GluA2 
(Lussier et al., 2012).  It will be of particular interest to examine whether more 
than one E3 ligase targets GluA1.  As Nedd4 is a HECT domain-containing E3 
ligase, it may be possible that an E3 ligase containing a RING domain may also 
ubiquitinate GluA1 and occupy a different functional role than Nedd4 in regulating 
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GluA1.  Some future E3 ligases involved in neurological disorders that would be 
of special interest to examine include E6AP, which is involved in Angelman 
Syndrome, and parkin, which is involved in Parkinson’s Disease.   Whether these 
E3 ligases, or others, can interact with GluA1 can be addressed using 
ubiquitination assays, with Nedd4 as a positive control.   
5.2.3 GluA1 deubiquitination 
Ubiquitination is a reversible PTM.  In C. elegans, AMPAR ubiquitination 
can be reversed by the protein deubiquitination enzyme USP-46 (Kowalski et al., 
2011) and likely also AMSH (associated molecule with the SH3 domain of STAM) 
(Suzuki et al., 2011).  However, it is unknown in the mammalian system what 
deubiquitination enzyme may be specific for GluA1.  It would be of significant 
interest and importance to ascertain if either USP-46 or AMSH are capable of 
deubiquitinating ubiquitinated-AMPARs.  This question can be addressed by 
either overexpression or siRNA knockdown of USP-46 or AMSH and observation 
of the subsequent effects on GluA1 surface and total expression levels.  
Similarly, ubiquitination assays can be used to determine if there is a reduction in 
the typical ubiquitin smear when overexpressing USP-46 or AMSH. 
5.2.4 Ubiquitin chains and K868 
Although I identify the predominant site of GluA1 ubiquitination at K868, it 
is unclear what type of ubiquitin chain may be conferred at this site.  However, it 
is known that Nedd4 preferentially catalyzes K63 ubiquitination (H. C. Kim et al., 
2009).  It will be of further interest to determine whether K63 chains are indeed 
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the preferred Ub chain at K868.  To determine this, a series of ubiquitination 
assays would have to be performed using both GluA1 and ubiquitin mutants.  
Using the GluA1 wild-type as a positive control and the 4KR as a negative 
control, the F3R mutant containing an intact K868 site would be co-transfected 
with ubiquitin mutants that form linkage-specific chains, such as Ub63 and Ub48, 
to determine which linkage type is present at the K868 site. 
Considering the complexity of ubiquitin regulation and the propensity of 
ubiquitin to forms chains mediating unique cellular properties, it will be worth 
further investigation whether a sequential system of E3 ligases and 
deubiquitination enzymes co-exist to regulate AMPAR trafficking by attaching 
different ubiquitin chains to GluA1, such as a Ub63 chain for internalization, 
followed by a Ub48 chain for degradation.  Such a mechanism would have an 
expansive effect on the functional trafficking of AMPARs. 
 
5.3   Eps15-mediated internalization of ubiquitinated GluA1 
My studies show that mutation of the lysine residues at the GluA1 C-
terminal suppresses both constitutive and glutamate-induced receptor 
internalization, thus supporting a role for the direct involvement of GluA1 
ubiquitination in AMPAR internalization.  The molecular basis underlying 
ubiquitination-mediated endocytosis remains unclear.  Previous studies establish 
that AMPARs internalize through the clathrin-coated pit pathway following 
binding of the clathrin adaptor protein AP2 to the GluR C-terminus (S. H. Lee et 
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al., 2002; Man et al., 2000).  However, since ubiquitination is not shown to 
directly regulate AP2 binding, I propose that there is an adaptor that specifically 
recognizes ubiquitinated AMPARs for internalization.  I found a role for the 
adaptor protein Eps15 in ubiquitination-dependent AMPAR trafficking.   
5.3.1 Eps15 may recruit AP2 
Interestingly, although Eps15 interacts with AP2 as part of a large 
endocytotic protein machinery network, I found that the AP2 binding region of 
Eps15 is not required for GluA1 and Eps15 binding.  While previous studies have 
indicated that AP2 binding to the conserved K819 residue is critical for AMPAR 
endocytosis, these studies have primarily examined GluA2 and have not 
considered whether AP2 may actually be recruited by another adaptor protein.  
As my work demonstrates that the AP2 binding region of Eps15 is not necessary 
for Eps15-GluA1 interaction, this suggests that it may be Eps15 that recruits AP2 
to bind to AMPARs, indicating a potentially larger role for Eps15 in AMPAR 
endocytosis than previously considered.  However, it is possible that Eps15-
mediated AMPAR endocytosis is specific for activity-dependent internalization of 
ubiquitinated AMPARs while AP2 may be specific for constitutive endocytosis 
and recycling of AMPARs.  It will be of future interest to determine whether this is 
the case.  One possible method of addressing this possibility is to knockdown 
AP2 in neurons and to observe AMPAR surface expression and internalization 
under basal and activity-dependent conditions.  It would also be interesting to 
knockdown both AP2 and Eps15 and observe AMPAR trafficking to determine if 
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other potential adaptors, such as epsin, may also play a role in mediating 
AMPAR endocytosis.   
 
5.4 Future Directions 
Although new insights into the mechanisms underlying AMPAR 
ubiquitination and trafficking have been achieved, several important fundamental 
questions remain.  For instance, what role does AMPAR ubiquitination play in 
learning and memory?  As ubiquitination of AMPARs induces receptor 
internalization, this reduces the abundance of AMPARs on the postsynaptic 
membrane.  Likely, this could lead to LTD, or potentially be involved in 
homeostatic regulation.  Can synaptic activity selectively regulate ubiquitination 
of AMPARs?  Synaptosomal preparations examining the ubiquitination levels of 
cells under different synaptic activity paradigms may address this question.   
Another question is whether other PTMs, such as phosphorylation, play a 
role in promoting AMPAR ubiquitination?  Mutations of GluA1 phosphorylation 
sites to assess whether ubiquitination of these phospho-mutants occurs may 
consequently answer this question.  As phosphorylation plays an important role 
in AMPAR regulation during synaptic plasticity, its role preceding or following 
ubiquitination will be an important question to address.  Or conversely, does 
AMPAR ubiquitination promote further AMPAR PTMs, such as calpain cleavage?  
Examination of ubiquitination assays utilizing an antibody against the GluA1 N-
terminal for evidence of cleavage can be done.  It is also possible that other 
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PTMs similar to ubiquitination, such as SUMOylation or acetylation may target 
the lysine residues on AMPARs, and it may be of future interest to examine if 
such competition for ubiquitin binding sites on AMPARs may occur.  Ultimately, 
clarifying how AMPAR ubiquitination regulates AMPAR trafficking will lead to a 
further understanding of how synaptic plasticity is mediated and thus, a greater 
understanding of how higher brain functions and neurological dysfunctions are 
regulated.   
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